A systems biology perspective on the consequences of aneuploidy in human cells by Dürrbaum, Milena Rosa
 
    
Dissertation zur Erlangung des Doktorgrades  
der Fakultät für Biologie  
der Ludwig-Maximilians-Universität München 
 
 
 
A SYSTEMS BIOLOGY PERSPECTIVE ON 
THE CONSEQUENCES OF ANEUPLOIDY  
IN HUMAN CELLS  
 
 
 
 
 
 
 
 
 
Vorgelegt von 
Milena Rosa Dürrbaum 
aus 
Lörrach, Deutschland 
Dezember, 2016 
  
 
    
 
 
 
Eidesstaattliche Erklärung 
Hiermit erkläre ich an Eides statt, dass ich die vorliegende Dissertation selbstständig und 
ohne unerlaubte Hilfe angefertigt habe. Ich habe weder anderweitig versucht eine 
Dissertation einzureichen oder eine Doktorprüfung durchzuführen, noch habe ich diese 
Dissertation oder Teile derselben einer anderen Prüfungskomission vorgelegt. 
München, den Milena Dürrbaum 
Promotionsgesuch eingereicht am: 15.12.2016 
Datum der mündlichen Prüfung: 10.03.2017 
Erster Gutachter: Prof. Dr. Angelika Böttger 
Zweiter Gutachter: Prof. Dr. John Parsch
10.3.2017
 
    
 
    
List of publications  
 
Die vorliegende Arbeit wurde zwischen Januar 2013 und Oktober 2016 unter der 
Anleitung von Prof. Zuzana Storchova, Ph.D. und Dr. Bianca Habermann am Max-Planck-
Institut für Biochemie in Martinsried durchgeführt. 
 
Wesentliche Teile dieser Arbeit wurden in den folgenden Publikationen veröffentlicht: 
 
Dürrbaum M, Kuznetsova AY, Passerini V, Stingele S, Stoehr G, Storchová Z.  
Unique features of the transcriptional response to model aneuploidy in human cells.  
BMC Genomics 2014 Feb 18; 15 (1), 1–14. 
 
Donnelly N, Passerini V, Dürrbaum M, Stingele S and Storchová Z.  
HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of 
aneuploid human cells. 
The EMBO journal 2014 Oct 16; 33(20):2374-87.  
 
 
Kuznetsova AY, Seget K, Moeller GK, de Pagter MS, de Roos JA, Dürrbaum M, Kuffer C, 
Müller S, Zaman GJ, Kloosterman WP, Storchová Z. 
Chromosomal instability, tolerance of mitotic errors and multidrug resistance are 
promoted by tetraploidization in human cells.  
Cell Cycle 2015 Jul 07;14(17):2810–2820. 
  
 
    
 
    
Declaration of contributions as co-author 
 
 Dürrbaum M, Kuznetsova AY, Passerini V, Stingele S, Stoehr G, Storchová Z. 
Unique features of the transcriptional response to model aneuploidy in human cells. BMC 
Genomics 2014 Feb 18; 15 (1), 1–14. 
 
Milena Dürrbaum contributed to this work by designing and performing the transcriptome 
data analysis presented in figure 1, 2C-E, 3 and 4, table 1 and 2 as well as the 
corresponding supplementary figures and tables. Further, she performed the real-time PCR 
in figure 5. In addition, she contributed to the design and creation of figures, the 
interpretation and discussion of the results. 
 
 Donnelly N, Passerini V, Dürrbaum M, Stingele S and Storchová Z. HSF1 deficiency 
and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells. 
The EMBO journal 2014 Oct 16; 33(20):2374-87.  
 
Milena Dürrbaum contributed to this work by performing the transcriptome and proteome 
data analysis presented in figure 5 and corresponding supplementary figures. In addition, 
she contributed to the design and creation of figure 5 as well as to the interpretation and 
discussion of the results. 
 
 Dürrbaum M, Kruse C, Nieken KJ, Habermann B, Storchová Z. microRNA 
deregulation contributes to the cellular response to aneuploidy  
Manuscript in preparation 
 
Milena Dürrbaum contributed to this work by designing and performing or supervising the 
data analysis and experiments for all figures and tables. In addition, she designed and 
created all figures and tables, contributed to the interpretation and discussion of the 
results and wrote the manuscript. 
 
 Kuznetsova AY, Seget K, Moeller GK, de Pagter MS, de Roos JA, Dürrbaum M, 
Kuffer C, Müller S, Zaman GJ, Kloosterman WP, Storchová Z. Chromosomal instability, 
tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in 
human cells. Cell Cycle 2015 Jul 07;14(17):2810–2820. 
 
Milena Dürrbaum contributed to this work by performing the transcriptome analysis 
presented in figure 4E and supplementary table 1. In addition she contributed to the 
discussion of the manuscript. 
!
Milena Dürrbaum       Prof. Dr. Zuzana Storchova   Prof. Dr. Angelika Böttger 
 
  
 
    
 
 
 
 
    
Table of contents 
1! Abbreviations .............................................................................................................. 1!
2! Summary ..................................................................................................................... 3!
3! Zusammenfassung ...................................................................................................... 5!
4! Aims ............................................................................................................................ 7!
5! Introduction ................................................................................................................ 9!
5.1! The leap of big data – a new perspective on aneuploidy ............................................. 9!
5.1.1! Technological advances enable new systematic insights into biological problems .. 9!
5.1.2! A big data science perspective on aneuploidy in health and disease ..................... 14!
5.2! Routes to aneuploidy ................................................................................................ 19!
5.3! Model systems of aneuploidy .................................................................................... 24!
5.4! The “omics” landscape of aneuploid cells ................................................................. 26!
5.4.1! Effects of aneuploidy on the genome .................................................................... 26!
5.4.2! The presence of extra chromosomes affects the transcriptome and proteome ....... 27!
5.4.3! Aneuploidy affects genome-wide expression ......................................................... 28!
5.5! Physiological consequences of aneuploidy ................................................................ 30!
5.5.1! Aneuploidy affects proliferation and cell metabolism ........................................... 30!
5.5.2! Aneuploidy affects the proteostasis network ......................................................... 32!
5.6! Consequences of whole-genome doubling ................................................................ 33!
5.7! miRNAs – a new “omics” layer .................................................................................. 35!
5.7.1! Biogenesis and function of miRNAs ....................................................................... 35!
5.7.2! Association of miRNAs with aneuploidy in cancer ................................................ 37!
6! Results ....................................................................................................................... 41!
6.1! Unique features of the transcriptional response to model aneuploidy in human  
 cells ........................................................................................................................... 41!
6.2! HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of  
 aneuploid human cells .............................................................................................. 57!
6.3! microRNA deregulation contributes to the cellular response to aneuploidy .............. 73!
6.4! Chromosomal instability, tolerance of mitotic errors and multidrug resistance are  
 promoted by tetraploidization in human cells ........................................................ 107!
7! Discussion ............................................................................................................... 121!
7.1! Proteotoxic stress underlies the response to aneuploidy ......................................... 121!
7.1.1! Protein deposits and elevated autophagy as a consequence of proteotoxic stress  
 in aneuploid cells ................................................................................................ 121!
7.1.2! Proteotoxic stress might contribute to the proliferation defect of aneuploid cells 122!
7.1.3! Proteotoxic stress might affect genomic maintentance of aneuploid cells ........... 123!
7.1.4! Proteotoxic stress shapes the conserved transcriptional response to aneuploidy . 123!
7.2! Implications of the transcriptional response to aneuploidy in cancer ...................... 126!
7.3! microRNA regulation of the response to aneuploidy in human cells ....................... 127!
7.4! Tolerance to genomic instability in post-tetraploid cells and its implications in  
 cancer ..................................................................................................................... 129!
7.5! Big data in aneuploidy research – conclusions and perspective .............................. 130!
8! References ............................................................................................................... 132!
9! Acknowledgements ................................................................................................. 151!
10! Curriculum vitae ..................................................................................................... 153!
 
    
 
       
    1 
1 Abbreviations 
AGO Argonaute protein  
APC/C Anaphase-Promoting Complex/ Cyclosome  
ATM Ataxia Telangiectasia Mutated 
ATP Adenosintriphosphat 
ATR Ataxia Telangiectasia and Rad3-Related Protein 
BRAF B-Raf Proto-Oncogene 
BRCA2 Breast Cancer 2 
BUB1 Budding Uninhibited By Benzimidazoles 1 
BUB3 Budding Uninhibited By Benzimidazoles 3 
BUBR1 Budding Uninhibited by Benzimidazole-Related 1 
CCR4-NOT Negative Regulator Of Transcription 
CDC20 Cell Division Cycle 20 
CDC23 Cell Division Cycle 23 
CDC28 Cell Division Cycle 28 
CDK4 Cyclin-Dependent Kinase 4 
cDNA complementary Deoxyribonucleic Acid 
CHIP Chromatin Immunoprecipitation 
CHK1 Checkpoint Kinase 1 
CHK2 Checkpoint Kinase 2 
CIN Chromosomal Instability 
CIN70 Chromosomal Instability transcriptional signature 70 
cDNA complementary Deoxyribonucleic Acid 
DCP2 Decapping MRNA 2 
DDX6 DEAD-Box Helicase 6 
DGCR8 DiGeorge Syndrome Critical Region 8 
eIF4A Eukaryotic Translation Initiation Factor 4A 
eIF4G Eukaryotic Translation Initiation Factor 4 Gamma 
ERBB2 Erb-B2 Receptor Tyrosine Kinase 2 
ESR Environmental Stress Response 
FISH Fluorescence In Situ Hybridization 
GAL1 Galactokinase 
GIN Genomic Instability  
HBV Hepatitis B Virus  
HCV Hepatitis C Virus 
HMGA2 High Mobility Group AT-Hook 2 
HPV Human Papillomavirus 
HSF1 Heat Shock Transcription Factor 1 
HSP70 Heat Shock Protein 70kDa 
HSP90 Heat Shock Protein 90kDa 
HSPA8 Heat Shock Protein Family A (HSP70) Member 8 
iASPP Inhibitor of Apoptosis-Stimulating Protein of p53  
kb kilobase 
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KRAS Kirsten Rat Sarcoma Viral Oncogene Homolog 
LATS1 Large Tumor Suppressor Kinase 1 
LATS2 Large Tumor Suppressor Kinase 2 
MAD1 Mitotic Arrest Deficient 1 
MAD2 Mitotic Arrest Deficient 2 
p38/MAPK p38 Mitogen-Activated Protein Kinase 
MCM Minichromosome Maintenance Complex 
MDM2 Mouse Double Minute 2 
MEF Mouse Embryo Fibroblast 
MHC Major Histocompatibility Complex 
miRNA microRNA 
miRNAome microRNAome 
MPS1 Monopolar Spindle 1 
MS mass spectrometry 
MYC V-Myc Avian Myelocytomatosis Viral Oncogene Homolog 
NCBI National Center for Biotechnology Information 
NCI-60 National Cancer Institute -60 human tumor cell lines 
NGS Next-Generation Sequencing 
p53 Tumor Protein P53 
p62/ SQSTM1 62 kDa protein/ Sequestosome 1 
PABP Poly(A) Binding Protein 
PAN2 /3 PAB1P-dependent poly(A)-nuclease 2 /3 
RISC RNA-inducing Silencing Complex 
RNA Ribonucleic Acid 
RPKM Reads Per Kilobase per Million  
SAC Spindle Assembly Complex 
SILAC Stable Isotope Labeling with Amino acids in Cell culture 
SNP Single Nucleotide Polymorphism 
STAG2 Stromal Antigen 2 
TCGA The Cancer Genome Atlas 
TFEB Transcription Factor EB 
TOP Terminal Oligopyrimidine Tract  
UBP6 Deubiquitinating Enzyme 6 
UPR Unfolded Protein Response 
UTR Untranslated Region 
VHL von Hippel-Lindau tumor suppressor 
XRN1 5'-3' Exoribonuclease 1 
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2 Summary 
 Aneuploidy describes an abnormal unbalanced karyotype that has severe 
consequences for the cellular physiology and is associated with diseases such as cancer. In 
model cell lines, aneuploidy leads to impaired proliferation, disturbed proteostasis and 
specific transcriptome as well as proteome changes. Yet, the common molecular 
mechanisms underlying the response to aneuploidy are not well understood.  
 The work presented in this thesis was set out to study the response to aneuploidy 
and to elucidate the involved pathways from a systems biology perspective. We previously 
generated whole-chromosome aneuploid model cell lines with one or two extra 
chromosomes and post-tetraploid cell lines with a complex aneuploid karyotype. 
 Large-scale analysis of transcriptome data revealed that aneuploidy results in a 
conserved and distinct transcriptional response independent of the cell type, origin and 
type of aneuploidy. This response is characterized by the deregulation of similar pathways. 
In addition, we identified 23 aneuploidy markers that are similarly deregulated in a panel 
of aneuploid cell lines.  
In the second study, we found that the transcriptional response to aneuploidy is 
remarkable similar to the transcriptome changes of cells with deficient heat shock 
transcription factor (HSF1). Indeed, we demonstrated that aneuploid cells suffer from 
proteotoxic stress with compromised activity of HSF1 and reduced HSP90 folding capacity. 
Global proteome analysis uncovered that the HSP90 client proteins are downregulated and 
that the overall aneuploid proteome resembles the proteome changes after HSP90 
inhibition.  
In the third study, we demonstrated that also the microRNAome (miRNAome) is 
altered in response to aneuploidy. Integrated miRNAome, transcriptome and proteome 
analysis indicated that the deregulated miRNAome negatively affects cellular 
development, growth and proliferation in the analyzed aneuploid cell lines. Besides the 
negative effect on the aneuploid cell physiology, the commonly upregulated microRNA 
(miRNA) hsa-miR-10a-5p may positively affected the survival of aneuploid cells by 
protecting them from stress- induced shut down of ribosomal protein translation.  
In the fourth study, we followed the fate of surviving cells after whole-genome 
doubling, which is detrimental for the majority of the cells. The resulting complex 
aneuploid cells exhibit high chromosomal and genomic instability as well as a higher 
tolerance to mitotic errors. Transcriptome analysis revealed abnormalities in the p53 
pathway suggesting an underlying mechanism to the tolerance and survival of complex 
aneuploid cells.  
 Taken together, this systems biology perspective on the response to aneuploidy 
revealed common affected pathways by the deregulated miRNAome, transcriptome and 
proteome. Moreover, our results suggest that it is the proteotoxic stress, which underlies 
the conserved transcriptome and proteome changes. In addition, we show that the 
deregulated miRNAome might contribute to the previously observed proliferation defect of 
aneuploid cells. Thus, the “omics” perspective on the consequences of aneuploidy as 
presented in this thesis benefits the aneuploidy research not only by systematic and global 
comparison of the aneuploid cell physiology in many different cell lines, but also by 
identifying potential molecular mechanisms in an unbiased manner. Besides a deeper 
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understanding of the aneuploid cell physiology, the results in this thesis deliver important 
indications for new approaches in therapeutic cancer research.  
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3 Zusammenfassung 
 Aneuploidie beschreibt einen veränderten, unnatürlichen Karyotyp, welcher 
weitreichende Auswirkungen auf die Physiologie der Zelle hat. Aneuploidie tritt häufig im 
Zusammenhang mit Krankheiten auf. Das bekannteste Beispiel ist Trisomie 21, auch 
Down-Syndrom genannt, aber auch Krebszellen weisen einen aneuploiden Karyotyp auf. 
In Modellsystemen führt Aneuploidie zu beeinträchtigter Zellproliferation, gestörter 
Proteostase und spezifischen Veränderungen des Transkriptoms und Proteoms. Die 
zugrundeliegenden Mechanismen für diese Auswirkungen von Aneuploidie sind jedoch 
nicht völlig verstanden. 
 Die vorliegende Arbeit hatte zum Ziel die Konsequenzen von Aneuploidie 
systembiologisch zu untersuchen und die involvierten Signalwege aufzuklären. Hierfür 
wurde in vorangegangenen Forschungsarbeiten sowohl aneuploide Zelllinien mit einem 
oder zwei zusätzlichen Chromosomen, sowie Zelllinien mit einem komplexen aneuploiden 
Karyotyp generiert. 
 Transkriptom Datenanalysen zeigten, dass Aneuploidie zu konservierten 
Veränderungen des Transkriptoms führt, unabhängig von dem Zelltyp, des Ursprungs oder 
der Art der Aneuploidie. Charakteristisch für diese Transkriptomveränderungen ist die 
Deregulation gleicher zellulärer Signalwege. Zusätzlich konnten wir 23 Aneuploidiemarker 
identifizieren, welche die gleiche Deregulation in einer Reihe von aneuploiden Zelllinien 
zeigten.  
In der zweiten Studie fanden wir heraus, dass die Transkriptionsveränderungen in 
aneuploiden Zellen ähnlich zu den Veränderungen von Zellen mit defektem Hitzeschock 
Transkriptionsfaktor (HSF1) sind. Tatsächlich konnten wir zeigen, dass aneuploide Zellen 
unter proteotoxischem Stress stehen und beeinträchtigte HSF1 Aktivität sowie reduzierte 
HSP90 Proteinfaltungskapazität aufweisen. Proteomanalysen zeigten zudem, dass HSP90 
Klientenproteine nach unten reguliert sind und das gesamte aneuploide Proteom dem der 
HSP90 Inhibition gleicht.  
In der dritten Studie demonstrierten wir, dass auch das miRNAom in aneuploiden 
Zellen verändert ist. Analysen von miRNAom, Transkriptom und Proteom wiesen darauf 
hin, dass das deregulierte miRNAom die zelluläre Entwicklung, Wachstum und 
Proliferation negativ beeinträchtigt. Abgesehen davon, scheint die in der Mehrheit der 
aneuploiden Zelllinien hoch regulierte hsa-miR-10a-5p die Zellen vor Stress-induzierter 
Abschaltung der Translation ribosomaler Proteine zu schützen.  
In der vierten Studie charakterisierten wir überlebende Zellen nach einer 
zelltoxischen Genomduplikation. Die resultierenden komplex-aneuploiden Zellen wiesen 
eine hohe chromosomale und genetische Instabilität, sowie Toleranz für mitotische Fehler 
auf. Transkriptomanalysen zeigten Abnormalitäten im p53 Signalweg, was auf den 
zugrundeliegenden Mechanismus des Überlebens dieser Zellen hinweist. 
 Durch unsere systembiologische Perspektive auf die Konsequenzen von 
Aneuploidie fanden wir heraus, dass gleiche Signalwege durch die Deregulation von 
miRNAom, Transkriptom und Proteom betroffen sind. Zudem legen unsere Resultate nahe, 
dass der proteotoxische Stress den konservierten Veränderungen von Transkriptom und 
Proteom zugrunde liegt. Des Weiteren zeigten wir, dass das deregulierte miRNAom 
möglicherweise zu dem Proliferationsdefekt aneuploider Zellen beiträgt. Die in der 
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vorliegenden Arbeit beschriebene „omics“ Perspektive auf die Konsequenzen von 
Aneuploidie trägt nicht nur durch systematische und globale Untersuchung der 
aneuploiden Zellphysiologie zum Verständnis von Aneuploidie bei, sondern auch durch die 
unvoreingenommene Identifizierung potentieller molekularer Mechanismen. Neben dem 
vertieften Verständnis für die aneuploide Zellphysiologie, liefert diese Forschungsarbeit 
neue Ansatzpunkte für die therapeutische Krebsforschung. 
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4 Aims 
 Aneuploidy describes an abnormal karyotype and is detrimental for cell physiology. 
The aneuploid karyotype is highly variable as structural and numerical aneuploidy can 
occur and may affect different chromosomes to a different extent. Yet, the observed 
phenotypes in aneuploid model cell lines appear remarkably similar. This suggests that the 
molecular determinants of the physiological response are common to the majority of 
aneuploid cells. In this thesis, I set out to identify the common determinants of the 
response to aneuploidy by applying in-depth analysis of transcriptome, proteome and 
microRNAome data to multiple different aneuploid model cell lines. 
 First, I asked whether there is a similarity in the transcriptional response to 
aneuploidy among different cell lines, different chromosomes and different origins of 
aneuploidy. To address this question, we acquired transcriptome data of human aneuploid 
model cell lines previously generated in our research group. In addition, I used publicly 
available transcriptome data from model aneuploid cell lines generated in other 
laboratories. To uncover similarities and differences in the transcriptional response to 
aneuploidy, I systematically analyzed and compared the aneuploid transcriptomes. To 
elucidate the triggers of the global gene expression changes, I compared the 
transcriptional response to aneuploidy to transcriptional changes in response to various 
cellular stresses. 
 Second, we addressed the hypothesis that the presence of additional chromosomes 
affects cellular proteostasis. To test this hypothesis, we investigated the capacity of 
aneuploid cells to fold proteins under normal and stress conditions. We further 
determined the molecular cues of the compromised proteostasis in aneuploid cells. To 
elucidate the effects on the proteostasis network from a systems perspective, I analyzed 
the large-scale transcriptomics and proteomics datasets available in our laboratory.  
 Third, we investigated another category of post-transcriptional regulators of the 
response to aneuploidy – miRNAs. We hypothesized that the observed global gene 
expression changes as well as the molecular and phenotypic consequences of aneuploidy 
might be at least partially governed by miRNA regulation. To gain a comprehensive insight 
into the miRNA-target landscape in aneuploid cells, we sequenced miRNAs as well as 
mRNAs and combined this dataset with previously derived proteome data. I performed 
sequencing data analysis and compared the miRNA deregulation of different aneuploid 
cell lines to identify similarities and differences in response to various types of aneuploidy. 
To unravel the contribution of miRNAs to the cellular response to aneuploidy, I performed 
integrated analysis of miRNA and their target mRNA and protein expression levels. 
 The fourth aim was to analyze the long-term consequences of tetraploidy that often 
results in high genomic instability and complex aneuploidy. Since high rates of genomic 
instability are lethal to tetraploid cells, we hypothesized that the rare surviving cells have 
evolved mechanisms to tolerate genomic instability. Therefore, we followed the fate of 
rare tetraploid surviving cells and monitored their mitotic efficiency and fidelity. Further, 
we analyzed the levels and proficiency of the key factors that could restrict cell cycle 
progression. Finally, to gain a systems perspective on compromised pathways, I performed 
in-depth analysis of the transcriptome of post-tetraploid cells.  
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5 Introduction 
5.1 The leap of big data – a new perspective on aneuploidy 
5.1.1 Technological advances enable new systematic insights into biological problems 
Cells are the smallest entities of life and although diverse in function and 
appearance, share common properties: the information of the building blocks of a cell is 
encoded in the DNA as genes, the transcripts of these genes are stored in RNA molecules 
and the translated building blocks of a cell are composed of proteins. In a human cell, the 
DNA encodes for approximately 20,000 genes (Pertea and Salzberg, 2010). From these 
genes, up to 16,000 protein-coding RNA molecules and more than 10,000 proteins can be 
detected in human cells (Nagaraj et al., 2011). The entire complexity of a cell might be 
orders of magnitudes higher. For instance, protein modifications, diverse subcellular 
locations and assembly to different complexes resulting in differential functions of a 
protein add an additional complexity (Harper and Bennett, 2016). Moreover, the 
functionality of a cell is intrinsically determined by the differential gene expression and 
the different protein levels. Therefore, differences in the composition of all mRNAs 
(transcriptome) and all proteins (proteome) of a cell, but also the quantitative levels of 
mRNAs and proteins give important insights into the cellular state and the differences for 
example between tissue cells or health and disease states. Nowadays, technological 
advances accelerate our understanding of the cellular system in health and disease. Yet, 
the ever increasing amount, but also the complexity of the biological data bears a major 
challenge to researchers and the term “big data” has entered biological science (Check 
Hayden, 2015). 
Big data science is characterized by the same properties as big data in other areas. 
That is, big data does not only refer to a growing amount of information, but also 
indicates a wide variety of the data types and a high velocity at which the information is 
gathered (Gandomi and Haider, 2015). Depending on the field the definitions slightly 
differ and sometimes include characteristics of big data analytics such as cross-relation of 
the information types in order to generate new information. For example in market 
research, cross-relation of data from social networks, tweets and blogs with consumer 
product preferences allows to assess the target group needs and to optimize business 
strategies. In big data science, the thousands of molecules in a biological system, such as 
the cell, make up the volume of information. Moreover, the state of these molecules, for 
example the phosphorylation state of a protein, adds an additional layer to the data 
complexity and makes up the variety of the data that can be gathered from a cell. Cross-
relation of the information types, such as the expression of RNA and the level of the 
corresponding protein generates new information similar as in the market research 
example.  
In summary, the mass of DNA (genome), RNA (transcriptome) and proteins 
(proteome) and also the low molecular weight components (metabolome) describe a 
biological cell from a holistic view- the “omics” perspective (Figure 1). To gain an “omics” 
perspective of a cell, simultaneous measurement of thousands of molecules is required. 
Nowadays, high-throughput technologies such as next-generation sequencing (NGS) and 
Introduction – The leap of big data – a new perspective on aneuploidy 
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mass spectrometry allow qualitative and quantitative analysis of the “omics” of a cell at 
reduced time and cost.  
Figure 1. The “omics” perspective of a cell. The DNA, packed in chromosomes, encodes the 
majority of the genes of a cell. In genomics, the DNA is analyzed by next-generation sequencing. 
Genes are transcribed into RNA. In transcriptomics, the quantity and quality of RNA molecules is 
measured by next-generation sequencing. RNA molecules are translated into proteins. In 
proteomics, all proteins of a cell are measured by mass spectrometry. For instance performing mass 
spectrometry on an Orbitrap results in mass over charge mass spectrometry spectra. In addition, 
new “omics” fields emerged. For instance, the measurement of the metabolites of a cell by mass 
spectrometry. 
Technological advances in genomics and transcriptomics 
The essential method to assess the genome or transcriptome of a cell is DNA 
sequencing. The sequencing methods have been rapidly advancing in the last ten years, 
largely fueled by the Human Genome Project that was completed in 2003. The human 
genome was first fully sequenced by the Sanger chain termination sequencing method 
described in 1977. Even though Sanger sequencing evolved for instance by capillary 
electrophoresis systems, the required cloning steps and the low parallelization limited the 
speed and accuracy of this sequencing method (reviewed in (Mardis, 2013)). This 
limitation promoted the development of NGS methods. The advances of NGS over Sanger 
sequencing is best illustrated by the fact that whereas the Human Genome Project took 15 
years for its completion with Sanger sequencing, the Illumina next-generation sequencer 
released in 2014 sequences 45 genomes in one day (Illumina, 2016). The introduction of 
NGS platforms has also revolutionized transcriptome profiling. Before NGS sequencing 
became broadly available, microarrays were the tool of choice for the quantification of 
RNA molecules. However, microarrays are limited by the extent of known RNA molecules, 
which are hybridized on an array, as well as by the dynamic detection range (Wang et al., 
Introduction – The leap of big data – a new perspective on aneuploidy 
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2009b). In NGS-based transcriptome profiling, the RNA molecules are reverse transcribed 
to cDNAs that can be sequenced with the same methods as DNA. 
A number of different NGS platforms exist today that differ in their sequencing 
approach and therefore also in the possible sequence length, error rate, speed and 
application range (reviewed in (Mardis, 2013; Goodwin et al., 2016)). One of the widely 
used sequencing systems is the Illumina system that belongs to the group of short read 
next-generation sequencers. In short read sequencing approaches the DNA or cDNA is 
fragmented and the fragments are ligated to universal adapters that allow amplification 
and later sequencing. The fragments are immobilized by adapter hybridization to linkers 
that are covalently attached to either beads or a solid surface. Amplification of the 
fragments creates clusters of each single DNA fragment amplifying the sequencing signal 
for the sequencing step. The two major methods for short read sequencing of genomes or 
transcriptomes are sequencing by ligation and sequencing by synthesis. The latter is 
employed on Illumina platforms and involves DNA polymerase and step-wise 
incorporation of nucleotides into a complementary elongating strand. The identity of the 
incorporated nucleotide is read out by ion concentration or fluorophore release. This 
method allows low and high coverage sequencing of genome and transcriptome as well as 
exome-sequencing, chromatin immunoprecipitation (CHIP) and DNA methylation 
sequencing. While the accuracy rate is above 99.5%, the major drawback is the increasing 
error rate with increasing read length. In third generation sequencers this major limitation 
of short read sequencers is overcome by new sequencing approaches such as in the 
nanopore sequencer (Munroe and Harris, 2010). After the sequencing step, the sequence 
of each fragment has to be mapped to a reference genome or assembled to the original 
DNA or RNA.  
Sequencing of DNA or cDNA reveals the sequence identity of the genome or 
transcriptome of an analyzed sample. For example, mapping the reads to a reference 
genome can identify structural variations. Moreover, if the read depth is high enough, 
single nucleotide polymorphisms can be identified. It should be noted that DNA 
microarray technologies are still widely used for the identification of common 
polymorphisms or known structural variations. In addition to qualitative measurements, 
NGS methods allow also the quantification of the sequenced molecules, i.e. RNAs. In this 
case, sequenced reads are mapped to a reference genome. The number of reads that map 
to a transcript is linearly related to its abundance in the cell. Since the number of reads 
scales also with transcript length, normalization to length and total number of mapped 
reads resulting in reads per kilobase (kb) of transcript per million mapped reads (RPKM) 
is widely applied (Mortazavi et al., 2008). With the advances of sequencing technologies 
also the data analysis strategies such as correction for technical and biological variability 
and statistical testing have evolved. For instance, systematic variability between the 
sequencing runs and between library preparations of different samples has to be 
accounted for (Marioni et al., 2008; Bullard et al., 2010). While technical variability can 
be modeled by Poisson distribution, the variability between biological replicates would be 
underestimated by the Poisson model (Anders and Wolfgang, 2010). Therefore, to test 
whether a difference in read count is greater than expected by random variation a 
binominal distribution is employed to model the variance. Since the number of biological 
replicates is small in most of the sequencing studies, methods such as DeSeq2 (Love et al., 
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2014) overcome this limitation by pooling information about the variances of different 
genes with the same read count. Applying these normalization and dispersion estimate 
methods to the raw read counts enables quantification of the RNA molecule levels in a 
sample. Thus, novel normalization methods have been developed in parallel to sequencing 
techniques allowing nowadays a robust quantification of genome and transriptome. 
Technological advances in proteomics 
Proteins execute structural, as well as enzymatic and signaling functions in the cell. 
They are biochemically diverse and dynamic by nature, differing not only in the amino 
acid sequence, but also in their secondary, tertiary and quaternary structures. Profiling of 
the identity and quantity of almost all proteins in a cell can be achieved by high-resolution 
mass spectrometry based proteomics. The most widely used approach is the “bottom-up” 
approach, in which proteins of a sample are digested into short peptides. The identity of 
each peptide is determined by mass spectrometry and used to reassemble the proteins. To 
deconvolute the complex peptide mixture a chromatographic separation is employed 
before the mass spectrometric analysis. For the peptide identification in the mass 
spectrometer, mass-over-charge ratios of molecules are determined. To this end, the 
Orbitrap mass analyzer is frequently used where ions are trapped on orbital trajectories 
along a spindle-form like electrode. Their oscillation frequency solely depends on the m/z 
(m = mass; z = charge) and is recorded as an induced current in two outer electrodes. 
While the frequency provides information on the identity of the ion, the amplitude of the 
induced current indicates the amount of that ion. In a complex protein sample, peptides 
with similar masses but different amino acid sequences exist. Therefore, peptides are 
fragmented (MS2 or tandem MS) and the exact sequence is determined based on the 
fragment masses. The combined information of the full ion MS1 spectra and the 
fragmented ion MS2 spectra facilitates the bioinformatic identification (via search engines 
like Mascot and Andromeda) of the peptides from which the abundance of individual 
proteins are calculated. 
Mass spectrometry can be used to quantify the protein abundance (reviewed in 
(Aebersold and Mann, 2003; Cox and Mann, 2011)). One of the most frequent approaches 
is stable isotope labeling in cell culture (SILAC). This involves incorporation of a heavy 
isotope labeled arginine or lysine into one condition, which has similar biochemical 
properties as the light isotope labeled amino acids that are incorporated into the other 
condition. Subsequently, the samples are pooled and subjected to MS where they can be 
distinguished by the mass over charge offset in the MS1 spectrum. The relative 
abundances between the treated and untreated conditions are determined by peak 
intensities. With a state of the art mass spectrometer and bioinformatics data analysis 
pipeline, it is possible to measure more than hundred thousand different peptides 
including their posttranslational modifications. This allows the identification and 
quantification of over 10,000 proteins in cellular systems and has hugely contributed to 
our understanding of living organism since its broader application in recent years. 
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Big data science complexity 
The technological advances in the fields of genome, transcriptome and proteome 
profiling results in vast amounts of information. The majority of the data is accessible for 
researchers in public databases such as the NCBI Human Genome Resources 
(https://www.ncbi.nlm.nih.gov/genome/), NCBI Gene Expression Omnibus 
(https://www.ncbi.nlm.nih.gov/geo/) or The Human Proteome Atlas 
(http://www.proteinatlas.org/). Previously it used to be challenging to acquire the data; 
today’s challenge is to make sense of the data: to analyze, integrate, visualize and 
communicate the findings buried in numerous data sets. This is best exemplified with the 
international cancer genome sequencing efforts such the “International Cancer Genome 
Consortium” and the component of it, the “The Cancer Genome Atlas” (TCGA) Project of 
the U.S. National Cancer Institute (https://cancergenome.nih.gov/). One of the goals of 
these projects, to fully catalogue cancer genomes and common genomic alteration, has 
been reached. With the announced completion, nearly 10 million cancer-related mutations 
could be catalogued by 2015 (Ledford, 2015). However, the hope that this would provide 
the ultimate understanding of cancer has not been fulfilled. Instead, the sequencing 
projects uncovered a much higher complexity of the genomic alterations than ever 
anticipated. For instance, intra- and inter-tumor heterogeneity, tumor subtype specificity 
and driver versus passenger mutations complicate a clear picture of the cancer landscape 
(Vogelstein et al., 2013). Thus, the analysis of the generated data is one of the major 
challenges of scientists nowadays (Adams, 2015). Moreover, the effects on cellular 
pathways must be anticipated in order to understand the biological relevance of certain 
mutations. Therefore, integration with other “omics” data such as proteomics and 
metabolomics is necessary to interpret the impact of genomic alterations in cancer. In 
addition, clinical data will help the transition from knowledge to clinical application. For 
example, correlation of certain mutation types with a population subgroup helps to 
individualize the treatment. Along these lines, an additional challenge lies in the 
communication of the information on cancer genome alterations to the clinic. 
Bioinformatics tools to visualize the information, user interfaces to easily access and filter 
the data are therefore indispensable.  
In summary, progress in high-throughput technologies to sequence genome and 
transcriptome as well as measure protein levels has accelerated the information gathered 
about complex biological systems, such as the human genome or a cancer cell. 
Understanding the relevance of the information and setting the information into the 
biological context remains a challenge to researchers. 
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5.1.2 A big data science perspective on aneuploidy in health and disease 
Technological advances of high-throughput sequencing methods facilitate not only 
the detection of sequence aberrations such as variations smaller than 1 kb (e.g. single 
nucleotide polymorphisms (SNPs) or small indels), but also structural variations ranging 
from 1 kb to several mega base pairs (e.g. insertions, deletions, inversions, translocations 
as well as copy number variations (Feuk et al., 2006; MacDonald et al., 2013)). Moreover, 
it is nowadays possible to infer copy number variations as large as a chromosome arm or 
even gain or loss of a whole 
chromosome, since specialized 
algorithms retrieving this 
information from DNA 
sequencing data have been 
developed in the last years (for 
example (Bao et al., 2014; Holt 
et al., 2014)). Large-scale 
genome alterations are also 
referred to as aneuploidy. 
Whereas whole-chromosome 
aneuploidy refers to gain or loss 
of entire chromosomes, 
segmental aneuploidy describes 
alterations in chromosomal 
regions such as a chromosome 
arm and structural aneuploidy 
stems from copy number 
variations (Figure 2). The ability 
to detect aneuploidy in a fast, 
reliable and cost effective 
manner has become important 
because of their detrimental 
effects for human development 
and the association with cancer 
and neurodegenerative diseases.  
Constitutional aneuploidy in humans 
In a multicellular organism, aneuploidy can either affect all cells, so called 
constitutional aneuploidy, or a subset of the cells, called somatic aneuploidy. In case of 
constitutional aneuploidy, aneuploidization occurs during the germ development 
(reviewed in (MacLennan et al., 2015)). In addition, mitotic errors during early 
embryogenesis result in mosaic aneuploidy with intermixed diploid and trisomic cells that 
are for example commonly observed in trisomy 21 patients (reviewed in (Papavassiliou et 
al., 2014)). Estimated 10-30% of fertilized oocytes harbor an abnormal copy number and 
Figure 2. The different types of aneuploidy. Whereas 
the diploid karyotype is balanced, the unbalanced 
aneuploid karyotype is characterized by either 
numerical or structural chromosome changes. Whole- 
chromosome aneuploidy describes the gain or loss of 
one or more chromosomes. Segmental aneuploidy 
describes the deletion, amplification or unbalanced 
translocation of chromosome segments. Complex 
aneuploidy is characterized by complex segmental 
changes of different chromosomes, often combined with 
numerical chromosome changes. 
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the percentage increases with maternal age in humans (MacLennan et al., 2015). In 
addition, in vitro fertilized embryos have high rates of chromosomal aneuploidy. 
Aneuploidy is the leading cause of spontaneous miscarriages and only gain of a copy of 
chromosome 13, 18, 21, X and Y or loss of chromosome X or Y are compatible with a 
viable birth. Due to the severe developmental defects, only approximately 10% of children 
with trisomy 13 (Patau syndrome) or trisomy 18 (Edwards syndrome) survive to one year 
after birth (Rasmussen et al., 2011). Individuals with trisomy of chromosome 21, also 
known as Down syndrome, survive until adulthood, but suffer from multiple defects such 
as intellectual disability, increased rates of congenital heart disease, epilepsy and acute 
leukemia (Asim et al., 2015).  
To improve the success of fertilization, prenatal or pre-implantation screening of 
embryos for aneuploidy is offered. Prenatal screening has greatly benefited from continued 
improvements of NGS technologies. Noninvasive prenatal screening methods subject cell 
free fetal DNA in the maternal blood to massive parallel shotgun sequencing, where the 
number of sequences mapping to maternal chromosomes versus cell free DNA is predictive 
of aneuploidy (Gregg et al., 2014; Rink and Norton, 2016). Other screening methods such 
as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization 
are being replaced by NGS techniques (Fiorentino et al., 2014; Zheng et al., 2015). 
Comparative analysis of the methods proved high concordance and enhanced precision for 
the sequencing methods, thus paving their way for routine clinical application. 
Somatic aneuploidy in humans 
Whereas constitutional aneuploidy is detrimental for life, somatic aneuploid cells 
were identified in the liver and brain of healthy individuals (Duncan et al., 2012a). 
Indeed, the percentage of aneuploid hepatocytes ranges from one third to one half in 
healthy liver samples. Studies in mice and human suggest that hepatocytes become 
polyploid during early postnatal development and some cells subsequently become 
aneuploid through aberrant mitosis and chromosome missegregation (Margall-Ducos et 
al., 2007; Duncan et al., 2010; 2012a). In this context aneuploidy seems to be beneficial. 
One hypothesis poses that aneuploid cells allow phenotypic variability and increase the 
adaptive potential of liver tissue to chronic injury or metabolic stresses (Duncan et al., 
2012a). Similarly, aneuploidy was detected in the human developing brain tissue and 
across adult brain tissue in non-neuronal cells and mature neurons by spectral karyotyping 
or FISH (Rehen, 2005; Yurov et al., 2007; Pack et al., 2014). Surprisingly, only 2.2% and 
4% of aneuploid cells were detected in the human brain and in human hepatocytes, 
respectively, using single cell NGS, a method that determines whole chromosome 
aneuploidy and complex aneuploidy in somatic cells in an unbiased manner (Knouse et al., 
2014). The authors attribute the deviations between the results from single cell 
sequencing and previous reports to the frequent artifacts in FISH assays. Nevertheless, 
high rates of structural aneuploidy and copy number variations can be identified in 
neurons (Cai et al., 2014). Thus, the higher resolution of genome-wide sequencing 
compared to classical approach such as FISH suggests that while somatic whole-
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chromosome aneuploidy is not as widespread as previously assumed, large structural copy 
number variations occur frequently in neurons.  
Aneuploidy in ageing and neurodegeneration 
Besides these instances of somatic aneuploidy in healthy tissue, aneuploidy has 
been associated with declining cellular fitness and ageing. Evidence comes from mouse, 
where the ageing is associated with increased incidence of aneuploidy in the brain 
(Faggioli et al., 2012). Further, mouse models of the mutant spindle assembly checkpoint 
protein BUBR1 that leads to high chromosome missegregation rates develop aneuploidy. 
These mice develop premature ageing-associated phenotypes such as short lifespan, loss of 
subcutaneous fat, impaired wound healing and vascular ageing (Baker et al., 2004; 
Matsumoto et al., 2007). Concordantly, overexpression of BUBR1 preserves genomic 
stability and extends lifespan in mice (Baker et al., 2012). Whether aneuploidy is a 
passenger of the ageing process due to defects in genome maintenance or whether 
aneuploidy plays an active role is not completely understood. Interestingly, increased 
aneuploidy is often observed in Alzheimer´s disease, as FISH analysis revealed high rates 
of aneuploidy of chromosome 11, 17, 18, 21 and X with a prevalence for chromosome 21 
and X (Iourov et al., 2009; Yurov et al., 2014). Intriguingly, the amyloid precursor protein 
(APP) that has a pivotal role in Alzheimer´s disease is encoded on chromosome 21. 
Overexpression of APP leads to increased levels of neurotoxic amyloid peptide Ab42 that is 
associated with plaque formation in Alzheimer’s disease. Aneuploidy of chromosome 21 
may therefore promotes this disease. Yet, single cell NGS did not confirm higher rates of 
aneuploidy in 893 neurons derived from 10 individuals with Alzheimer´s disease (van den 
Bos et al., 2016). Despite these recent results, the fact that the majority of individuals with 
Down syndrome are diagnosed with an early onset Alzheimer´s disease by the age of 40 
(Gardiner et al., 2010) hints to an association of trisomy of chromosome 21 and 
Alzheimer´s disease or impaired neuronal function. Further NGS and functional studies on 
a larger cohort will be necessary to elucidate the exact association between aneuploidy 
and ageing as well as neurodegenerative diseases. 
Aneuploidy and cancer 
 Already a century ago, Theodor Boveri postulated that unbalanced chromosome 
numbers might contribute to malignant tumor development (Boveri, 1914). His hypothesis 
has gained significant experimental support recently and aneuploidy is nowadays 
considered a hallmark of cancer (Sheltzer and Amon, 2011). Primary evidence stems from 
cytogenetic studies of patient derived tumor samples revealing that 90% of solid tumors 
and 70% of blood cancers show some degree of aneuploidy (Weaver and Cleveland, 2006; 
Mitelman et al., 2016). Although cytogenetic techniques are widely applicable in hospital 
settings, their low resolution limits the detection of structural aneuploidy. The complex 
landscape of somatic copy number variations in cancer has been revealed by high-
throughput methods such as SNP-Arrays and NGS. On average as much as 25% of each 
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genome is affected by somatic copy number variations of a whole chromosome arm in an 
analysis of 3131 cancer samples by SNP arrays (Beroukhim et al., 2014).  
The role of aneuploidy in tumorigenesis is not entirely clear. One central question 
is, whether aneuploidy is a driver of tumor development or arises as a side effect of the 
relaxed checkpoints and increased instability. From an “omics” perspective, this question 
has been tackled by identifying the relation between copy number variations and well-
known tumor suppressors or oncogenes, as well as by studying the evolutionary timeline 
of aneuploidy in cancer. Large-scale analysis of copy number variations in cancers found 
33% of amplifications associated with validated oncogenes such as MYC, Cyclin D1, CDK4 
and KRAS. Additionally, 11% of deletions were found in regions with tumor suppressor 
genes (Beroukhim et al., 2014). This suggests that at least a subset of copy number 
alterations might have a causal role in tumorigenesis by affecting the expression of 
oncogenes and suppressors. For this analysis, only experimentally validated oncogenes and 
tumor suppressors have been explored. Yet, new data analysis methods can predict new 
drivers and suppressors by the analysis of somatic mutation patterns across large numbers 
of cancers (Davoli et al., 2013). Therein, the analysis of 8,200 tumor samples estimated 
320 suppressors and 250 oncogenes. Intriguingly, the distribution and potency of these 
drivers and inhibitors of tumorigenesis is predictive for the pattern of aneuploidy observed 
in a range of tumor samples (Davoli et al., 2013; Zack et al., 2013). The potency of a gene 
to support or impair tumor development might pose a selective pressure for a gain or loss 
of the associated genomic region. Thus, aneuploidy might promote tumor development by 
affecting the gene copy numbers of drivers and suppressor.  
Tumor development is driven by clonal evolution defined by acquisition of genetic 
variations and natural selection for beneficial traits (Stratton et al., 2009). However, the 
largely heterogeneous tumor cells hamper the evolutionary study of aneuploidy in cancer. 
Single-cell sequencing has advanced the study of tumor evolution and gives also insights 
into the occurrence of aneuploidy during tumor development. Copy number profiling of 
100 single cells by NGS revealed defined aneuploid subpopulations within the tumor mass 
(Navin et al., 2011). Interestingly, the aneuploid subpopulation has separated in early 
tumor development from the diploid subpopulation based on chromosome breakpoint 
phylogeny analysis. Recent single-cell sequencing results further support the view that 
aneuploidy occurs early in tumor development and that mutations accumulate gradually, 
but account for the genetic diversity (Wang et al., 2015). While these results suggest that 
aneuploidy rather develops early in tumorigenesis, the complexity of aneuploidy and the 
rate by which aneuploidy changes, termed chromosomal instability (CIN), correlates with 
tumor aggressiveness (Carter et al., 2006; Birkbak et al., 2011). Indeed, elevated 
expression of a gene group that correlates with aneuploidy and CIN is sufficient to predict 
poor prognosis (Carter et al., 2006; Birkbak et al., 2011). In summary, compelling 
evidence indicates that aneuploidy is not a mere passenger of tumorigenesis, but causally 
contributes to tumor development and malignancy. 
The manifold occurrences of aneuploidy in health and disease illustrate that the 
impact of aneuploidy on cell physiology and ultimately on cellular fitness is largely context 
dependent. Constitutional aneuploidy is detrimental for development, whereas somatic 
aneuploidy is found in both healthy cells and disease states. On one hand, aneuploidy 
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might serve as a source for genetic variation that allows faster adaptation to adverse 
condition, hence providing a selective advantage. For example, aneuploidy in liver was 
suggested as a mechanism to rapidly adapt to chronic live injury in mice (Duncan et al., 
2012b). Similarly, aneuploid cancer cell lines are more tolerant to stress conditions 
(Rutledge et al., 2016). On the other hand, studies in various aneuploid model systems 
demonstrate that aneuploidy itself is largely detrimental for cells. To understand the 
context dependent effects of aneuploidy, it is essential to gain an in-depth knowledge of 
the molecular consequences of aneuploidy per se. Aneuploidy can occur in many variations 
affecting different chromosomes and genomic regions. Therefore, high-throughput system 
biology approaches allow the parallel and holistic study of diverse aneuploidy types and 
careful analysis of the data allows deducing the common consequences of aneuploidy on 
the cell physiology. 
Introduction – Routes to aneuploidy 
19 
5.2 Routes to aneuploidy 
To maintain a balanced karyotype, faithful segregation of the duplicated 
chromosome sets to the two daughter cells is crucial. Abnormalities in the karyotype in 
form of whole chromosome aneuploidy originate mainly from errors in chromosome 
segregation. At the beginning of mitosis accurate chromosome segregation is initiated by 
separation of centrosomes, the microtubule organizing centers of the cell and by nuclear 
envelope breakdown (Magidson et al., 2011). Each of the sisters of the chromatid pair that 
is held together by sister chromatid cohesion attaches via its kinetochore to microtubules 
nucleating from the centrosomes, thereby forming a bipolar mitotic spindle (Figure 3A). In 
order for each chromatid to be pulled to opposite sides of the cell, each kinetochore must 
attach to microtubules emanating from opposite centrosomes. Only if correct kinetochore-
microtubule attachments are established, the mitotic spindle assembly checkpoint (SAC) 
allows separation of the chromatids to opposite spindle poles. 
Figure 3. Causes of aneuploidy. A Normal, bipolar mitotic spindle. B Causes of chromosome 
missegregation include abnormal mitotic spindle formation. This can be the result of monotelic, 
syntelic and merotelic microtubule-kinetochore attachments. In addition, multipolar spindle 
geometry and premature separation of sister chromatids results in chromosome missegregation. C 
Aneuploidy may derive from a tetraploid intermediate. Causes of tetraploidy include fusion of two 
cells or failure of cytokinesis.  
Aneuploidy through chromosome missegregation 
Chromosome missegregation mainly stems from abnormalities in mitotic spindle 
formation and subsequent bypass or failure of the mitotic checkpoint. In case of a single 
unattached kinetochore (monotelic attachment, Figure 3B) the SAC core components of 
the mitotic checkpoint proteins MAD1, MAD2, BUB1, BUB3, BUBR1, Aurora B and MPS1 
are recruited to the unattached sites (Heinrich et al., 2013). Two sister kinetochores 
attached to microtubules originating from the same centrosome (syntelic attachment, 
Figure 3B) are sensed by the chromosomal passenger complex that, via the activity of 
Aurora B kinase, destabilizes mal-attachments, thus facilitating correction and at the same 
time creating unattached kinetochores, which in turn trigger the recruitment of mitotic 
checkpoint proteins (reviewed in (Nezi and Musacchio, 2009; Wang et al., 2014)). As a 
result the co-activator CDC20 of the anaphase-promoting complex / cyclosome (APC/C) is 
inhibited and the mitotic progression is delayed. Recent data suggests that the protein 
abundances are critical to maintain a functional checkpoint as the reduction of MAD2 and 
MAD3 (BUBR1) to 60-30% of the normal abundance noticeably weakens the SAC function 
in fission yeast (Heinrich et al., 2013). Thus, depletion of one of the checkpoint 
components such as one MAD2 allele in human colorectal cancer cell lines (Michel et al., 
Introduction – Routes to aneuploidy 
20 
2001) or BUBR1 deletion in HeLa cells (Lampson and Kapoor, 2004) or mice (Jeganathan 
et al., 2007) is sufficient to compromise the mitotic checkpoint. Moreover, mutations of 
SAC components have been associated with increased rates of chromosome missegregation 
in cancer (Li and Benezra, 1996; Cahill et al., 1998; Percy et al., 2000; Wang et al., 2000; 
2002; Kim et al., 2005). Increased rates of chromosome missegregation might also explain 
why offsprings of mice with heterozygous knockout of Mad1 or Mad2 show higher 
incidences of spontaneous tumors (reviewed in (Giam and Rancati, 2015)). In addition, 
mutations in BUBR1 have been associated with the mosaic variegated aneuploidy 
syndrome that is characterized by CIN, mosaic aneuploidy and predisposition to childhood 
cancer. Thus, an impaired SAC should be in principle sufficient to drive aneuploidy and 
cancer development.  
Although an impaired SAC induces aneuploidy, sequencing of cancer cell lines and 
tumor tissues revealed that SAC mutations are not among the core driver mutations in 
cancer (Sjöblom et al., 2006; Wood et al., 2007; Greenman et al., 2007; Jones et al., 2008; 
Parsons et al., 2008; Bleeker et al., 2009). This suggests that aneuploidy in cancer arises 
by other means. Merotelic attachments, where a single kinetochore attaches to two 
microtubules from opposite spindle poles, do not efficiently activate the mitotic checkpoint 
and therefore often result in lagging chromosomes and subsequent aberrant karyotypes in 
the daughter cells (Cimini et al., 2001; 2004). Intriguingly, lagging chromosomes are 
frequent in cancer cells with high rates of chromosome missegregation (Thompson and 
Compton, 2008), suggesting that merotelic attachments are a source of chromosome 
missegregation in cancer. Although merotelic attachments can be corrected in early 
anaphase, increased incidences or reduced correction efficiency of merotelic attachments 
elevate the frequency of lagging chromosomes (reviewed in (Cimini, 2008). One source 
for an increased frequency of merotelic attachments is a multipolar spindle formation by 
multiple centrosomes (Ganem et al., 2009; Silkworth et al., 2009). In fact, supernumerary 
centrosomes are frequent in cancer and were associated with increased incidences of 
chromosome missegregation (Lingle et al., 2002; Sato et al., 2001; Silkworth et al., 2009; 
Ganem et al., 2009). Additionally, decreased correction efficiency of merotelic 
attachments by hyperstabilization of incorrect microtubule-kinetochore attachments 
increases the rates of lagging chromosomes (Bakhoum et al., 2009; Kabeche and Compton, 
2012). For instance, MAD2 overexpression stabilizes merotelic kinetochore attachments 
(Kabeche and Compton, 2012) and is associated with elevated rates of lagging 
chromosomes in cancer (Tanaka et al., 2001; Li et al., 2003; Sotillo et al., 2007; 2010; 
Hisaoka et al., 2008; Wang et al., 2009a; Kato et al., 2011). Thus, the major source of 
missegregated chromosomes is attributed to merotelic attachments. 
Besides mal-attachments in early mitosis, premature separation of chromatids 
results in chromosome missegregation (Figure 3B). Sister chromatids are held together by 
sister chromatid cohesion that dissociates at chromosome arms in early mitosis, 
maintaining the cohesion at the centromeres. Centromeric cohesion facilitates correct 
bipolar kinetochore-microtubule attachments and metaphase alignment and is resolved 
only after the SAC is satisfied. Mutations in proteins of the cohesion complex, such as the 
inactivation of the cohesion subunit STAG2 in human cell lines mediates premature 
chromatid separation and hence chromosome missegregation (Solomon et al., 2011). 
Knock out of mouse Stag1 results in increased aneuploidy (Remeseiro et al., 2012). 
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Moreover, STAG2 mutations or low expression have been identified in various human 
cancers (Solomon et al., 2011; 2013; Kim et al., 2012; Wilson et al., 2012).  
 In summary, many different mutations of SAC components can lead to increased 
chromosome missegregation and aneuploidy. Yet, these mutations are rarely found in 
cancer. Mutation in the cohesion subunit STAG2 presents one of the few links of mutations 
and aneuploidy in cancer. Merotelic attachments are most likely the major source of 
chromosome missegregation and aneuploidy in cancer. 
 
 
Aneuploidy through tetraploid intermediate 
 
 Multiple observations in aneuploid cancers and cell lines revealed that aneuploidy 
might derive from a tetraploid intermediate state during cancer progression. First, in 
several aneuploid cancers, a subpopulation of tetraploid cells was reported (Wijkstrom et 
al., 1984; Kallioniemi et al., 1988; Levine et al., 1991; Dutrillaux et al., 1991; Michels et 
al., 2000; Barrett et al., 2003; Olaharski, 2006). Second, there is a clear correlation 
between the tetraploidy status and the progression to aneuploidy as well as p53 
inactivation during neoplastic progression in Barrett's esophagus (Galipeau et al., 1996). 
Third, recent cancer sequencing projects provided compelling evidence that 37% of 
cancers underwent a whole-genome duplication at some point of tumorigenesis (Zack et 
al., 2013). More directly, tetraploid p53-nulls cells induced tumorigenesis when injected 
into nude mice, while diploids did not lead to tumor formation (Fujiwara et al., 2005). 
Lastly, experiments in cell lines demonstrated that induced cytokinesis failure leads to an 
unstable tetraploid intermediate that can evolve to aneuploid progenitor cells ((Vitale et 
al., 2010; Lv et al., 2014) and chapter 5.6 in this thesis).  
 Tetraploid cells emerge from three different mechanisms: cell fusion, cytokinesis 
failure or incomplete mitosis and endoreduplication (reviewed in (Davoli and de Lange, 
2011)). Cell fusion can be induced by viral infection (Duelli et al., 2007) and results in a 
binucleated intermediate that gives rise to tetraploid daughter cells (Figure 3C). All 
human oncogenic viruses such as papillomavirus (HPV), hepatitis B virus (HBV), hepatitis 
C virus (HCV) and others induce cell fusion (reviewed in (Gao and Zheng, 2011)). 
Together with the notion that tetraploid cells are frequent in virus-induced tumors, virus-
induced tetraploidization presents one path to near-tetraploid tumors.  
 Failure in cytokinesis, that is a failure to separate the two daughter cells, also 
results in a binucleated intermediate and mononucleated tetraploid cells in the subsequent 
mitosis (Figure 3C). Deregulation of multiple mitotic factors induces cytokinesis failure. 
For instance, impairment of the actin polymerization in mitosis by inhibition of the large 
tumor suppressor 1 kinase LATS1 leads to cytokinesis failure. Moreover, LATS1 is lost in a 
variety of cancers (reviewed in (Davoli and de Lange, 2011)).  
 Endoreduplication is the third mechanisms by which tetraploid cells can arise. 
During endoreduplication, the cells do not progress into mitosis, but skip it and enter a 
second S-phase in which the genome is duplicated. One trigger of endoreduplication by 
mitotic bypass is the prolonged telomere damage signal in the absence of a functional DNA 
damage checkpoint as seen in mouse embryonic fibroblasts (Davoli et al., 2010). In the 
absence of telomerase, telomeres shorten with each cell division. Short telomeres are 
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recognized by ATM/ATR kinases and lead to p53 or Rb-mediated apoptosis or senescence. 
Dysfunctional short telomeres are observed in early stage tumors and were proposed to be 
the source of DNA damage signals (De Lange, 2005). Given that p53 or Rb mutations or 
loss are common in cancer, prolonged ATM/ATR signaling inducing endoreduplication 
and mitotic failure might be a common cause of tetraploid cells in early tumor 
development (Davoli and de Lange, 2012).  
Sources of structural aneuploidy 
Structural aneuploidies such as deletions, insertions, translocations and 
duplications result mainly from improper repair of DNA damage or from unscheduled 
recombination events. Recurrent genomic alterations may result from misalignment and 
cross-over of genomic sequences with a high sequence identity (known as non-allelic 
homologous recombination) (reviewed in (Colnaghi et al., 2011)). Depending on the 
location and sequence orientation, non-allelic homologous recombination can result in 
deletion, duplication or inversion of DNA sequences. Genomic alterations that are not 
recurrent and occur at diverse breakpoints mainly arise during double strand break repair 
through non-allelic homologous end-joining that is inherently error prone. Joining the 
double strand break ends to incorrect sequences or at incorrect positions results in 
insertions and deletions (Hastings et al., 2009). More complex genomic alterations are 
characterized by multiple breakpoints flanked by unaffected stretches of genome between 
the rearranged regions and can be mediated by multiple mechanisms such as 
microhomology-mediated double strand break repair, fork stalling template switching 
mechanism or breakage fusion bridge cycle (Stankiewicz and Lupski, 2010). In the latter, 
chromosomes with damaged or shortened telomeres are fused by non-homologous end 
joining to other chromosomes forming an unstable dicentric chromosome (De Lange, 
2005; Jafri et al., 2016). As kinetochores from opposite spindle poles attach to the 
centromeres during anaphase, the dicentric chromosome may break due to opposing 
forces. The resulting new ends may lead to another breakage fusion bridge cycle, thus 
promoting genomic instability (GIN). Besides telomere associated GIN, common fragile 
sites in the genome are prone to double strand breaks. These sites are particularly 
susceptible to fork stalling during replication stress and contribute to genome instability 
and structural aneuploidy (Bignell et al., 2010; Dereli-Öz et al., 2011; Barlow et al., 
2013). Segmental rearrangements also occur due to lagging chromosomes. Chromosomes 
that lag behind during chromosome separations may become trapped in the cleavage 
furrow. This might either lead to their breakage, where the daughter cells inherit parts of 
the chromosome, or to the formation of a micronucleus (Janssen et al., 2011; Zhang et al., 
2015). Recent studies have demonstrated that the isolated chromosomes in micronuclei 
may be subjected to complex rearrangements and fragmentations characteristic for a 
process called chromothripsis (Zhang et al., 2015). Chromothripsis in micronuclei might 
be due to defective and delayed DNA replication (Crasta et al., 2012). That is, 
chromosomes from micronuclei can be reincorporated into the main nucleus in the 
subsequent mitosis, thus resulting in structural aneuploidy in the daughter cells.  
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In summary, multifold routes can result in aneuploidy, such as mutations and 
deregulation of various factors or mitotic errors. This presents a challenge to study the 
effect of aneuploidy, as it is often impossible to separate the causes and the consequences 
of aneuploidy from each other. Thus, novel cellular model systems may provide an 
important and resourceful tool for studying the consequences of aneuploidy per se. 
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5.3 Model systems of aneuploidy 
 Since the 21st century the study of the molecular consequences of aneuploidy in 
cancer or trisomy syndromes has been of great interest. To directly interrogate aneuploidy 
in the disease context, patient-derived cell lines or aneuploid preimplantation embryos 
have been available for research (Biancotti et al., 2010). However, the use of patients cell 
lines has marked limitations, because it has not been possible to obtain the corresponding 
control diploid cell lines. Moreover, the in vivo origin may limit the dissection of the 
primary molecular changes driven by aneuploidy from its secondary effects that may arise 
through adaptation of the aneuploid cells to the specific tissue niche. Especially in 
cancer-derived aneuploid cell lines, the additional molecular changes driven by mutations 
make it difficult to address the consequences to aneuploidy per se. Therefore, several 
aneuploid yeast strains, human cell lines and mouse models were established to study the 
effects of immediate and long-term effects of aneuploidy. 
 Since chromosome missegregation is the major source of aneuploidy, induction of 
chromosome missegregation is often employed to study the short-term effects of 
aneuploidy on the cellular physiology. For instance, depletion of the SAC components 
MAD2 or BUB1 results in missegregation of chromosomes in the majority of retinal 
pigment epithelial cells (Santaguida et al., 2015). Similarly, chemical inhibition of the SAC 
kinase MPS1 results in CIN (Hewitt et al., 2010; Santaguida et al., 2010). Using the same 
principle, chromosomally unstable mouse models were generated to study the effects of 
enhanced chromosome missegregation in vivo (reviewed in (Giam and Rancati, 2015) and 
(Simon et al., 2015)). Instead of using SAC depletion or inhibition, chromosome 
missegregation can be induced by the impairment of the mitotic spindle apparatus by drug 
treatments such as nocodazole or monastrol (Elhajouji et al., 1997; Thompson and 
Compton, 2008). Common to all these methods is that the induction of chromosome 
missegregation generates aneuploid cells with random and undefined karyotypes. Similar 
random aneuploidy fission or budding yeast can be generated through meiosis of yeast 
strains with an odd ploidy, such as tetraploidy or pentaploidy (Niwa et al., 2006; Pavelka 
et al., 2010). Yet, to attribute the aneuploidy response to specific karyotype changes, 
defined aneuploid cells are required. For example, microcell-mediated chromosome 
transfer has been developed allowing the addition of a specific chromosome to a cell 
(Fournier, 1981). The resulting aneuploid cell lines enable the study of the consequences 
of a defined aneuploidy in comparison to the parental cell line that serves as a perfect 
matched control (Upender et al., 2004; Stingele et al., 2012). The occurrence of 
Robertsonian metacentric chromosomes in mice has been used to generate trisomic mouse 
embryonic fibroblasts (Gropp et al., 1983; Williams et al., 2008). Robertsonian fusions 
arise as a fusion of non-homologous chromosomes at the centromeres. Crossing of mice 
with different Robertsonian chromosomes results at a low frequency in progenies with 
trisomies due to meiotic non-disjunction. In budding yeast, defects in nuclear fusion of the 
karyogamy gene mutants can be used for chromosome transfer (Conde and Fink, 1976; 
Torres et al., 2007). During these abortive matings, chromosome transfer from one mating 
partner to the other occurs in rare cases. In another approach, targeted addition or 
removal of a chromosome can be achieved by modification of the centromere (Reid et al., 
2008; Anders et al., 2009). Therein, a conditional centromere can transiently block sister 
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chromatid separation leading to yeast cells disomic for a specific chromosome (Anders et 
al., 2009). Similarly, loss of a specific chromosome can be achieved by transcription from 
a GAL1 inducible promoter adjacent to centromere sequences.  
The above-described aneuploid model systems mostly present random or defined 
simple aneuploidies. However, aneuploidy in cancer can be highly complex and may arise 
through a tetraploid intermediate state (see chapter 5.2). To study the fate of tetraploid 
cells, whole-genome doubling is induced by treatment with actin inhibitors such as 
cytochalasin D that lead to cytokinesis failure (Fujiwara 2005). These tetraploid cells are 
chromosomally unstable and usually become aneuploid through multipolar mitosis (Vitale 
et al., 2010).  
In summary, multiple different methods can be applied to generate random, 
defined or complex aneuploidies in different model organisms. Depending on the method 
applied, the generated aneuploid model cells are inheritably stable or exhibit genome 
instability. In this thesis, defined whole-chromsome aneuploid model cell lines, generated 
by microcell-mediated fusion have been used to study the consequences of aneuploidy 
(Donnelly et al., 2014; Dürrbaum et al., 2014). In addition, aneuploid post-tetraploid cells 
have been used to determine the consequences of a complex aneuploid karyotype derived 
from an intermediate tetraploid karyotype (Kuznetsova et al., 2015). 
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5.4 The “omics” landscape of aneuploid cells 
5.4.1 Effects of aneuploidy on the genome 
Aneuploidy in cancer cells appears in form of changes in the numbers of 
chromosomes but also as diverse structural changes, such as deletions, duplications, 
unbalanced inversions and translocations (Mitelman et al., 2016). The data obtained in 
large-scale cancer genome sequencing efforts present a comprehensive landscape of the 
genomic changes in cancer revealing the overwhelming complexity of structural changes 
and somatic mutations in cancer (Vogelstein et al., 2013). While the sequencing data 
uncovers that the number of mutations per tumor may reach up to 100,000 in melanomas 
and glioblastomas (Alexandrov et al., 2013), it is not entirely understood how tumors 
acquire these high numbers of mutations. According to the view that cancer develops in a 
multistage process, somatic mutations would accumulate and are selected during 
tumorigenesis ((Vogelstein and Kinzler, 1993) reviewed in (Jeggo et al., 2016)). The 
complexity of aneuploidy correlates with poor prognosis of cancer patients (Sheltzer, 
2013). In addition, aneuploidy and somatic mutations coincide in tumors (Duesberg et al., 
1998; Lengauer et al., 1997; 1998). These two observations suggest that aneuploidy itself 
might drive the accumulation of somatic mutations. In support, single cell sequencing of 
breast cancer cells revealed that while copy number changes and rearrangements occur 
early in tumor development, somatic mutations appear gradually (Wang et al., 2015). 
Intriguingly, at least two studies show that the mutation rates are increased near the 
breakpoints (De and Babu, 2010; Drier et al., 2013), suggesting that aneuploidy may 
promote genomic variations.  
Aneuploidy has been correlated with karyotype instability in human colon cancer 
cell lines (Lengauer et al., 1997) and in p53 knock out colon cancer cell lines (Thompson 
et al., 2010). Moreover, the higher the aneuploidy the more unstable is the karyotype in 
transformed Chinese hamster embryo cells (Duesberg et al., 1998). These observations 
indicate that aneuploidy promotes karyotype instability. In support, budding yeast cells 
with an extra chromosome exhibit an increased chromosome missegregation frequency 
(Sheltzer et al., 2011). Disomic yeasts also show a higher mutation rate and defects in 
recombination and DNA repair, suggesting a link not only between aneuploidy and CIN, 
but also between aneuploidy and GIN. Human cell lines with an artificially introduced 
extra chromosome also display signs of CIN and/or GIN, such as chromosome aberrations 
in primary human fibroblasts with an extra copy of chromosome 8 (Nawata et al., 2011) 
and higher rates of chromosome missegregation in human colorectal cancer cells with an 
extra copy of chromosome 7 or 13 (Nicholson et al., 2015). 
While aneuploid model cell lines have been previously linked to CIN and GIN, only 
advanced sequencing technologies allow a systematic study of the effects of aneuploidy on 
the genome. Recent results from mate-pair NGS of trisomic and tetrasomic human cell 
lines revealed de novo chromosomal rearrangements that did not occur in the parental 
control (Passerini et al., 2016). Further SNP analysis of clonal cell lines originating from a 
trisomic cell line confirmed the increased occurrence of de novo chromosomal 
rearrangements in comparison to the clones originating from the diploid parental cell line. 
Analysis of the protein levels of DNA replication factors revealed a down-regulation 
specifically for the replicative helicases MCM2-7 (Passerini et al., 2016). Depletion of these 
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factors in diploid cells leads to a similar GIN phenotype as observed in aneuploid cells. 
Moreover, overexpression of MCM subunits rescues DNA damage foci formation in the 
aneuploid cells. Intriguingly, downregulation of DNA replication proteins was also 
observed as a response to chromosome missegregation due to SAC attenuation (Ohashi et 
al., 2015). The damage observed in these cells seems not to stem from the chromosome 
missegregation itself, but from reduced replication activity in the surviving cells. Thus, 
these results suggest that replication stress in aneuploid cells leads to GIN. In summary, 
cumulative evidence indicates that the presence of extra chromosomes promotes GIN at 
least in aneuploid model cell lines.  
5.4.2 The presence of extra chromosomes affects the transcriptome and proteome 
The consequences of aneuploidy on the cell physiology are determined by 
transcriptome and proteome changes. Continued improvement of technologies facilitates 
the documentation of the effects of aneuploidy in cancer but also in model cell lines on 
mRNA and protein level and allows a new perspective on the cellular response to 
aneuploidy. 
It is now well established that the addition of extra chromosomes results in 
correlative expression changes according to the gene copy number in yeast (Chikashige et 
al., 2007; Torres et al., 2007), mammalian cell lines (Upender et al., 2004; Williams et al., 
2008; Nawata et al., 2011; Stingele et al., 2012), A. thaliana (Huettel et al., 2008; 
Sheltzer et al., 2012) and maize (Birchler, 2013). In a few cases a broad range of 
expression changes was reported, which, however, may be a consequence of differences in 
the data analysis strategies (reviewed in (Dürrbaum and Storchova, 2015a)). For instance, 
25-56% of the genes encoded on trisomic chromosome 21 are expressed at diploid levels 
in mouse model of trisomy 21 or patient derived cells, although the averaged gene 
expression of chromosome 21 genes is elevated above diploid level (Aït Yahya-Graison et 
al., 2007; Chou et al., 2008; Biancotti et al., 2010; Vilardell et al., 2011; Wang et al., 
2011). All of the above-cited studies investigated the effects of extra chromosomes on the 
transcriptome, whereas the consequences of monosomies have not been not broadly 
investigated so far. The few studies available derive from Drosophila, where monosomy of 
chromosome X and 4 are buffered by two evolved dosage compensation mechanisms 
(Larsson et al., 2001; Johansson and Stenberg, 2007; Laverty et al., 2010). In addition, 
segmental monosomies are also partially dosage compensated in Drosophila as suggested 
by the only minor reduction in expression levels (Stenberg et al., 2009). From these 
studies, it appears that also loss of chromosomes or chromosome parts is detrimental, at 
least for Drosophila. However, whether the response to monosomies in mammalian cells is 
similar remains to be investigated.  
The analysis of the transcriptional response to aneuploidy in cancer is complicated 
by the intertwined appearance of somatic mutations with aneuploidy, epigenetic 
alterations and the high intra-tumoral heterogeneity (Vogelstein et al., 2013). Moreover, 
different data analysis strategies make it difficult to compare the results between the 
studies (reviewed in (Dürrbaum and Storchova, 2015a)). Correlations at single gene level 
appear to be less robust and probably reflect the complex genomic and epigenomic 
alterations in cancer. However, if distinct regions are summarized and correlated, a weak 
Introduction – The “omics” landscape of aneuploid cells 
    28 
but consistent correlation of gene copy number and expression can be found. Moreover, 
using a novel method that corrects for major non-genetic factors in meta-analysis of 77840 
cancer expression profiles clearly demonstrates a correlation between gene copy number 
alterations and gene expression (Fehrmann et al., 2015).  
 
 Protein expression scales with the gene copy number changes in disomic yeast and 
tri- or tetrasomic mammalian cells (Pavelka et al., 2010; Torres et al., 2010; Stingele et 
al., 2013). Yet, certain proteins are dosage compensated; that is, their expression is lower 
than expected and more similar to wild type levels (Torres et al., 2007; Pavelka et al., 
2010; Stingele et al., 2012; Dephoure et al., 2014; Donnelly et al., 2014). Specifically, the 
expression levels of subunits of macromolecular complexes are subjected to dosage 
compensation in disomic yeast as well as in human cells with extra chromosomes. In 
addition, abundance of many protein kinases is attenuated to normal levels as well. 
Especially for the formation of macromolecular complexes balanced concentration of the 
complex subunits is important. This was elegantly demonstrated by the “genetic tug of war 
method” that identified 115 dosage sensitive genes. Most of them are protein complex 
members (Makanae et al., 2013). In this study, target genes were cloned into a plasmid, 
which additionally harbors positive selection markers for growth on limited media. The 
limit for overexpression of a specific gene was assessed by its toxic effect preventing high 
plasmid copy numbers. Whereas an increase up to 100 copy numbers would not affect the 
cells for over 80% of genes, for 115 genes, enriched for members of protein complexes, the 
permissive plasmid copy number was limited and lower than expected. When the binding 
partners of the dosage sensitive genes were simultaneously overexpressed, the sensitivity 
could be rescued. This suggests that in aneuploid cells, the members of protein complexes 
are especially sensitive to copy number changes. However, the mechanism of dosage 
compensation is not understood. 
 In cancer, the correlation of gene copy number variations with protein abundance 
is rather weak, with a Spearman rank correlation of 0.1 in lung cancer (Li et al., 2014) 
and 0.22 and 0.28 in two breast cancer cell lines (Geiger et al., 2010). In the latter, only 
4.8% and 7.8% of the protein levels could be directly correlated to the corresponding copy 
number changes. Yet, the few studies and the small sample size of aneuploid cancer 
proteomics do not allow making general conclusions on the effect of aneuploidy on the 
proteome. In cancer, the weak correlation in tumors is probably due to the additional 
aberrations of genes and pathways in cancer that makes the relation of an abnormal 
karyotype with the proteome much more complex. 
 
5.4.3 Aneuploidy affects genome-wide expression 
 Aneuploidy does not only lead to changes in transcriptome and proteome of the 
genes encoded on the extra DNA, but also to extensive genome-wide expression changes 
(Upender et al., 2004; Torres et al., 2007; Sheltzer et al., 2012; Stingele et al., 2013; 
Gemoll et al., 2013) reviewed in (Dürrbaum and Storchova, 2015a)). Similarly, about 
90-98% of deregulated genes were encoded on the disomic chromosomes in cells derived 
from trisomy 13 or 18 amniotic fluid samples and trisomy 21 chorionic villus samples 
(Hervé et al., 2016). It was first observed in aneuploid yeast strains that the 
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transcriptional changes are similar to a previously identified environmental stress response 
of yeast (Torres et al., 2007). Therein, differentially expressed genes were associated with 
RNA processing and ribosomes as well as nucleic acid metabolism and carbohydrate 
metabolism. Later studies in mammalian aneuploid model cell lines and aneuploid cells 
from Down syndrome patients indicated that the genome-wide transcriptome deregulation 
affects common gene ontology pathways (Sheltzer et al., 2012; Stingele et al., 2012; Foijer 
et al., 2013). A more systematic study revealed that aneuploid cell lines exhibit a similar 
pathway deregulation independent of the type of the aneuploid chromosome, the cell line 
or the laboratory in which the cell line or transcriptome data were generated (Dürrbaum 
et al., 2014). Similar to the response in aneuploid yeast cells, gene annotations associated 
with DNA and RNA pathways were consistently downregulated, while gene annotations 
associated with extracellular regions and lysosomes were upregulated. Of note, the 
expression pattern on single gene level is diverse and overlaps poorly. Thus, while there 
are similarities in the specific affected pathways, each cell line has different determinants 
of pathway deregulation. 
In summary, large-scale analysis of genome, transcriptome and proteome allow to 
comprehensively assess the quantitative and qualitative response to aneuploidy on 
molecule level. Yet, the fact that primary and secondary effects are most likely reflected in 
the steady state “omics” data makes it difficult to dissect causes and consequences. 
Particular in cancer studies, multiple other molecular changes and an evolutionary 
adaptation process to aneuploidy probably mask the primary consequences of aneuploidy. 
In-depth data analysis and comparison of the aneuploidy response on transcriptome and 
proteome level might give further insights into the processes altered in aneuploid model 
cells.  
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5.5 Physiological consequences of aneuploidy 
5.5.1 Aneuploidy affects proliferation and cell metabolism 
 Most aneuploidies are not compatible with life and account for one third of 
spontaneous miscarriages in humans (reviewed in (Hassold et al., 2007)). In surviving 
embryos, aneuploidy is the leading cause of mental retardation and developmental 
disabilities as seen in individuals with trisomy of chromosome 21. If isolated, induced 
pluripotent stem cell from Down syndrome fibroblasts have longer doubling times and an 
increased G1-cell fraction (Li et al., 2012; Jiang et al., 2013). Intriguingly, loss of the 
aneuploid chromosome results in proliferation improvement compared to the trisomies. 
This is in line with the observed proliferation defects of cells with extra chromosomes such 
as in aneuploid fission and budding yeast strains, mouse embryonic fibroblasts and human 
cell lines (Williams et al., 2008; Torres et al., 2007; Stingele et al., 2012).  
 What are the underlying mechanisms of the reduced proliferative capacity? As an 
immediate response to chromosome missegregation during mitosis, the proliferation is 
limited by p53 pathway activation (Li et al., 2010; Thompson and Compton, 2010; 
Janssen et al., 2011; Ohashi et al., 2015). Cells in which the SAC is compromised by 
mutation or depletion of individual SAC components show increased levels of chromosome 
missegregation followed by nuclear accumulation of p53 (Li et al., 2010). Along these 
lines, triggering erroneous microtubule-kinetochore attachments via monastrol treatment 
induces chromosome missegregation and p53 activation (Thompson and Compton, 2010; 
Janssen et al., 2011). The p53 activation mechanisms remain unclear; on one hand 
monastrol induced chromosome missegregation correlates with increased number of DNA 
damage foci and activation of the DNA damage response pathway involving ATM and p53 
(Janssen et al., 2011). On the other hand, another study did not detect any signs of DNA 
damage, but found the p53 activation after chromosome missegregation depended on the 
p38 stress-response kinase (Thompson and Compton, 2010). Recent work suggests that 
p53 is activated by differential phosphorylation of histone 3.3 at Serine31 (Hinchcliffe et 
al., 2016). The authors demonstrated that histone 3.3 phosphorylation marks 
missegregated chromosomes. The subsequent genome-wide spreading of the 
phosphorylation signal induces p53. Concordantly, masking the phosphorylation 
diminishes p53 activation. Activation of the p53 pathway subsequently limits the 
propagation of cells with missegregated chromosomes. Induction of chromosome 
missegregation in p53 deficient cells allows accumulation of aneuploid progeny. This is 
true also in vivo, since p53 null mice with mutations in the SAC component Cdc20 have a 
higher survival rate than p53 positive mice and show an increased rate of aneuploid cells 
and thymic lymphoma development (Li et al., 2010). Thus, p53 is the key factor limiting 
the propagation of aneuploids. 
 Interestingly, the growth impairment in chronic aneuploid model cell lines seems 
to be p53 independent, since activation of p53 has not been observed in these cells so far 
(Tang et al., 2011), our unpublished data)). Characteristic for the slower growth of 
aneuploid model cell lines is a delay in G1 phase of the cell cycle (Torres et al., 2007; 
Stingele et al., 2012). More detailed analysis in aneuploid yeast cells revealed that 
defective G1 cyclin accumulation underlies the prolonged G1 phase, which can be rescued 
by overexpression of the G1 cyclin CLN2 (Thorburn et al., 2013). Similarly, the global 
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transcriptome analysis of different aneuploid model cell lines indicates a downregulation 
of cell cycle associated factors (Dürrbaum et al., 2014). However, the exact molecular 
mechanisms of the growth defect in aneuploid cells remain elusive. 
 An open question is whether the growth delay is governed by the copy number 
changes of specific genes encoded on the aneuploid chromosome or whether the 
cumulative deregulation of gene expression in aneuploid cells affects proliferation. The 
former might be the case for budding yeast with extra chromosome VI, which survives 
only at a very low frequency (Campbell et al., 1981; Dutcher, 1981). This lethality was 
linked to an extra copy of the β-tubulin gene, since an excess of β-tubulin over α-tubulin is 
not well tolerated (Katz et al., 1990). However, this seems to be rather an exception and 
the observation that the cell cycle delay of yeast aneuploid cells correlates with the size of 
the additional chromosome speaks for a cumulative gene expression effect (Thorburn et 
al., 2013). In support, overexpression of individual genes, previously identified to slow 
growth at high copy numbers, does not result in marked growth impairment similar as 
observed in aneuploid yeast cells (Bonney et al., 2015). Only the combined overexpression 
of highly dosage sensitive genes results in growth impairment. These results suggest that 
hindered proliferation of aneuploid cell lines is a result of the cumulative effects of 
aneuploidy.  
 The addition of extra chromosomes also affects cellular metabolism. For instance, 
aneuploid mouse embryonic fibroblasts display metabolic alterations such as increased 
glutamine consumption, ammonium and lactate production, which points to alterations in 
the energy metabolism (Williams et al., 2008). Aneuploid yeast strains have increased 
glucose uptake, but less biomass production per glucose molecule (Torres et al., 2007). 
Whether and how these metabolic alterations are connected to the slow proliferation 
remains elusive.  
 Interestingly, under environmental stress conditions aneuploidy confers a growth 
advantage in comparison to euploidy. Despite growth defects under normal conditions, 
aneuploid budding yeast strains show a growth advantage under various non-standard 
conditions such as the tumorigenic compound 4-nitroquinoline-N-oxide (Pavelka et al., 
2010). Similarly, colorectal cancer cell lines with an extra chromosome are less sensitive 
to serum deprivation, hypoxia or cytostaticum 5-fluorouracil and grow slightly better than 
diploid cells under the same stress conditions (Rutledge et al., 2016). Hence, although the 
addition of extra chromosomes negatively affects proliferation, under stress conditions 
that affect the proliferation of wild type cells, aneuploid cells are less sensitive.  
 In summary, aneuploidy has detrimental effects on cellular growth and alters 
cellular metabolism. The fact that impaired growth is a shared phenotype of many 
different aneuploid cells suggests common molecular triggers. Yet, there are remaining 
open questions: What are the molecular causes of the compromised growth capacity? How 
is this phenotype linked to the other physiological consequences of aneuploidy in model 
cells? And is slower growth a mere byproduct of the negative effects of aneuploidy on the 
cell physiology or is it the cause for the observed phenotypes? 
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5.5.2 Aneuploidy affects the proteostasis network 
Cellular functions strongly rely on a functional balance of the proteome that is 
described as protein homeostasis, or proteostasis. Proteostasis not only includes regulated 
protein synthesis and degradation, but also the maintenance of protein stoichiometry and 
individual protein levels. To preserve proteostasis, multifold pathways and mechanisms 
have evolved that build a proteostasis network. Involved are the three major mechanisms 
of protein synthesis, protein folding 
and protein degradation for clearance 
of misfolded or dispensable proteins 
(Figure 4). Disturbance of proteostasis 
has been linked to aging (reviewed in 
(Taylor and Dillin, 2011; Labbadia and 
Morimoto, 2015)) and 
neurodegenerative diseases such as 
Alzheimer´s disease, in which 
characteristic protein aggregates 
accumulate (reviewed in (Soto and 
Estrada, 2008)). 
There are several lines of 
evidence that aneuploidy results in 
proteotoxic stress, a state where the 
cellular proteostasis is impaired. First, 
aneuploid cells are sensitive to 
impairment of the first step of 
proteostasis, the protein synthesis 
machinery. Inhibition of protein 
synthesis by cycloheximide, 
hygromycin, radicicol or rapamycin 
treatment impairs proliferation in 
aneuploid yeast strains stronger than 
in euploid cells (Oromendia et al., 
2012; Pavelka et al., 2010; Torres et 
al., 2007). Second, aneuploidy renders cells susceptible to functional impairment of the 
protein quality control. Protein quality control has a central function in the proteostasis 
network, as chaperone-assisted folding of newly synthesized proteins into their functional 
3-dimensional shape, assembly of multiprotein complexes and reversion of protein 
misfolding or aggregation are crucial for proteostasis (reviewed in (Hartl et al., 2011; 
Balchin et al., 2016)). Inhibition of HSP90 by 17-AAG leads to higher cell death rate in 
aneuploid mouse embryonic fibroblasts than in the diploid control cells (Tang et al., 
2011). Moreover, this sensitivity seems to be dependent on aneuploidy as highly 
aneuploid cancer cell lines exhibit a greater sensitivity to HSP90 inhibition than near-
euploid cancer cell lines (Tang et al., 2011). Investigations of the HSP90 activity using a 
sensor based on the human tyrosine kinase Src in aneuploid yeast cells revealed reduced 
protein folding capacity (Oromendia et al., 2012). Similar impairment of the protein 
Figure 4. The proteostasis network. Protein 
homeostasis is achieved by balanced protein 
synthesis, efficient protein folding and degradation 
of protein products. Medium and large proteins 
undergo chaperone-assisted folding. Misfolded or 
insoluble proteins aggregate. Protein aggregates 
are cleared either by autophagy or the ubiquitin/ 
proteasome system.  
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folding capacity was observed in aneuploid human cell lines (Donnelly et al., 2014). Third, 
accumulation of HSP104 positive inclusions and ubiquitin-positive foci were detected in 
aneuploid yeasts (Oromendia et al., 2012) and in human aneuploid cell lines (Stingele et 
al., 2012). While these inclusions reflect compromised proteostasis in aneuploid cells, the 
exact source is not clear. Aneuploid yeast cells challenged with aggregation prone von-
Hippel-Lindau protein (VHL) show a higher percentage of protein aggregates than the 
haploid control strains, indicating a defect in proteosomal clearance of protein aggregates 
(Oromendia et al., 2012). Conversely, increased autophagy factor levels and the co-
localization of ubiquitin-positive inclusions with the cytosolic receptor for selected 
autophagy p62 (SQSTM1) indicate that autophagy is activated to facilitate clearance of 
the protein aggregates in aneuploid human cells (Stingele et al., 2013). Similarly, 
activation of autophagy was detected in breast epithelial cell lines with extra chromosomes 
(Ariyoshi et al., 2016). In addition, aneuploidy induced by impairment of SAC components 
leads to ER expansion and increased lysosome and aggresome formation, indicating 
increased autophagy (Ohashi et al., 2015).  
In summary, aneuploid cells exhibit multiple features of proteotoxic stress, which 
go in hand with an increased sensitivity to stresses that affect protein homeostasis such as 
protein translation inhibition, protein quality control inhibition as well as to heat shock 
stress (Donnelly and Storchova, 2015). It is important to note that it is difficult to dissect 
the causes from consequences of proteotoxic stress. As little as 0.1% of misfolded proteins 
can impair the overall protein quality control and the fitness as demonstrated in yeast 
(Geiler-Samerotte et al., 2011). Therefore, it is likely that already initial low levels of 
misfolded proteins in aneuploid cells trigger multifold secondary changes in the 
proteostasis network. Moreover, misfolded proteins and unstable subunits of molecular 
complexes may titrate away components of the protein folding machinery, thus causing 
even more misfolded proteins in a self-promoting cycle. For instance, in C. elegans the 
toxicity of misfolded, aggregated mutant proteins was increased in a background in which 
destabilized polymorphic proteins compete for the protein folding machinery (Gidalevitz 
et al., 2009). Although it seems clear that the proteostasis network in aneuploid cells is 
compromised, many open questions remain to be addressed: What is the primary cause of 
impaired proteostasis? What is the underlying cause of the protein folding defect? And 
how does this affect or relate to other observed phenotypes of aneuploid cells? 
5.6 Consequences of whole-genome doubling 
Doubling of the whole-genome presents an alternative route to aneuploidy in 
cancer (see chapter 5.2). Proliferating tetraploid cells appear to be chromosomally 
unstable (Fujiwara et al., 2005; Storchova et al., 2006) and evolve to a variable 
aneuploidy, mostly to near-triploidy and near-tetraploidy (Davoli and de Lange, 2012; Lv 
et al., 2014; Kuznetsova et al., 2015). Yet, survival of tetraploid cells is largely p53 
dependent and only abrogation of p53- or Rb- signaling allows further proliferation (Lanni 
and Jacks, 1998; Andreassen et al., 2001; Castedo et al., 2006; Ganem et al., 2009; Kuffer 
et al., 2013).  
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p53 activation in tetraploid cells has been attributed to different cues. For example, 
altered centrosome numbers affecting the spindle geometry and centrosome integrity was 
suggested to activate the p38/MAPK pathway, which activates p53 (Vitale et al., 2008). In 
an alternative scenario, erroneous bipolar or multipolar mitosis in tetraploid cells results in 
p53 activation. Indeed, cytokinesis failure induced tetraploid cells to undergo multipolar 
mitosis or erroneous bipolar mitosis and subsequently arrest or die upon p53 activation 
(Kuffer et al., 2013). Lagging chromosomes emerging from aberrant mitosis can be 
damaged during cytokinesis (Janssen et al., 2011) or through merotelic attachments 
(Guerrero et al., 2010). These might in turn activate DNA damage signaling and lead to 
downstream p53 activation. However, DNA damage could not be observed after 
multipolar or bipolar mitosis with p53 accumulation (Kuffer et al., 2013). Instead, markers 
for oxidative DNA damage coincided with p53 activation. Chromosome missegregation 
induces oxidative stress and activation of the ATM-CHK2 pathway in diploid cells (Li et al., 
2010). Therefore, oxidative stress from abnormal mitosis can be one activator of p53.  
Apart from p53, other regulators of the tetraploid cell cycle arrest were identified 
in an unbiased RNAi screen (Ganem et al., 2014). This method identified the kinase 
LATS2, a core component of the Hippo pathway. Further experiments revealed that LATS2 
interacts with MDM2 that targets p53 for destruction, thereby stabilizing p53. This 
response depends on RAC1 activation and RHOA reduction, vice versa RAC1 inhibition or 
RHOA activation diminished Hippo pathway signaling. A possible upstream trigger might 
be the increased centrosome mass, since increased microtubule dynamics stimulates RAC1 
activity (Waterman-Storer et al., 1999; Godinho and Pellman, 2014). 
Mutations in p53 are common in cancer, which enables bypassing the proliferative 
limit of tetraploid cells. Yet, the exact molecular cues for post-tetraploid cell survival are 
not clear. What is the fate of rare survivors and what are the long-term effects of whole-
genome doubling? Scant data is available, which suggests that evolved tetraploid cells 
show higher tolerance to CIN by providing karyotypic heterogeneity for further evolution 
(Dewhurst et al., 2014). In our current study we analyzed the evolutionary fate of 
post-tetraploid human cells and its association with p53 signaling suppression (Kuznetsova 
et al., 2015). 
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5.7 miRNAs – a new “omics” layer 
The complex network that regulates gene expression and thereby cellular 
phenotypes has been recently extended by the discovery of its regulation via small RNA 
molecules, so called miRNAs. To date, 1881 miRNAs are identified in humans (mirbase 
release June 2014 http://www.mirbase.org/) and over 60% of protein coding genes are 
predicted to be regulated by miRNAs (Friedman et al., 2009). The first discovered miRNA 
negatively regulates translation of the lin-14 gene by complementary base paring in the 
3’UTR, thereby controlling cell differentiation in C. elegans (Lee et al., 1993; Wightman et 
al., 1993). Since the general regulatory function of this new class of RNAs was recognized 
in 2001 (Lagos-Quintana et al., 2001; Lee and Ambros, 2001), the discovery of new 
miRNAs, their function and their association with various diseases grew exponentially 
according to the PubMed statistics. Whether and how miRNAs functions in the context of 
aneuploidy per se has not been studied so far.  
5.7.1 Biogenesis and function of miRNAs 
miRNA biogenesis 
The genomic locations of miRNAs are equally distributed between intergenic or 
intragenic regions. That is, miRNAs are encoded between two protein-coding genes or 
within a protein-coding gene, respectively (Hinske et al., 2010) (Figure 5). Most intragenic 
miRNAs are encoded within the intron, only about 5% are exonic. While intergenic 
miRNAs have their independent promoter, intragenic miRNAs can either be transcribed 
with the host gene promoter or from an independent intergenic or from an upstream 
intronic promoter (Monteys et al., 2010; Ozsolak et al., 2008). Some intragenic miRNAs 
show correlative expression with their host 
genes (Rodriguez et al., 2004). Similarly, 
miRNAs clustering in close proximity to 
each other are generally co-transcribed, as 
for example the deeply conserved clusters 
mir-100, let-7 and mir-125 (Altuvia, 2005). 
However, this is not always the case, 
supposedly because of independent 
Figure 5. The miRNA biogenesis pathway. 
miRNAs are encoded within a gene (intragenic) 
or between two genes (intergenic). Intragenic 
mir genes lie either within the exon sequence 
(exonic) or intron sequence (intronic). Drosha 
cleaves the transcribed pri-miRNA into the 
pre-miRNA. Pre-miRNAs are exported to the 
cytoplasm by Exportin-5 and further processed 
by Dicer into a miRNA:miRNA duplexes. The 
guide strand is then incorporated into the RISC. 
Complementary binding to the target mRNA 
leads to translational repression and/or mRNA 
decay. 
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transcriptional regulation or alternative splicing (Monteys et al., 2010; Ramalingam et al., 
2013). The majority of miRNAs are transcribed by RNA Polymerase II that generates a 
capped and polyadenylated primary miRNA (pri-miRNA). In addition, transcription by 
RNA Polymerase III was reported for a subset of miRNAs (Borchert et al., 2006; Ozsolak et 
al., 2008). The pri-miRNA is subsequently processed by the RNA III-type endonuclease 
Drosha with its essential co-factor DiGeorge Syndrome Critical Region 8, DGCR8 
(reviewed in (Ha and Kim, 2014)). Intronic miRNA processing may occur after the 
incorporation into the spliceosome complex, but before splicing catalysis, thus not 
affecting the host gene transcription (Kim and Kim, 2007). Yet, alternative pathways have 
been suggested, such as splicing-mediated miRNA biogenesis that bypasses the Drosha 
processing (Berezikov et al., 2007; Westholm and Lai, 2011). Following preprocessing, 
precursor miRNAs (pre-miRNA) are exported to the cytoplasm by Exportin-5 and 
subsequently processed into their mature form. This is mediated by RNA III-type 
endonuclease Dicer that binds either the 5’ and/or 3’ overhang and cleaves a 22nt long 
RNA duplex (Park et al., 2011). The RNA duplex is then loaded onto the Argonaute 
protein (AGO), thus forming the pre-RNA-inducing silencing complex, which matures by 
unwinding of the RNA duplex and removal of the passenger strand. A member of the 
HSP70 family, HSPA8, together with HSP90 mediates the conformational change of AGO 
proteins in an ATP-dependent manner to facilitate its binding of the RNA duplex in 
Drosophila (Iwasaki et al., 2010). This is interesting given the reduced heat shock protein 
levels in human aneuploid model cell lines (see chapter 5.5.2). Within the mature RNA-
inducing silencing complex (RISC), the mature single-stranded miRNA guides the complex 
to target mRNAs, where complementary sequence binding elicits miRNA function. 
miRNA functional mechanism 
There are two possible mechanisms how miRNAs affect gene expression (reviewed 
in (Iwakawa and Tomari, 2015)). First, stringent complementary binding to the target 
mRNA results in mRNA decay. Second, partial base pairing promotes translational 
repression of the target mRNA. miRNAs target mRNAs via a 5’end 7-8 nt long seed region 
and partial complementary positions of the 3’ end (John et al., 2004; Lewis et al., 2005; 
Saito and Sã Trom, 2010). Whereas it has been accepted for a long time that miRNAs 
recognize the 3’UTR of a target mRNA, miRNA binding sites in the coding region and 
5’UTR have been identified in the past years (Schnall-Levin et al., 2011; Zhou et al., 2009; 
Hafner et al., 2010; Liu et al., 2013).  
Target mRNA decay is mediated by recruitment of the deadenylase complexes to 
the RISC. Therein, the protein GW182 interacts with AGO and serves as an essential hub 
for the deadenylating protein complexes CCR4-NOT and PAN2-PAN3, as well as the 
poly(A)-binding protein PABP (Zekri et al., 2009; Braun et al., 2013; 2011; Fabian et al., 
2011). Subsequent to deadenylation, the 5’cap structure of the mRNA is removed by the 
catalytic subunit of the decapping complex DCP2 and the decapping activators DCP1, 
RCK/p53/DDX6, which are recruited onto the CCR4-NOT complex (Nishimura et al., 
2015). The final step in mRNA decay is the exonucleolytic mRNA degradation by the 
exoribonuclease 1, XRN1 (Braun et al., 2012).  
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Translational repression of target mRNA is less well understood. Several 
mechanisms have been proposed, but recent evidence indicates that miRNAs inhibit 
cap-dependent translation at the initiation step. Translation initiation is mediated by the 
interaction of the poly(A)-binding protein PABP and the 5’-cap bound eukaryotic 
translation-initiation factor 4G, eIF4G, which results in the formation of a circular mRNA 
(Derry et al., 2006). Displacement of PABP by GW182 was suggested to disrupt the mRNA 
circularization, thereby preventing mRNA translation (Zekri et al., 2013; Iwakawa and 
Tomari, 2015). Another suggested mechanism includes dissociation of the RNA helicase 
eIF4A subunits from the translation initiation complex ((Fukao et al., 2014), reviewed in 
(Fukao et al., 2015; Iwakawa and Tomari, 2015)). Yet, the detailed molecular mechanism 
remains to be clarified in the future.  
A longstanding debate in the field concerns the relative contribution of mRNA 
decay and translational repression to the miRNA-dependent post-transcriptional regulation 
(Guo et al., 2010; Huntzinger and Izaurralde, 2011; Hu and Coller, 2012; Eichhorn et al., 
2014). Quantitative approaches comparing gene and protein expression after deletion of 
specific miRNAs revealed that target mRNA and protein levels are changed, although for a 
subset of targets only proteins were affected with little or no change on mRNA level (Baek 
et al., 2008; Selbach et al., 2008). Another approach uses polysome profiling and 
ribosome profiling for determination of the mRNA translation efficiency. Comparison of 
the target translation efficiency with total mRNA and protein levels demonstrated that 
mRNA decay explains the majority of the target repression, whereas translational 
repression contributes only with 10-25% to the overall repression activity (Hendrickson et 
al., 2009; Guo et al., 2010). Kinetic studies of translational repression and mRNA decay of 
a reporter mRNA revealed that translational repression precedes mRNA decay (Djuranovic 
et al., 2012). Extended studies on the mRNA decay dynamics in various mammalian cell 
types showed that translational repression occurs fast, but only with a weak repression 
effect (Eichhorn et al., 2014). By the time translational repression shows its effect, mRNA 
degradation is dominating the miRNA-mediated repression effect. Thus, miRNA-target 
interaction results mainly in mRNA decay. Of note, the effects of miRNAs on a specific 
target are seldom the result of a one-to-one interaction, but rather reflect the cumulative 
effect of the entire miRNAome. Hence, one miRNA not only targets multiple genes, but 
also one gene is targeted by multiple miRNAs (Zhou et al., 2013). Synergistic miRNA 
repression of specific targets was shown in gastric cancer (Hashimoto et al., 2013). 
Moreover, competing endogenous RNAs can act as sponges and titrate miRNAs away from 
their targets, for instance, HMGA2 competes for the let-7 family in lung cancer (Kumar et 
al., 2013). Therefore, a profiling of the complete set of miRNAs in a cell, the miRNAome, 
is essential to fully understand the function of miRNAs in the biological context. 
5.7.2 Association of miRNAs with aneuploidy in cancer 
The miRNAome is tissue specific and its function was associated with a variety of 
essential cellular processes such as cell proliferation or cell death (Lagos-Quintana et al., 
2002; Landgraf et al., 2007; Hwang and Mendell, 2006). Thus, it is not surprising that 
miRNA deregulation is associated with complex diseases such as cancer (Calin and Croce, 
2006; Dalmay and Edwards, 2006). Accelerated by advanced sequencing methods, cancer 
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specific miRNA expression profiles and oncogenic as well as tumor suppressive miRNAs 
have been identified (for example (Akao et al., 2006; Dvinge et al., 2013; Schee et al., 
2013; Busch et al., 2016)). Deregulation of miRNAs occurs at different steps of miRNA 
biogenesis and stems from multiple sources. For instance, transcriptional regulation of the 
factors involved in pri-miRNA processing, nuclear export or pre-miRNA processing as well 
as a hypoxia activated stress response may affect miRNA maturation (reviewed in (Lin and 
Gregory, 2015)). Further, epigenetic regulations, transcription factor activity or genetic 
alterations can regulate the expression of a miRNA itself.  
Genomic alterations were associated with the deregulation of miRNA expression in 
a number of cancer studies. Frequent loss of genomic region 13q14 was associated with 
downregulation of mir-15a and mir-16a in chronic lymphocytic leukemia (Calin et al., 
2002). Similarly, systematic analysis demonstrated an association of let-7 family 
downregulation with the copy number changes and focal deletions in medulloblastoma, 
breast and ovarian cancer (Wang et al., 2012). Not only small genomic alterations, but 
also the gain of an extra chromosome arm, such as 1q in cervical cancer, have been related 
to altered miRNA expression (Wilting et al., 2012). Genome-wide analyses of regions 
encoding for miRNAs show a high frequency of copy number abnormalities in ovarian 
cancer, breast cancer, melanoma and lung cancer (Zhang et al., 2006; Czubak et al., 
2015). These results suggest that the alteration of miRNA expression originates from 
segmental or structural aneuploidy at least in some cancers. Mapping miRNAs to the 
human genome revealed that about 50% map to common fragile sites and 
cancer-associated genomic regions, which are regions with common breakpoints, frequent 
loss of heterozygosity or amplifications (Calin et al., 2004). These sites are associated with 
GIN in cancer, thus suggesting that miRNA deregulation due to genomic alterations might 
be the result of ongoing GIN in cancer. Two studies report no correlation between the 
copy number status and miRNA expression in haematopoetic cancer and acute myeloid 
leukemia (Ramsingh et al., 2013; Veigaard and Kjeldsen, 2014). This indicates that 
genomic copy number alterations might be just one of multiple causes of miRNA 
deregulation in cancer.  
Another association of aneuploidy and miRNAs in cancer might lie in the influence 
of miRNAs on GIN and CIN. For example, overexpression of miR-28-5p leads to the 
reduction of MAD2 levels, thus affecting the mitotic checkpoint and ultimately promoting 
CIN in four different human cell lines, among them a human colorectal cancer cell line 
(Hell et al., 2014). Conversely, inhibition of miR-28-5p restored chromosomal stability in 
renal carcinoma cells and an in vivo mouse model. In another study, deletion of a specific 
miRNA subset correlates with the occurrence of chromosomal aberrations across ovarian 
tumor samples (Choi et al., 2014): miR-1255b, miR-148b*, and miR-193b* specifically 
repress homologous recombination in G1 phase, thereby maintaining the balance between 
homologous recombination and non-homologous end joining. Depletion of these miRNAs 
was suggested to allow homologous recombination in G1, leading to mitotic 
recombination and loss of heterozygosity.  
In summary, miRNA deregulation can result from segmental and structural 
aneuploidy in cancer. In turn, miRNAs might promote GIN and CIN in some cases. The 
detrimental effects of aneuploidy on proliferation in model systems may be largely 
attributed to the gene dosage effects (see chapter 5.5.1). However, cancer cells are 
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characterized by sustained growth, hence they have seemingly overcome the adverse 
effects of aneuploidy (Hanahan and Weinberg, 2011). An intriguing possibility is that 
miRNAs might play a role in this adaptation process, for example by regulating the 
expression of dosage sensitive genes. A recent study suggests that miRNAs more frequently 
target dosage sensitive genes (Li et al., 2015). In this case, an integration of miRNA 
expression, target gene expression and copy number alterations revealed that miRNAs 
target amplified genes, thereby regulating their expression to normal levels in breast 
cancer, glioblastoma and ovarian cancer samples. miRNA-mediated alleviation of the 
consequences of copy number changes might be favored not only because of the dosage 
sensitivity of the repressed genes, but also to avoid negative effects on the proteostasis 
network. Thus, miRNA expression in cancer might contribute to the adaptation of cancer 
to the consequences of gene copy number alterations. However, the causal association of 
aneuploidy and miRNAs has not been studied in detail so far. In the cancer context, the 
complex molecular and genomic alterations diminish our chances to clearly map the link 
between aneuploidy and miRNA expression. Investigation of the miRNAome of different 
human aneuploid model cell lines in comparison to their diploid counterpart might help us 
to understand whether and how the miRNAome affects the cellular response to 
aneuploidy.  
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6 Results 
6.1 Unique features of the transcriptional response to model aneuploidy in human cells 
Dürrbaum M, Kuznetsova AY, Passerini V, Stingele S, Stoehr G, Storchová Z. Unique 
features of the transcriptional response to model aneuploidy in human cells. BMC 
Genomics 2014 Feb 18; 15 (1), 1–14. 
In this study we systematically investigated the effect of aneuploidy on the 
transcriptome in different human cell lines. Aneuploidy affects multiple different 
chromosomes either in form of whole-chromosome aneuploidy or as a complex aneuploidy 
with additional variable genomic aberrations and may originate from different sources. 
Compelling evidence from budding yeast suggests that the consequences of aneuploidy are 
caused by the cumulative changes in gene expression levels per se (Bonney et al., 2015; 
Thorburn et al., 2013; Torres et al., 2007). However, the transcriptional landscape of 
aneuploid human cells and their relation to known phenotypic consequences have not 
been comprehensively studied. Therefore, we analyzed the transcriptome of human 
aneuploid model cell lines of different types and origin.  
We found a common transcriptional response despite the different identity of the 
aneuploid chromosomes and variable cell types. The common response is characterized by 
the deregulation of similar pathways, in particular the up-regulation of categories 
associated with the endoplasmic reticulum, Golgi apparatus, lysosomes and vacuoles, 
membrane metabolism and MHC protein complex as well as antigen processing. 
Commonly downregulated annotation categories include DNA replication, DNA repair, 
transcription or RNA splicing. Moreover, this aneuploidy response pattern is similar in cell 
lines with complex aneuploidy that were derived from a tetraploid intermediate. Whereas 
common stress responses differ from the aneuploidy response pattern, the transcriptional 
changes due to impaired translation and autophagy partially resemble the aneuploid 
transcriptome changes. Despite similar pathway deregulation in all aneuploids, the genes 
that contribute to the overall deregulation differ between the aneuploid cell lines. Only 23 
genes show a similar deregulation in all aneuploid cell lines; several of these genes were 
previously linked to cancer.  
The identified common transcriptional response to aneuploidy indicates that the 
characteristic phenotypic consequences of aneuploidy such as impaired proliferation and 
activation of autophagy may originate from a similar transcriptional program. Aneuploidy 
in cancer is usually complex, affecting multiple different genomic regions. A common 
transcriptional response to aneuploidy in model cell lines might help to better understand 
the adaptations to the aneuploid karyotype in cancer, which most likely results in an 
evolved transcriptional response. Further, the 23 similarly deregulated genes might serves 
as markers for aneuploidy to assess tumor malignancy.  
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Abstract
Background: Aneuploidy, a karyotype deviating from multiples of a haploid chromosome set, affects the
physiology of eukaryotes. In humans, aneuploidy is linked to pathological defects such as developmental
abnormalities, mental retardation or cancer, but the underlying mechanisms remain elusive. There are many
different types and origins of aneuploidy, but whether there is a uniform cellular response to aneuploidy in
human cells has not been addressed so far.
Results: Here we evaluate the transcription profiles of eleven trisomic and tetrasomic cell lines and two cell
lines with complex aneuploid karyotypes. We identify a characteristic aneuploidy response pattern defined by
upregulation of genes linked to endoplasmic reticulum, Golgi apparatus and lysosomes, and downregulation of
DNA replication, transcription as well as ribosomes. Strikingly, complex aneuploidy elicits the same transcriptional
changes as trisomy. To uncover the triggers of the response, we compared the profiles with transcription changes
in human cells subjected to stress conditions. Interestingly, we found an overlap only with the response to
treatment with the autophagy inhibitor bafilomycin A1. Finally, we identified 23 genes whose expression is
significantly altered in all aneuploids and which may thus serve as aneuploidy markers.
Conclusions: Our analysis shows that despite the variability in chromosome content, aneuploidy triggers uniform
transcriptional response in human cells. A common response independent of the type of aneuploidy might be
exploited as a novel target for cancer therapy. Moreover, the potential aneuploidy markers identified in our analysis
might represent novel biomarkers to assess the malignant potential of a tumor.
Background
Aneuploidy, or a change in cellular chromosome numbers,
has profound effects on the physiology of all eukaryotic
cells analyzed to date [1]. Aneuploid yeasts are character-
ized by slow growth, altered sensitivity to various stresses
and increased genomic instability [2-4]. At the same time,
aneuploidy drives genetic variability and cellular adap-
tation capacity in yeast [5,6]. Plants are in general more
tolerant to gene dosage changes, yet aneuploidy often
impairs their vigour and alters their phenotype [7]. An-
euploid mammals are rarely viable and the sporadic
survivors are affected on multiple levels. In humans,
aneuploidy is responsible for a substantial proportion
of spontaneous abortions and the rare survivors with
trisomy of chromosome 13, 18 and 21 (Patau, Edward and
Down syndrome, respectively) are severely handicapped;
only trisomy 21 is compatible with survival until adult-
hood [8]. Aneuploidy is also linked to cancer, as nearly
90% of solid tumors and 75% of hematopoietic cancers
show abnormal chromosome dosage [9]. Recently it has
been shown that the occurrence of aneuploid cells in-
creases with aging [10] and an increased incidence of
aneuploidy in the brain has been linked to neurodegen-
erative diseases [11].
The exact mechanisms underlying the detrimental
effects of aneuploidy remain unclear, but it has been
convincingly shown that they are caused by the expression
of the extra genes on the supernumerary chromosome [3].
In most aneuploid cells the chromosome dosage changes
lead to correlating changes in mRNA (e.g. [3,12-15]) as
well as on protein levels [6,15,16]. These analyses further
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revealed that besides the increased abundance of transcripts
and proteins originating from the aneuploid chromosome,
the expression of multiple other genes is altered as well
[3,13,15,17]. This is likely a consequence of two different
phenomena. First, an increase in gene copy number of a
transcription factor or other regulatory factor might affect
transcription levels of genes on other chromosomes [18].
Second, specific pathways might be activated in a cellular
response to aneuploidy. Recent attempts to uncover the
consequences of aneuploidy suggest that aneuploidy indeed
instigates a specific response in eukaryotic cells [3,15,19].
Haploid yeast strains carrying an additional chromosome
(hereafter referred to as disomes) exhibit a common tran-
scriptional signature that has been previously identified in
budding yeast as a so called environmental stress response
that is triggered upon various exogenous stresses, such as
oxidative stress, heat shock or slow growth [3,20]. A similar
response was identified in a study comparing transcriptome
data from disomic and complex aneuploid strains of
budding yeast, partial aneuploids of fission yeast, aneu-
ploid Arabidopsis thaliana plant cells, mouse cell lines
with Robertsonian translocations that lead to trisomies,
and human cells from patients with trisomy syndromes
[19]. Additionally, comparative transcriptomics and prote-
omics of model human trisomic and tetrasomic cells
identified a common pattern in the transcriptional response
to aneuploidy [15]. These studies pointed out similarities in
the response to aneuploidy in most eukaryotes. At the same
time, the results showed that the response in mammalian
cells diverges from the response in other model organisms,
because the correlation of the transcription changes in
aneuploid mammalian cells with transcriptional changes
in other aneuploid species is rather modest [19]. More-
over, as there is no equivalent of the environmental stress
response identified so far in mammalian cells, it remains
unclear what triggers the transcriptional changes.
To obtain a comprehensive insight into the changes
specific for human cells, we evaluated in detail multiple
tri- and tetrasomic cell lines as well as model complex
aneuploid human cell lines with hypotetraploid karyo-
types more similar to cancer cells. Remarkably, we found
that the cellular responses to complex multichromoso-
mal aneuploidy and trisomy or tetrasomy of one single
chromosome closely correlate. As the identified pathway
pattern resembles the cellular stress response, we com-
pared the aneuploidy response to the transcriptional
changes in human cells subjected to various stress con-
ditions. Additionally, we have also identified 18 genes
that were upregulated and 5 genes downregulated in all
analyzed aneuploid cell lines and might thus serve as
markers of aneuploidy. This is the first study which
compares a variety of different human cell lines with
aneuploidy of different types and origins. By uncovering
a uniform aneuploidy response pattern our results outline
the cellular consequences of an abnormal karyotype in
human cells.
Results
Common cellular response to trisomy and tetrasomy in
human cell lines
Recently, we established de novo human aneuploid cell
lines that were derived from diploid and chromosomally
stable cells by a micronuclei-mediated chromosome trans-
fer [15]. We performed transcriptional analysis of the
original diploid cell lines and their trisomic and tetrasomic
derivatives (HCT116: trisomy of chromosome 3 – 3/3;
tetrasomy of chromosome 5 - 5/4; RPE1: trisomy of chro-
mosome 5 and 12 - 5/3 12/3, trisomy of chromosome
21 - 21/3, see Methods for further details) and calculated
the aneuploid-to-diploid fold change for all detected
mRNAs. Similarly, we calculated the relative aneuploid-
to-diploid ratio to determine the transcriptional changes
in trisomic human cells lines generated from the diploid
colorectal adenocarcinoma cell line DLD1 by introduction
of an extra copy of chromosome 3, 7 or 13 [13]. To
identify the similarities and differences among the
transcriptional profiles of the model aneuploid cell
lines in response to aneuploidy, we used an algorithm
called 2-dimensional annotation analysis that quantifies
the relative up- and downregulation of cellular pathways.
Hereby, abundance changes of all factors assigned to
each pathway are compared to the overall abundance
distribution and relative values are calculated [21]. Add-
itionally, significantly up- and downregulated pathways
were validated by the annotation enrichment tool DAVID,
which employs a different algorithm for the analysis (data
not shown) [22]. As expected, pathways altered and
enriched in the 2-dimensional annotation analysis were
also identified as enriched by DAVID in all cell lines.
Our analysis identified a specific pattern of pathways
that are altered in all compared model trisomic and tetra-
somic cell lines (Table 1). Among the most upregulated
categories we identified the endoplasmic reticulum (ER),
Golgi apparatus, lysosomes and vacuoles, membrane
metabolism and the MHC protein complex and anti-
gen processing. In contrast, DNA and RNA metabolic
pathways – e.g. DNA replication, repair, transcription or
RNA splicing - were significantly downregulated (Figure 1A,
Additional file 1: Figure S1A). Remarkably, although similar
pathways are up- and downregulated in all aneuploid cell
lines, we noticed that the specific factors that significantly
contribute to the differentiated regulation are variable.
For example, the members of the proton oligopeptide
cotransporter family SCL15 (Gene Ontology Cellular
Component “membrane, lysosome, lytic vacuole”) show
variable expression levels in the analyzed aneuploid cell
lines: SLC15A3 is upregulated in all of the HCT116 de-
rived aneuploid cell lines, but not in the RPE1 derived
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aneuploid cell lines, whereas SLC15A4 is upregulated
only in HCT116 H2B-GFP 5/4 and SLC15A1 is upregu-
lated in three out of seven aneuploid cell lines derived
from HCT116 and RPE1 (Additional file 2: Table S1).
Interestingly, DLD1 with trisomy of chromosome 7
shows only partial overlap with the other aneuploid cell
lines: pathways related to splicing and to DNA and RNA
metabolism were similarly downregulated, and vacuole
was upregulated, whereas additional changes in the tran-
scription profile differed from the other trisomic and
tetrasomic cell lines (Additional file 1: Figure S1B, Table 1).
We also determined the response to aneuploidy in three
clones with trisomy of chromosome 8 (here labeled as
HE35 8/3_1, 2, and 3) derived from human primary
embryonic fibroblasts HE35 by microcell-mediated chro-
mosome transfer [17]. Using the 2-D annotation analysis
algorithm, we observed similar changes in pathway regu-
lations in the HE35-derived trisomies as in the other
tri- and tetrasomic cell lines (Figure 1B, Additional file 1:
Figure S1C, Table 1). Taken together, the results indicate
that all the analyzed human cells with de novo created
trisomies and tetrasomies elicit a nearly identical pattern
of pathway changes regardless of the identity of the super-
numerary chromosome and the cell line.
Complex aneuploidy triggers the same pathway changes
as low-complexity aneuploidy
Next, we asked whether similar pattern of changes in
gene expression could be observed in cells with complex
aneuploidy. This type of karyotypic changes might more
closely resemble the situation observed in tumors that
often harbor multiple changes in chromosome numbers
and structures, including deletions, translocations and
amplifications [23]. To this end, we used cell lines derived
from HCT116 that underwent a transient tetraploidy
induced by cytokinesis failure (Figure 2A). As tetraploidy
leads to catastrophic mitosis and chromosomal instability,
the majority of cells die soon after the tetraploidization
[9,24], and the chromosome numbers of the few survivors
are remarkably altered (Figure 2B). We analyzed the tran-
scriptional changes identified in two clonal survivors,
cell lines HPT1 and HPT2, by calculating the fold
change of the transcripts in comparison to the original
HCT116. This first global analysis of the transcriptional
response in human cells with model complex aneuploidy
reproduced the pattern of pathway changes observed in
the tri- and tetrasomic cell lines (Figure 2C,D, Additional
file 1: Figure S1D, E, Table 1, Additional file 3). Im-
portantly, the duration of the cell cycle of the complex
aneuploid cell lines is indistinguishable from diploids
(Additional file 1: Figure S2). Previously, it has been
proposed that the transcriptional changes identified in
aneuploid cells are caused by the slow growth, which is
typical for model trisomic cell lines [3,14,15]. Thus,
our finding indicates that the response to aneuploidy
in mammalian cells is not always associated with a
slower progression through the cell cycle, and thereby
the slower proliferation cannot be the only cause of
the identified transcriptional changes.
Distance matrix of the Spearman rank correlation of
all analyzed cell lines confirmed the high similarity
among the transcriptional changes triggered by aneuploidy
Table 1 Pathway classes recurrently and significantly altered in aneuploid cell lines
Replication Transcription Ribosome Golgi ER Lysosomes Membrane
metabolism
Vacuole Mitochondria Spliceosome MHC class
proteins
HCT116 5/4 - - - + + + + + - - +
HCT116 3/3 - - - + + + + + - -
HCT116 5/4* - - - + + + (+) + - / +
HPT1 - - + - + + + + / - +
HPT2 - - - + + + + + + - +
RPE1 12/3
5/3
- - + + + + + + + + +
RPE1 21/3* - - - + + + + + - - +
DLD1 3/3 - - - + / / + + - - /
DLD1 7/3 - - / / / / / + / - /
DLD1 13/3 - - - + / / + + - - /
HE35 8/3_1 +/− - - - - / / +/− / + + /
HE35 8/3_2 - - - + + / +/− / +/− + +
HE35 8/3_3 - −/+ - + + + +/− + (+) + /
Asterisks indicate the cell lines expressing H2B-GFP.
/ = annotation not significantly altered.
+= annotation category upregulated.
- = annotation category downregulated.
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(Figure 2E). We call the identified common pattern of
transcriptional changes the Aneuploidy Response Pattern
(ARP). Our results demonstrate that trisomy can serve as
a valuable model for analysis of complex aneuploidy.
Moreover, the identification of ARP suggests that chromo-
somal imbalance itself might be exploited as a novel target
for cancer therapy regardless the type of aneuploidy and
the mechanism by which it was generated.
Comparison of the aneuploidy response pattern with
transcriptional responses to stress stimuli
What triggers the specific transcriptional response to
aneuploidy in human cells? Current analysis in budding
yeast suggests that mutations interfering with cell pro-
liferation result in similar gene expression changes as
aneuploidy [19]. Alternatively, the transcription changes
may be triggered by cellular stress caused by the presence
of an extra chromosome. Thus, we asked whether there
are stress stimuli that trigger reprogramming of gene
expression similar to the ARP. To this end, we compared
the transcription profiles of HCT116 cells exposed to
sub-lethal concentrations of hydrogen peroxide, nitric
oxide, hydroxyurea, actinomycin D and bafilomycin A1,
or grown under hypoxic conditions as well as in medium
with either low or high glucose (for further details see
Methods). Strikingly, the majority of the stressors trig-
gered pathway changes that are remarkably different
from the ARP (Figure 3A, Additional file 1: Figure S3).
In contrast, we observed a partial similarity between
the ARP and the transcriptional changes in HCT116
treated with actinomycin D, a polypeptide antibiotic that
inhibits the activity of RNA polymerases (Figure 3B,D).
The 2-D annotation analysis revealed that treatment
with actinomycin results in downregulation of DNA- and
RNA- metabolism as well as in upregulation of ER,
membrane metabolism and lysosome. This might indicate
that the downregulation of DNA- and RNA metabolism
in aneuploid cell lines is due to transcriptional inhibition
and its consequences. However, the overlap includes only
a few genes with a low Spearman correlation coefficient
and thus the distance of the Spearman rank correlation is
higher compared to the distances between the aneuploid
cell lines (Figure 3D). Remarkably, treatment with
bafilomycin A1 that inhibits vacuolar-ATPases showed
transcriptional changes nearly identical to the ARP
(Figure 3C,D). Bafilomycin A1 impairs vesicle fusion
[25] and thus inhibits the final steps of autophagy due
to the failure of autophagosome-lysosome fusion. As
in aneuploids, the transcriptional changes include down-
regulation of DNA and RNA metabolism, whereas mem-
brane associated annotations are upregulated. In contrast,
treatment with bafilomycin does not lead to upregulation
of ER, Golgi or lysosomal pathways (Figure 3C). The simi-
larity with transcriptional effects of autophagy-inhibiting
drug suggests that one of the main consequences of aneu-
ploidy in human cells is the overload of the autophagic
pathway. Taken together, our findings imply that the tran-
scriptional changes in response to aneuploidy differ from
most of the common stress responses, but show shared
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Figure 1 Pathway alterations in tri- and tetrasomic cell lines.
A. 2-dimensional pathway analysis comparison of HCT116 with
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chromosome 21. Asterisks indicate the cell lines with H2B-GFP.
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Figure 2 Complex aneuploidy triggers similar pathway changes as trisomy or tetrasomy. A. Schematic depiction of the construction
of aneuploid cell lines with complex karyotype changes. B. Chromosome numbers in clonal cell lines originating from an unstable tetraploid
intermediate. The numbers above the plot indicate the median chromosome number. C. 2-dimensional pathway analysis comparison of the complex
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Asterisks indicate the cell lines with H2B-GFP.
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features with response to conditions limiting autophagy
and transcription.
Markers of aneuploidy
Our results imply the existence of factors with recurrent
expression changes triggered by aneuploidy that might
serve as general markers of aneuploidy in human cells. To
identify genes that are consistently up or downregulated
in aneuploid cells, we merged all available datasets of
aneuploid cell lines created in our laboratory. This
yielded 18 genes whose expression is more than 1.4 fold
increased and 5 genes whose expression is more than
1.4 fold decreased in all analyzed aneuploids (Figure 4,
Table 2). The changes in mRNA levels are consistent
with proteomics measurements in 7 out of 8 proteins for
which the data are available [15] (Table 2). Importantly,
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expression of only one of these 23 genes (FRY) is similarly
upregulated by the stress stimuli, suggesting that the
recurrent expression changes are indeed in response to
aneuploidy. Using quantitative real-time PCR we validated
the expression levels of four of the identified upregulated
genes in eight aneuploid cell lines and corresponding
diploid controls (RAB27B, COL13A1, HOXB5, GLRX).
This approach confirmed overexpression of all four genes
in response to aneuploidy. Interestingly, none of the tested
transcripts was confirmed in one of the complex aneu-
ploid cell line, HPT1 (Figure 5). These candidate markers
could potentially enable the discrimination of tumors with
low frequency of aneuploid cells from tumors with high
levels of aneuploidy and thus higher malignant potential.
Further experiments will be required to determine
whether the candidate markers can be used for clinical
purposes for example by standard immunohistochemistry.
Discussion
Significant recent progress in the analysis of aneuploidy
in eukaryotes has revealed multiple novel features linked
to aneuploidy such as growth defects, abnormal protein
homeostasis and increased genomic instability. These fea-
tures appear to be conserved among eukaryotes, an obser-
vation which is further supported by the finding that
the transcriptional response to aneuploidy in different
species remarkably correlates [19]. We analyzed in detail
the transcriptional changes in aneuploid human cells by
comparing the calculated aneuploid-to-diploid ratio. The
comparison of eleven aneuploid model cell lines derived
from four different diploid progenitor cell lines by either
chromosome transfer of seven different chromosomes or
by clonal propagation from unstable tetraploid progenitors
revealed a striking similarity among the cell lines. The
identified signature of pathways that was altered in all
analyzed cell lines, which we term the aneuploidy response
pattern - ARP - is characterized by upregulation of the ER
and Golgi related pathways, lysosome and lytic vacuoles,
MHC protein complex and antigen processing, whereas
DNA and RNA metabolism and ribosome-related path-
ways were always downregulated (Figures 1, 2, Tables 1,
2). Our results reveal that the transcriptional changes to
aneuploidy in human cells are not mediated by a canonical
p53-dependent stress response, because DLD1 and its
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aneuploid derivatives carry mutant p53. A remarkable
feature of the identified transcriptional changes is that
although similar pathways are up- and downregulated
in individual aneuploids, the individual genes whose
expression is altered are often variable among the dif-
ferent cell lines. Furthermore, several pathways were
up- or downregulated in the analyzed cells that were
not recurrent and thus cannot be regarded as a general
consequence of aneuploidy per se. These changes are
probably specific to the type of extra chromosomes as
well as to the clonal selection. We also show for the
first time that the pathway changes in human cells with
complex, hypotetraploid karyotypes correlate with the
changes identified in simple trisomies. Thus, the analysis
of model trisomic cell lines might provide important
insights into the role of the more complex aneuploidy
that is frequently found in cancer.
Two of the analyzed cell lines (trisomy 7 in DLD1 and
one of the three clones of trisomy 8 in HE35) showed
only a partial aneuploidy response pattern (Additional
file 1: Figure S1B). There are several possible scenarios
to explain this finding. First, loss of some chromosome
parts or a mosaic aneuploid population could lead to a
weakening of the ARP. However, the transcription levels
of the transcripts coded on the extra chromosomes were
elevated in these cell lines as expected, which excludes
this possibility. Alternatively, features specific to the
supernumerary chromosome can be responsible for the
difference, such as in case of chromosome 7. This has
been previously observed in budding yeast, where some
disomes, e.g. disome of chromosome 1, do not trigger
the environmental stress response pattern (ERS) other-
wise observed in other disomic strains [3]. In support
of this possibility is the observation that chromosome 7
Table 2 List of consistently up- and downregulated transcripts (cut off 1.4 fold change)
Gene Chromosome Function Protein
levels
Link to cancer?
1 PLAUR 19 Plasminogen activator, urokinase receptor 4/5 Ovarian and colorectal cancer
2 RAB27B 18 Secretory GTPase 4/4 Breast cancer
3 P4HA2 5 Procollagen-proline 4/6 Metastasis
4 FRY 13 Regulator of actin cytoskeleton 0/3
5 BDKRB1 14 Bradykinine receptor NA Breast and lung cancer
6 HOXB5 17 Transcription factor NA Leukemia, ovarian carcinoma and
others
7 GDF15 19 Growth differentiation factor 1/2 Ovarian and prostate cancer
8 OASL 12 2'-5'-oligoadenylate synthetase-like NA
9 SERPINE2 2 Serpine protease inhibitor 4/4 Metastasis
10 IFI44 1 Interferon-induced protein 44 NA
11 AMDHD1 12 Protein with amidohydrolase domain NA
12 TMEM171 5 Transmembrane protein 171 NA
13 GLRX 5 Glutaredoxin 4/4 Pancreatic cancer
14 TMEM169 2 Transmembrane protein 169 NA
15 DMBT1 10 Membrane glycoprotein NA Multiple cancers
16 COL13A1 10 Collagen type XIII, alpha1 1/1
17 SH2D1B 1 Signal transduction control NA
18 MIA Melanoma inhibitory activity NA Neuronal tumors
1 XYLB 3 Xylulokinase homologue NA
2 LOXL3 2 Lysyl oxidase homologue NA
3 MYB/NFIB
fusion
6 Myb – NFIB fusion NA
4 EEPD 7 Endonuclease/exonuclease/phosphatase domain
containing
NA
5 ARHGEF39 9 Rho guanine nucleotide exchange factor 39 NA
The column “Protein levels” shows how often corresponding changes of the protein levels were identified by Stingele et al. [15] (number of cell lines with altered
protein expression/number of cell lines where the protein was quantified; NA – proteomics data not available). The rows 1-18 show upregulated genes; the rows
1- 5 (below) show downregulated genes.
Dürrbaum et al. BMC Genomics 2014, 15:139 Page 8 of 14
http://www.biomedcentral.com/1471-2164/15/139
is one of the few chromosomes which is more often
gained than lost in chromosomally unstable cancer cells
[26]. Thus, an extra copy of chromosome 7 likely repre-
sents a lesser burden for the cells than most of the
other chromosomes. Finally, the deviation from the ARP
might arise due to a mutation occurring during the clonal
selection after the chromosome transfer. This is likely
the case in HE35 8/3, where two clones correlate stron-
ger with other aneuploids than the third trisomy 8
clone (Figure 2E). Despite these exceptions, our results
show that aneuploidy triggers a uniform transcriptional
response in human cells that is independent of the
identity and quantity of the extra chromosomes and
their combination as well as of the cell line type.
The ARP is characterized by strong downregulation of
DNA and RNA metabolism, which correlates with the
slow growth observed in nearly all aneuploid cells analyzed
to date. Indeed, many factors required for DNA replication
are less abundant, such as the heterohexameric replicative
helicase MCM (Additional file 2: Table S1), and this may
partially explain the previously observed slow progression
through the S-phase [15]. However, the complex aneuploid
cell lines progress through interphase at a rate closely
matching the rate of the corresponding diploid cell
lines and yet the levels of factors involved in replication
are similarly decreased (Additional file 1: Figure S2).
Therefore, we conclude that the proliferation impairment
cannot be the only cause of ARP.
DNA repair is significantly downregulated, which might
lead to increased accumulation of DNA damage. The
abundance changes in the DNA replication and repair
factors might explain how aneuploidy increases genome
instability, as has been observed in yeast [4] as well as
in human aneuploids (S.S., V.P., Z.S., unpublished results).
RAB27B
0
2
4
6
8
10
15
20
25
30
fo
ld
ch
an
ge
to
di
pl
oi
d
HOXB5
0
1
2
3
4
8
10
12
14
fo
ld
ch
an
ge
to
di
pl
oi
d
GLRX
0
1
2
3
4
fo
ld
ch
an
ge
to
di
pl
oi
d
COL13A1
0
2
4
6
8
10
40
50
60
70
80
fo
ld
ch
an
ge
to
di
pl
oi
d
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
A B
C D
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
Figure 5 Quantitative real-time PCR analysis of putative aneuploidy markers. A. Fold change mRNA expression levels of COL13A1
quantified by real-time PCR. B. Fold change mRNA expression levels of RAB27B. C. Fold change mRNA expression levels of HOXB5. D. Fold change
mRNA expression levels of GLRX. Asterisks indicate the cell lines expressing H2B-GFP.
Dürrbaum et al. BMC Genomics 2014, 15:139 Page 9 of 14
http://www.biomedcentral.com/1471-2164/15/139
Further research should elucidate what are the causes
of the consistent downregulation of DNA metabolism
pathways and what consequences it brings upon aneu-
ploid cells.
Among the most upregulated pathways we observed
the Golgi network, ER related pathways, lysosomes and
lytic vacuoles, membrane metabolism and the MHC
protein complex and antigen processing. The function
of MHC protein complexes is to display fragments of
proteins from within the cell to immune cells [27]. Cur-
rently we do not understand the reasons for the increased
levels of the MHC protein complex transcripts in aneu-
ploid cells. We hypothesize that increased protein expres-
sion and degradation elevates the peptide presentation
by MHC complex, thus elevating the immunogenicity of
aneuploid cells, similarly as it has been recently observed
in murine aneuploid tumors [28]. In the future it will be
important to confirm this observation on the protein level
and to determine whether the MHC proteins are correctly
localized and functional.
Elevated expression of ER related genes might suggest
an expansion of the ER that was shown in budding
yeast to occur in order to alleviate ER stress [29]. This
phenomenon is accompanied by elevated lipid biosyn-
thesis, but unchanged amounts of ER chaperones [29],
which closely resembles the transcriptional changes
observed in aneuploid cell lines. This suggests, together
with the fact that mouse trisomic MEFs are more sensitive
to the Hsp90 inhibitor 17-AAG [30], that aneuploid cells
suffer from protein folding defects, most likely due to the
saturation of the cellular folding capacity [31]. ER stress
is often observed in various cancers, where it is usually
attributed to tumor microenvironments characterized by
hypoxia, nutrient limitation and low pH [32]. It will be
interesting to test whether chromosomal copy number
changes also contribute to the ER stress in cancer cells.
Previously, it was proposed that the transcriptional
response to aneuploidy is indicative of stress and slow
growth [1]. Therefore, we were interested whether
treatment with stress inducing agents will elicit similar
response as the presence of an extra chromosome. Since
chromosome missegregation was shown to trigger oxi-
dative stress [24,33], we analysed the transcriptional
response to oxidative stress inducers nitric oxide and
hydrogen dioxide. Aneuploidy was also recently linked
to DNA damage and replication stress [34], therefore
we analyzed the response to the replication inhibitor
hydroxyurea and transcription inhibition by actinomycin
D. Further, aneuploidy was shown to trigger proteotoxic
stress and to activate autophagy [3,15,30,31]. Therefore,
we compared the response to aneuploidy to the tran-
scriptional changes elicited by cells grown under hypoxic
conditions, which is known to result in energy and ER
stress with subsequent proteotoxic stress. Similarly, we
tested the transcriptional changes in cells where au-
tophagy was inhibited, a condition known to trigger
proteotoxic stress. The comparison with transcription
profiles of cells grown on high or low glucose was of
particular interest, because aneuploid cells show changes
in the metabolic pathways and higher energy demands
[3,14,15]. Remarkably, we found that none of the stress
conditions triggers response similar to ARP.
The only significant exception was the striking similarity
between the ARP and the transcriptional changes observed
in cells treated with sub-lethal concentrations of bafilomy-
cin A1 (Figure 3). Treatment with bafilomycin A1 leads to
the accumulation of vesicles and membranes and reduces
cell proliferation. The similarity of cellular response to
inhibition of autophagy and to aneuploidy might suggest
that aneuploidy inhibits autophagy. This however is not
true as we previously documented by an observation that
autophagic flux (the dynamic flow through autophagy) is
in aneuploids as efficient as in diploids [15]. Inhibition
of basal autophagy by bafilomycin A1 treatment causes
proteotoxic stress [35]. Current data suggest that aneu-
ploidy leads to proteotoxic stress as well [31]. We propose
that the similarity between the transcriptional response to
treatment with bafilomycin A1 and the ARP is because
both reflect transcriptional changes in cells suffering from
proteotoxic stress. In general, the effect of bafilomycin A1
further emphasizes the role of autophagy in mammalian
aneuploids. Aneuploidy leads to activation of autophagy
in human and mouse cells [15,30] and aneuploid cells
are more sensitive to the autophagy inhibiting drug
chloroquine [30]. The consistent upregulation of lysosomes
and lytic vacuoles appears to be specific for mammalian
cells as it was not observed in aneuploid yeasts and plants
[19]. In this context it is interesting that there is nearly no
correlation of ARP and transcriptional changes upon low
glucose condition, which is known to trigger autophagy
(Additional file 1: Figure S3). We believe that this is
because autophagy in aneuploids is not activated by energy
or nutrition deprivation, but by different, so far unidenti-
fied triggers [36]. Partial overlap of ARP was also observed
with the response to treatment with the drug actinomycin
D that represses transcription by RNA polymerase and,
among other effects, leads to an imbalance of ribosomal
subunits [37]. Transcription-related pathways are also
downregulated in aneuploids, suggesting the possibility
that some of the phenotypic features of aneuploid cells
might be caused by transcriptional deficiency.
Our work has also allowed the identification of several
genes that were consistently up- or downregulated in an-
euploid cell lines, but not in the HCT116 cells under
stress stimuli. Several of the identified factors have been
previously linked to cancer (Table 2). For example the
plasminogen activator and urokinase receptor PLAUR/
UPAR is frequently overexpressed in ovarian and
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colorectal cancers, where it facilitates cell motility and
metastatic potential and emerges as a marker of malig-
nancy [38]. P4HA2 is a precursor of collagen and a metas-
tasis marker [39] and HOXB5 is a homeobox
transcription factor whose overexpression has been
found in several malignant tumors [40]. Transcription of
the TGFβ superfamily cytokine GDF15 (growth differenti-
ation factor 15) is increased in multiple solid tumors,
where it promotes tumor growth and confers resist-
ance to several drugs such as bortezomib. Recent studies
proposed GDF15 as a prognostic marker for ovarian and
pancreatic carcinoma [41], two types of malignancies
with frequent aneuploidy and chromosomal instability
[9]. Glutaredoxin (GLRX) protects cells from oxidative
stress and serves as a potential marker of malignancy
in pancreatic carcinoma. Interestingly, some of the fac-
tors such as a xylulokinase homologue (XYLB), the 2′-5′-
oligoadenylate synthetase like (OASL) and the interferon-
induced protein (IFI44) have not been so far linked to can-
cer and may represent markers of aneuploidy that are not
linked to malignancy.
Aneuploidy is associated with poor prognosis and in-
creased drug resistance in tumors [42]. This suggests an
interesting possibility that some of the genes that are
expressed at higher levels in response to aneuploidy
in non-transformed cells may subsequently enhance
the malignant potential of these cells, whereas higher
expression of others might represent a barrier for car-
cinogenesis. The expression of the marker genes, if
confirmed in a wide range of aneuploid cell lines and in
cancer cells, might provide an excellent tool for cancer
biology and treatment, because it may allow distinguish
tumors with high aneuploidy from predominantly diploid
tumors. Moreover, pathways that are activated or inhibited
by aneuploidy may serve as novel targets for cancer
treatment. This has been recently demonstrated by the
fact that aneuploid cells are more sensitive to drugs
inhibiting HSP90, autophagy inhibitors and inhibitors
of the AMPK kinase, which strongly correlates with the
identified increased requirements for autophagy, protein
folding and energy metabolism in aneuploid mammalian
cells ([15,30] and this work). Further research should
elucidate the efficacy of this approach. Our work for the
first time identifies global changes in a broad spectrum of
human aneuploid cell lines and may therefore help to
generate new hypothesis for cancer treatments.
Conclusions
In this study we identified a transcriptional aneuploid re-
sponse pattern (ARP), a set of transcriptional changes,
common in a broad range of human aneuploid model
cell lines. This, for the first time, shows that complex
aneuploidy, which is frequently found in cancer cells,
exhibits the same transcriptional pathway changes as
simple trisomy and tetrasomy. A general response to
aneuploidy, as identified here in a variety of aneuploid
model cell lines, might serve as a novel therapeutic
target in cancer treatment. Further, we found 23 genes
consistently deregulated in our model aneuploid cell
lines. A confirmation of these markers in aneuploid
cells might open new strategies for identifying aneu-
ploid tumors. Since the fraction of aneuploid cells in
tumor correlates with malignant potential and poor
prognosis in cancer, simple and reliable biomarkers for
aneuploidy may help for determining the appropriate
cancer therapy.
Methods
Cell lines
Following model aneuploid cell lines were used for data
analysis: parental cell line HCT116 (human colon car-
cinoma cell line): HCT116 3/3 (trisomy 3), HCT116 5/4
(tetrasomy 5) [43]; parental cell line HCT116 H2B-GFP:
HCT116 5/4 (tetrasomy 5) [15], HPT1, HPT2 (hyperte-
traploids with complex karyotypes, A.Y.K. unpublished
data); parental cell line RPE1 (human retinal pigment
epithelial cell line, hTERT immortalized): RPE15/3 12/3
(trisomy 5, 12); parental cell line RPE1 H2B-GFP: RPE1
21/3 (trisomy 21) [15]; parental cell line DLD1 (human
colon adenocarcinoma cell line): DLD1 3/3 (trisomy 3),
DLD1 7/3 (trisomy 7), DLD1 13/3 (trisomy 13) [13], par-
ental cell line HE35 (human embryonic cell line): HE35
8/3, clones 1–3 [17].
Cell cultures
The HCT116- and RPE1- derived tri- and tetrasomic cell
lines have been described previously [15]. The post- tetra-
ploid cell lines HPT1 and HPT2 were generated by expan-
sion of individual tetraploids formed by induced inhibition
of cytokinesis through dihydrocytochalasin treatment. The
DNA content was determined by flow cytometry, standard
karyotyping, chromosome painting and array comparative
genomic hybridization as in [15]. Cells were maintained
in 10 cm dishes in Dulbecco’s Modified Eagle Medium
(DMEM) at 37°C and 5% CO2. Culture medium was
supplemented with growth factors from 5% Fetal Calf
Serum (FCS) and 1% Penicillin/ Streptavidin to avoid
bacterial growth and contamination. Specific antibiotics
were added to the medium when necessary to maintain
the supernumerary chromosomes. Cell lines were cultured
at 70- 90% confluence for a maximum of 10 passages.
Material for transcription analysis was obtained at
the earliest possible time point, after sufficient amount
of cells was achieved, approximately 25 generations
after the chromosome transfer or tetraploidization, re-
spectively. Similar approach was taken for the analysis
of trisomy 8 HE35-derived clones [17]. The mRNA of
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DLD1-derived aneuploids was isolated from multiple
different passages [13].
Cell growth analysis
Freshly cultured cells that carry H2B-GFP to fluorescently
label the chromosomes were seeded 24 h before the ex-
periment. Time laps movies were taken by imaging
asynchronous cells in a 10 min or 4 min interval for
72 or 48 h, respectively. The time in interphase was
measured as the time from nuclear envelope reformation
to nuclear envelope break down.
Quantitative real-time PCR
Total RNA was extracted with the RNeasy Mini Kit
(Qiagen), treated with DNAse (recombinant DNase, Roche)
and subsequently transcribed into cDNA (Transcriptor
First Strand cDNA Synthesis Kit, Roche Diagnostics).
Specific primers were designed using PrimerBlast; the
sequences are listed below. Quantitative PCR was
conducted using the Light Cycler 480 System (Roche
Diagnostics) with the KAPA SYBR FAST master mix
optimized for Roche Light Cycler 480 (KapaBiosystems).
Absolute quantification with an external standard was
performed and negative non-template controls were
tested in all experiments. The specificity of the primer
product amplification was confirmed in each run by
melting curve analysis. mRNA expression was normalized
to the control gene coding for ribosomal protein L30
(RPL30) and fold change to corresponding diploid mRNA
expression was calculated. Primers: COL13A1 – forward:
GGGGGAAGCAGGACTAGATG, reverse: CCTGAAGCT
CCGGGTAGTC, RAB27B - forward: TGCGGGACAAGA
GCGGTTCCG, reverse: GCCAGTTCCCGAGCTTGCCG
TT, HOXB5 - forward: TCCACAAATCAAGCCCTCCA,
reverse: GTCCGGGCCATTTGGATAAC, GLRX – forward:
AACGGTGCCTCGAGTCTTTA, reverse: CCTATGAGATC
TGTGGTTACTGC.
mRNA expression analysis by microarrays
Genome-wide expression profiling of HCT116- and RPE1-
derived aneuploid cells lines was conducted in three
replicates by IMGM laboratories GmbH (Martinsried,
Germany) as previously described [15]. cDNA was hybrid-
ized on Agilent Whole Human Genome Oligo microarrays
(4x44K format) for HCT116 diploid and HCT116 5/4,
or Agilent SurePrint G3 Human GE microarrays (8x60K)
for the other cell lines according to a One-Color based
hybridization protocol. Raw data was background normal-
ized. The data has been deposited in the NCBI Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/) accessible through GEO Series accession number
GSE47830 and GSE47836.
Microarray data of trisomic and diploid colorectal can-
cer cell lines DLD1 [13] were kindly provided by Thomas
Ried (National Institutes of Health, Bethesda, Maryland,
USA). All other mRNA expression data were obtained
from NCBI’s Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/). HCT116 cell line grown under high
and low glucose conditions: accession number GSE31084;
HCT116 after stress treatment: accession number GSE3176;
HCT116 cell line treated with actinomycin D: with
GSE12459, human embryonic diploid and trisomic
cells: accession number GSE28076.
Microarray normalization
Bioinformatics analysis of the microarray data was per-
formed using Perseus (1.2.6.16) as part of the MaxQuant
Software Package [21] and R on the free open source
integrated development environment R Studio. The gBG
SubSignal (green Background Subtracted Signal) from
background-normalized cDNA microarray data was used
for further normalization. The background-subtracted raw
intensities were log2 transformed and global normal-
ization of the log transformed raw data was performed by
subtracting the median of the overall signal intensities for
one experiment from each signal in this experiment. Probe
sets for one gene were summarized by taking the median.
The median of replicative probes signal intensities was
calculated for each cell line. For comparison of each
aneuploid cell line with the corresponding diploid cell
line gene, expression fold change ratios were calculated.
Data analysis
The Student’s t-test was performed to verify the statis-
tical significance of the fold change in mRNA expression
between the signal intensities of aneuploid and diploid
cell line. To correct the test statistics for multiple com-
parisons, false discovery rate control of the p-values was
applied. Both local and frequent FDR were calculated
with the “fdrtool” package [44]. For further analysis, a
fold change cut off 1.4 in mRNA expression was applied.
To investigate the correlation between the cell lines, a
distance matrix of the Spearman rank correlation coeffi-
cient was calculated in R using the “ClassDiscovery”
package in the OOMPA library and “mclust” package.
Distance of the correlation was visualized in a colored
matrix in the “spatstat” package. To investigate a global
response to aneuploidy on gene level, data sets were
filtered for those genes more than 1.4 fold up- or down-
regulated in all HCT116 and RPE1 derived cell lines.
The resulting gene lists were analyzed for their function
and relation using the DAVID functional annotation tool
[22], KEGG pathway and the NCBI Gene database.
Pathway enrichment analysis
Pathway enrichment analysis was conducted in Perseus
using the 2-dimensional annotation enrichment tool [21].
Thereby, enriched GO and KEGG annotations were
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identified by testing whether genes in an annotated cat-
egory have a significant preference to be altered com-
pared to the global fold change data distribution.
Significance was tested by a t-test followed by a false
discovery rate correction in the Benjamini-Hochberg
procedure (FDR cut off 0.02). Expression values for sig-
nificant enriched annotations were summarized in an
annotation score from −1 to 1 to represent levels of up-
or downregulation. Significant and enriched annotations
were summarized in larger, general categories for
visualization purposes. 2-dimensional annotations en-
richments of two cell lines were plotted in R. Highly up-
or downregulated pathways were cross validated by sub-
mitting the fold change cut off datasets to the annotation
enrichment tool DAVID [22].
Statistical analysis
Commonly used R packages were “lattice” [45], “genefilter”
[46], “fdrtool” [44] and “calibrate” [47]. In addition, Perseus
(1.2.6.16) as part of the MaxQuant Software Package [21]
was used for microarray analysis. All statistically evaluated
experiments were performed in at least three independent
biological replicates. The final plots were prepared in
GraphPad Prism 5 software or R.
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6.2 HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of 
aneuploid human cells 
Donnelly N, Passerini V, Dürrbaum M, Stingele S and Storchová Z. HSF1 deficiency and 
impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells. The 
EMBO journal 2014 Oct 16; 33(20):2374-87. Reproduced with permission from EMBO. 
In this study we investigated the effects of aneuploidy on the proteostasis network 
of human cell lines. It was previously shown that aneuploid cell lines exhibit features of 
proteotoxic stress such as sensitivity to inhibition of protein synthesis and folding as well 
as accumulation of cytoplasmic protein deposits and autophagy activation (Oromendia et 
al., 2012; Stingele et al., 2013; Tang et al., 2011; Torres et al., 2007). However, the 
underlying molecular mechanisms of these phenotypes have not been clear. 
To study the effect of aneuploidy on proteostasis network functions such as protein 
folding, we investigated the cellular sensitivity to protein folding stress as well as 
abundance and activity of the chaperone system. Aneuploid cell lines show impaired 
folding of a firefly luciferase sensor protein under normal conditions. In particular, the 
HSP90-dependent protein folding capacity appears to be compromised. Furthermore, 
viability of aneuploid cells is specifically sensitive to HSP90 inhibition, but not to other 
protein folding stresses. This goes in hand with reduced levels of HSP90 family expression. 
Moreover, global proteome analysis revealed that the abundance of HSP90 clients is 
reduced and that the proteome of aneuploid cells shows similar changes to the proteome 
after HSP90 inhibition. As an underlying cause we identified reduced expression levels 
and activity of HSF1. Overexpression of HSF1 mitigated the protein folding defect as well 
as the sensitivity to HSP90 inhibition. Moreover, aneuploid clones with an endogenous 
extra copy of HSF1 proliferated markedly better than other aneuploid cell lines. Finally, 
the overall transcriptional profile of aneuploid cells resembles the transcriptional profiles 
of cells with functional deficiency of HSF1. 
Compromised HSF1 activity was identified as the key causative factor of impaired 
proteostasis, but also contributes to the phenotypic alterations of aneuploid cells. HSF1 
overexpression is the first aneuploidy-tolerating mutation identified in higher eukaryotes 
so far. Given that HSF1 region is frequently amplified in cancer, this reveals a new link 
between aneuploidy and HSF1 in tumorigenesis. 
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Abstract
Aneuploidy is a hallmark of cancer and is associated with malig-
nancy and poor prognosis. Recent studies have revealed that aneu-
ploidy inhibits proliferation, causes distinct alterations in the
transcriptome and proteome and disturbs cellular proteostasis.
However, the molecular mechanisms underlying the changes in
gene expression and the impairment of proteostasis are not under-
stood. Here, we report that human aneuploid cells are impaired in
HSP90-mediated protein folding. We show that aneuploidy impairs
induction of the heat shock response suggesting that the activity
of the transcription factor heat shock factor 1 (HSF1) is compro-
mised. Indeed, increased levels of HSF1 counteract the effects of
aneuploidy on HSP90 expression and protein folding, identifying
HSF1 overexpression as the first aneuploidy-tolerating mutation in
human cells. Thus, impaired HSF1 activity emerges as a critical
factor underlying the phenotypes linked to aneuploidy. Finally, we
demonstrate that deficient protein folding capacity directly shapes
gene expression in aneuploid cells. Our study provides mechanistic
insight into the causes of the disturbed proteostasis in aneuploids
and deepens our understanding of the role of HSF1 in cytoprotec-
tion and carcinogenesis.
Keywords aneuploidy; cancer; HSF1; HSP90; protein folding
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Introduction
Aneuploidy is defined by karyotypes that differ from multiples of
the haploid chromosome set. Aneuploidy is not well tolerated in
higher eukaryotes and represents one of the leading causes of spon-
taneous abortions in humans, with the rare surviving newborns
suffering from multiple defects (Colnaghi et al, 2011). Moreover,
aneuploidy is prevalent in cancer, where nearly 80% of solid tumors
and approximately 60% of hematopoietic cancers show karyotypes
differing from normal diploidy (Stankiewicz & Lupski, 2010). At the
cellular level, aneuploidy is often associated with global pathway
deregulation, impaired proliferation, increased energetic and meta-
bolic demands and altered sensitivity to cytotoxic drugs (Upender
et al, 2004; Niwa et al, 2006; Torres et al, 2007; Williams et al,
2008; Pavelka et al, 2010; Nawata et al, 2011; Stingele et al, 2012).
The cellular response to aneuploidy is highly conserved from yeast
to human and remarkably, appears to be largely independent of the
exact karyotypic composition (Sheltzer et al, 2012; Stingele et al,
2012; Durrbaum et al, 2014). Experiments in budding yeast have
shown that the mere presence of a transcriptionally silent additional
chromosome does not lead to any apparent phenotypes; hence,
taken together, it is the gene expression of the aneuploid genome
that determines the phenotypic changes observed in aneuploids
(Torres et al, 2007). However, in spite of these important insights,
the molecular mechanisms underlying these global cellular changes
are not yet fully understood.
Recent progress in understanding the cellular effects of aneu-
ploidy was facilitated by analysis of model aneuploid cells with
defined karyotypic changes such as aneuploid budding and fission
yeast strains, fruit flies with segmental aneuploidy, mouse embry-
onic fibroblasts with unbalanced Robertsonian translocations and
trisomic and tetrasomic human cell lines (Upender et al, 2004; Niwa
et al, 2006; Torres et al, 2007; Williams et al, 2008; Stenberg et al,
2009; Pavelka et al, 2010; Nawata et al, 2011; Stingele et al, 2012).
Analysis of disomic budding yeast revealed increased sensitivity to
drugs that interfere with protein synthesis and degradation (Torres
et al, 2007). Moreover, the proliferation defect of some disomies can
be ameliorated by mutation of the Ubp6 protein, a deubiquitinating
enzyme that was proposed to negatively regulate protein degrada-
tion (Torres et al, 2007, 2010). In line with these findings in yeast,
aneuploidy in murine and human cells imposes profound changes in
protein homeostasis (proteostasis). Human trisomic cells show an
accumulation of cytoplasmic foci positive for both ubiquitin and
SQSTM1/p62, a marker of selective autophagy (Stingele et al, 2012).
Further, primary trisomic MEFs are sensitive to chemical inhibition
of the chaperone HSP90 as well as to the inhibitor of autophagy
chloroquine (Tang et al, 2011). In agreement with this finding,
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chromosomally unstable aneuploid cancer cell lines are more sensi-
tive to HSP90 inhibition than chromosomally stable cell lines (Tang
et al, 2011). A recent study demonstrates that aneuploid budding
yeast harbor protein aggregates and that protein folding of HSP90
clients is compromised in these cells (Oromendia et al, 2012). These
results suggest that the protein expression from supernumerary
chromosomes places a burden on cellular proteostasis and that the
HSP90 machinery might be particularly affected. However, the status
of HSP90 function and the protein folding capacity of aneuploid cells
in higher eukaryotes were so far unknown.
Here, we demonstrate for the first time that protein folding is
significantly impaired by aneuploidy in human cells. Taking advan-
tage of trisomic and tetrasomic human cells that we constructed
using micronuclei-mediated chromosome transfer into the human
near-diploid colorectal cancer cell line HCT116 and human immor-
talized retinal pigment epithelial cell line RPE-1 (Stingele et al,
2012), we show that in particular HSP90-mediated protein folding is
compromised. Intriguingly, we found that HSF1-dependent activa-
tion of the heat shock response (HSR) is impaired, suggesting a
mechanism by which aneuploidy impairs protein folding capacity.
Importantly, endogenous or exogenous overexpression of HSF1
counteracts the effects of aneuploidy on HSP90-dependent protein
folding, thereby identifying enhanced expression of HSF1 as the first
aneuploidy-tolerating genetic modification in human cells. Finally,
we demonstrate that the functional HSP90 and HSF1 deficiency has
marked consequences for protein abundance and shapes the
patterns of gene expression observed in aneuploid cells.
Results
Trisomic and tetrasomic human cell lines show defects
in protein folding
Using model trisomic and tetrasomic human cell lines, we previ-
ously found an increased amount of cytoplasmic ubiquitin-positive
foci in aneuploids in comparison to cognate diploids (Stingele et al,
2012). The accumulation of ubiquitinated proteins might be either
due to a defect in their removal or due to their increased production
in aneuploid cells. However, human aneuploid cells activate the
catabolic pathway of autophagy (Stingele et al, 2012), and protea-
some activity is not impaired by aneuploidy (Supplementary Fig
S1A–C). This suggests that ubiquitinated proteins accumulate at
higher rates, possibly due to an overwhelmed or impaired protein
folding capacity, as previously proposed (Oromendia et al, 2012;
Donnelly & Storchova, 2014). To directly test whether trisomic or
tetrasomic human cells display protein folding defects, we employed
a set of three Firefly luciferase-based sensor proteins comprising
wild-type Firefly luciferase (FlucWT) and single and double mutant
luciferase, FlucSM and FlucDM, that are highly sensitive to changes
in the protein folding environment (Gupta et al, 2011). First, we
performed luciferase refolding assays after transiently expressing
FlucWT in diploid HCT116 cells and HCT116* cells, which stably
express histone H2B-GFP, and their respective aneuploid deriva-
tives. To this end, we subjected transfected cells to heat shock at
43°C for 2 h, which is sufficient to denature > 70% of luciferase,
but does not result in toxicity. We then monitored refolding at 37°C
over 4 h by measuring luminescence. We observed a significant
impairment of FlucWT refolding in cells with trisomy and tetrasomy
of chromosome 5 compared to their respective parental cell lines
(Fig 1A and B). Next, we examined the effect of aneuploidy on the
more sensitive mutants FlucSM and FlucDM. The mutations disrupt
the stability of the Fluc protein, but do not affect its enzymatic activ-
ity. We thus hypothesized that the effect of aneuploidy on luciferase
refolding should be even more pronounced in cells transfected with
the destabilized mutant proteins. Indeed, the relative ability to
refold both FlucDM (Fig 1C and D) and FlucSM (Supplementary Fig
S1E and F) was almost threefold reduced in aneuploid cells in
comparison to the parental HCT116. Thus, aneuploidy causes
protein folding defects in human cell lines.
The HSP90 chaperone is required for the refolding of heat-
denatured luciferase, and the destabilizing mutations in FlucSM and
FlucDM lead to an indispensable requirement for HSP90 for folding
even in the absence of stress (Schneider et al, 1996; Gupta et al,
2011). Thus, whereas FlucWT activity is not impaired by HSP90
inhibition, the luminescent signal of FlucSM and FlucDM decreases
upon treatment with 17-N-allylamino-17-demethoxygeldanamycin
(17-AAG), a derivative of the antibiotic geldanamycin that binds the
ATP pocket of the chaperone HSP90 (Supplementary Fig S1D). To
specifically investigate HSP90-dependent protein folding capacity in
aneuploid cells, we transfected diploid and aneuploid HCT116 cells
with the Fluc sensors and measured luminescence in response to
treatment with 17-AAG. Strikingly, we observed a consistent and
significant decrease in FlucDM activity following treatment with
17-AAG in aneuploid cells compared to the control HCT116 cells
(Fig 1E). These findings indicate that HSP90 function is indeed
limiting in aneuploids. To exclude the possibility that the
aneuploidy-induced protein folding defect is specific for aneuploid
derivatives of HCT116 or for cells carrying extra copies of chromo-
some 5, we analyzed two additional aneuploid cell lines derived
from RPE-1 (trisomy 21 and trisomy of chromosomes 5 and 12).
Similarly as in HCT116-derived aneuploids, we observed consis-
tently lower relative levels of FlucDM activity in aneuploid cells in
contrast to diploid RPE-1 cells after treatment with 17-AAG (Fig 1F).
These observations provide direct evidence that impaired protein
folding and defective HSP90 function are common features of
human aneuploid cells.
Aneuploid cells are more sensitive to inhibition of HSP90 but not
to other inducers of protein folding stress
To elucidate in more detail the protein folding defect in human
aneuploid cells, we analyzed their sensitivity to drugs that either
directly inhibit molecular chaperones or impose a severe strain on
the protein folding machinery. To this end, we measured cell viabil-
ity after treatment with the HSP90 inhibitor 17-AAG, the HSC70/
HSP70 inhibitor VER 155008, L-azetidine-2-carboxylic acid (AZC), a
toxic L-proline analog that leads to the misfolding of newly synthe-
sized polypeptides (Qian et al, 2010), and heat shock (45°C, 15 h).
We observed a significant sensitivity of trisomic and tetrasomic
HCT116 and RPE-1 cells to 17-AAG as measured by both cell viabil-
ity as well as colony-forming assays (Fig 2A and B). In contrast, the
response to the other compounds was less uniform: While aneu-
ploid RPE-1 cells were more sensitive to HSC70/HSP70 inhibition by
VER 155008 than diploids, aneuploid HCT116 cells were slightly
more resistant to this treatment than controls (Fig 2C). Cell
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line-specific responses were also observed after heat shock: Only
HCT116* 5/3 cells were highly sensitive to heat shock, while the
other aneuploidies either showed a similar response as controls or
even a marked resistance (Fig 2D). Finally, aneuploid cells were not
significantly more sensitive to treatment with AZC (Supplementary
Fig S2A and B). We conclude that aneuploidy exerts profound
effects on cellular proteostasis, but only the increased sensitivity to
HSP90 inhibition was common to all aneuploid cells that we tested.
Thus, in line with previous observations from aneuploid yeast
(Oromendia et al, 2012) and murine cells (Tang et al, 2011), a
specific impairment of HSP90-mediated protein folding represents a
general and conserved consequence of aneuploidy.
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Figure 1. Trisomic and tetrasomic human cell lines show defects in protein folding.
A–D Refolding of the sensor proteins upon heat shock in control cells and in respective aneuploids. HCT116 and HCT116* stably expressing histone H2B-GFP and their
aneuploid derivatives were transfected either with FlucWT-mCherry (A, B) or FlucDM-mCherry (C, D) and subjected to heat stress for 2 h at 43°C. Controls were
maintained at 37°C. Luminescence readings were taken immediately from heat-stressed cells (0 min) and at indicated time points after recovery at 37°C. The
luminescence values of control cells maintained at 37°C were set to 100% (indicated by dotted line).
E, F Refolding of the sensor proteins upon HSP90 inhibition in control cells and in respective aneuploids. FlucWT-mCherry or FlucDM-mCherry was expressed in
parental and aneuploid HCT116 or HCT116* (E) and RPE-1 or RPE-1* (F) cell lines for 36 h. Cells were then incubated with either solvent control (DMSO) or 50 nM
17-AAG for 8 h followed by measurement of luminescent activity. The depicted values show the percentage of luminescence in cells treated with 17-AAG relative to
DMSO-treated cells (which were set to 100%).
Data information: All plots show the means of at least three independent experiments ! SEM. *P < 0.05; **P < 0.01; ***P < 0.001; non-parametric t-test.
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The basal and stress-induced activity of HSF1 is impaired in
human aneuploid cells
Our results suggest that aneuploid cells may be compromised in
their ability to mount a robust HSR when challenged with stress.
Moreover, the impaired ability to refold luciferase evident already
at very early time points of recovery (10, 20 min; Fig 1C and D)
may point to a reduction in steady-state protein folding capacity.
We hypothesized that the HSP90-specific protein folding defect
might be due to changes in expression levels of factors involved in
the maintenance of cellular proteostasis. Analysis of the expression
changes in heat shock protein families (Kampinga et al, 2007) from
our previously obtained global transcriptome and proteome data
(Stingele et al, 2012) revealed a small but statistically significant
reduction in both mRNA and protein abundance for the HSP90
family across a panel of six different aneuploid cell lines (Supple-
mentary Fig S3A). Protein levels of chaperonins were also slightly
decreased, although mRNA levels were not significantly changed
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Figure 2. Sensitivity to inhibition of HSP90 but not to other inducers of protein folding stress increases in aneuploid cells.
A Wild-type, trisomic and tetrasomic cells were treated with the indicated concentrations of 17-AAG, and cell number was determined 72 h thereafter. Cell number is
shown as the percentage of the DMSO-treated control.
B Colony formation efficiency of aneuploid and parental RPE-1 treated with either solvent control (DMSO) or 17-AAG at indicated concentrations. Cells were stained
with crystal violet after 2 weeks.
C Wild-type, trisomic and tetrasomic cells were treated with the indicated concentration of VER 155008, and cell number was determined 72 h thereafter. Cell number
is shown as the percentage of the DMSO-treated control.
D Wild-type, trisomic and tetrasomic cells were subjected to heat stress for 15 h at 45°C, and cell number was determined. Cell number is shown as the percentage of
the untreated control (maintained at 37°C).
Data information: All plots show the means of at least three independent experiments ! SEM. *P < 0.05; **P < 0.01; ***P < 0.001; non-parametric t-test.
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(Supplementary Fig S3A). Analysis by immunoblotting revealed
that the levels of HSP27, HSP70, and HSP90 were modestly, but
consistently and significantly reduced in the majority of aneuploid
cell lines analyzed (Fig 3A and B). The protein folding capacity
of molecular chaperones is regulated, in part, by binding to co-
chaperones and other co-factors. Phosphorylation at the C-termini
of HSP70 and HSP90 enhances binding to the co-chaperone HOP,
thereby increasing productive protein folding and cellular prolifera-
tion rates (Muller et al, 2013). However, the ratios of phosphory-
lated HSP90 and HSP70 over total levels were unchanged when
comparing parental cell lines and HCT116 aneuploid derivatives
(Supplementary Fig S3C and D). Our finding that the chaperone
expression is impaired in aneuploid cells prompted us to analyze
the expression of the heat shock response transcription factor and
master regulator of chaperone expression HSF1 as well. The immu-
noblotting revealed a consistent reduction in protein levels in all
four cell lines tested (Fig 3A and B). Notably, the transcription of
the HSF1 gene is not altered in aneuploid cells, as we observed only
negligible changes in HSF1 mRNA levels in qPCR experiments
(Supplementary Fig S3B).
In light of our observations regarding HSF1 protein levels, we
asked whether the induction of HSF1 activity, that is, the ability to
mount a HSR, was also impaired in aneuploid cells. To this end,
we expressed a HSP70-luc construct that contains the HSP70
promoter fused to luciferase in diploid and aneuploid cells
(Williams et al, 1989). We then treated the cells with 17-AAG and
the proteasome inhibitor MG132, compounds that induce acute
proteotoxic stress and are well-characterized activators of HSF1-
dependent transcription (Mathew et al, 2001; Sharma et al, 2012).
We observed that the parental cell lines induced the expression of
the HSP70-luc sensor two- to threefold soon after the proteotoxic
treatment and up to sevenfold in response to prolonged treatment
(Fig 3C and D). In contrast, the ability of HCT116-derived and
RPE-1-derived aneuploids to induce HSP70-luc was on average
reduced to 50 and 60% of the control at early and later time
points, respectively (Fig 3C and D). Interestingly, at the later time
point, RPE-1 21/3 had recovered the ability to activate the HSP70
promoter. This is in line with the relatively mild decrease in HSF1
and chaperone levels in this cell line and with its relatively modest
sensitivity to 17-AAG (Figs 2A and 3A and B). These observations
might be explained by the small size of chromosome 21; hence,
RPE-1 21/3 is burdened with the least amount of extra genetic
material of all the aneuploid cell lines analyzed in this study.
Consistent with these findings, we also observed an impaired ability
to induce HSP70 expression after acute heat shock in both
HCT116- and RPE-1-derived aneuploid cells (Supplementary Fig
S3E). The decrease in HSF1 expression observed in aneuploid cells
is relatively small, and therefore, we asked whether it is sufficient
to cause the observed impairment in maintenance of proteostasis
and protein folding. To address this concern, we transfected the
control cell lines with siRNA to partially deplete HSF1 to 75 and
50%, respectively (Fig 3E). Indeed, consistent with previous
results (Chen et al, 2013), this partial and transient depletion of
HSF1 rendered cells sensitive to treatment with 17-AAG, thus
suggesting a striking dosage sensitivity of the cellular response to
proteotoxic stress (Fig 3F). Therefore, we conclude that the protein
folding defect engendered by aneuploidy may be caused by inhibi-
tory effects on basal and induced HSF1 activity.
Endogenous or exogenous overexpression of HSF1 ameliorates
the negative effects of aneuploidy on protein folding
If the reduced protein folding capacity of aneuploid cells is due to
a deficiency in HSF1 function, aneuploid cells with increased levels
of HSF1 may be protected against this impairment. In fact,
increased expression of HSF1 due to gene amplification is frequent
in cancer, similarly as gain of chromosome 8 or its long arm
where the HSF1 gene is located on 8q24.3 (Beroukhim et al,
2010). Thus, we reasoned that cells that gained chromosome 8
with the resulting increased expression of HSF1 might escape the
defects in HSP90 function and protein folding caused by gain of a
chromosome without HSF1. To test this possibility, we generated
four clonal cell lines derived from individual HCT116 cells upon
micronuclei-mediated transfer of chromosome 8. Using chromo-
some painting, we confirmed the presence of an extra copy of
chromosome 8 in all imaged cells from all four clonal cell lines
(HCT116 8/3 c1-c4; Supplementary Fig S4A). Analysis of the
expression of HSF1 protein revealed an increased abundance
according to expected gene copy number, that is, approximately
1.5-fold higher relative to diploid HCT116, in the clonal cell lines
c1, c2, and c4. Interestingly, HSF1 levels were not substantially
changed in c3 (Fig 4A and B). This was likely due to a loss of the
distal region of chromosome 8 where HSF1 is located (Supplemen-
tary Fig S4B, our unpublished data). Thus, we reasoned that
comparison of c1, c2, and c4 with c3 would enable us to directly
test whether increased levels of HSF1 protect cells from the protein
folding defects caused by the introduction of the extra copy of
chromosome 8. We first analyzed the expression of HSP90.
Similarly to other trisomies and tetrasomies that we analyzed
(Fig 3A and B, and Supplementary Fig S3A), introduction of
chromosome 8 elicited a slight decrease in HSP90 levels in c3
(Fig 4A and B). Strikingly, however, in c1, c2, and c4, we
observed no decrease in HSP90 levels relative to control HCT116
(Fig 4A and B). Next, we tested the sensitivity of FlucDM to
17-AAG treatment in the four clones. The luminescent output of
FlucDM was significantly lower after treatment with 17-AGG in
HCT116 8/3 c3 compared to control HCT116. In contrast, the rela-
tive decreases in luminescence in response to 17-AAG treatment
were comparable to the control in the trisomic cell lines c1, c2,
and c4 (Fig 4C). Moreover, whereas c3 exhibited a sensitivity to
17-AAG that was comparable with the other trisomies, c1, c2, and
c4 were as resistant to 17-AAG as the parental HCT116 (Fig 4D).
Thus, the increased levels of HSF1 counteract the negative effect
of aneuploidy on HSP90 expression and on protein folding.
To directly determine a role for increased HSF1 activity in mitigat-
ing the effects of aneuploidy on HSP90 and protein folding, we
performed transient transfections with a constitutively active trun-
cated HSF1 allele (ca-HSF1) (Zuo et al, 1995). Immunoblotting
confirmed efficient expression of ca-HSF1 upon transient transfection
in HCT116 8/3 c3 aneuploids as well as in HCT116 5/4 and RPE-1
21/3 and increased the expression levels of its downstream targets
(Fig 4E). Importantly, the transient ca-HSF1 expression significantly
improved the survival of aneuploid cells in the presence of 17-AAG
as well as protected the folding of the FlucDM sensor against its
effects (Fig 4F and G). Our observations suggest that cellular sensi-
tivity to 17-AAG is finely tuned to the levels of HSF1. To test the
generality of this conclusion, we transfected the control HCT116 and
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Figure 3. The basal and stress-induced activity of HSF1 is impaired in human aneuploid cells.
A, B Western blot analysis for HSP27, HSP70, HSP90 (the used antibody recognizes both constitutive and inducible forms of HSP90) and HSF1 in parental and aneuploid
cell lines (A). Loading control: GAPDH; HSC70 (constitutively expressed chaperone) in RPE-1 5/3 12/3 and corresponding control (note that GAPDH is encoded on
chromosome 12). Shown are representative images of at least 3 independent experiments. In panel B the quantification of the signal intensities from the Western
blots shown in (A) are depicted, calculated relative to control cells (which were set to 1).
C, D HSP70-luc plasmid was expressed in parental and aneuploid HCT116 and RPE-1 cell lines for 36 h. Cells were then incubated with solvent control (DMSO), 2 lM
17-AAG or 5 lM MG132 for the indicated times. The depicted values show the fold induction in 17-AAG- or MG132-treated cells compared to DMSO-treated cells
(which were set to 1).
E HCT116 (left panel) and RPE-1 (right panel) cells were transfected with siRNA targeting HSF1 or the GL2 subunit of luciferase as a control (ctrl). Cell extract was
prepared 72 h after transfection and subjected to immunoblotting for HSF1 and GAPDH as a loading control. Quantification of the signal normalized to the loading
control is shown above the images.
F HCT116 (left panel) and RPE-1 (right panel) cells transfected with siRNA targeting HSF1 or the GL2 subunit of luciferase as a control (ctrl). Forty-eight hours after
transfection cells were incubated with the indicated concentrations of 17-AAG, and cell number was determined 72 h thereafter. Cell number is shown as the
percentage of the DMSO-treated control.
Data information: All data are the mean of at least three independent experiments ! SEM. *P < 0.05; **P < 0.01; ***P < 0.001; non-parametric t-test.
Source data are available online for this figure.
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RPE-1 cells with ca-HSF1 (Fig 4H). In agreement with our hypothe-
sis, the transient overexpression of ca-HSF1 also significantly
protected the control cell lines against 17-AAG-associated toxicity
(Fig 4I and J). Taken together, these results show that increasing the
levels of the HSR master regulator HSF1 is sufficient to counteract
the impaired HSP90 function of human aneuploid cells.
Since trisomy in human cells leads to proliferation defects, we
asked whether the difference in HSF1 expression is reflected by
changes in proliferative capacity. In line with our hypothesis that
HSF1 mitigates some of the phenotypes caused by aneuploidy, we
observed that HCT116 clones with high HSF1 expression prolifer-
ated markedly faster than HCT116 8/3 c3 (Supplementary Fig S4E).
This also suggests that the decreased protein folding capacity
contributes to the proliferation defects observed in trisomic cells.
Chromosome 8 carries approximately 4,170 open reading frames,
among them the CCNE2 gene encoding cyclin E2 that plays a critical
role in the G1 and in the G1-S transition and is often overexpressed
in cancers, and MYC encoding the c-Myc transcription factor, a criti-
cal oncogene which upregulates a large number of genes involved
in cell proliferation (Dang, 1999; Hwang & Clurman, 2005). We thus
asked whether increased levels of c-Myc or cyclin E2 may be
involved in improved proliferation rates in c1, c2 or c4. Western
blotting revealed that cyclin E2 levels were increased on average
1.23-fold, and c-Myc levels were either unchanged or slightly
reduced in all four HCT116 8/3 cell lines (Supplementary Fig S4C
and D), in line with our previous finding that the abundance of
some proteins is lower than expected based on the corresponding
copy number changes in aneuploid cells (Stingele et al, 2012). As
expected, based on these observations, Spearman correlation analy-
sis revealed that only HSF1 levels highly correlated with the sensi-
tivity of trisomic cells to HSP90 inhibition, their protein folding
capacity as well as with proliferation rate (Supplementary Fig S4F).
Taken together, both endogenous and exogenous overexpression of
HSF1 ameliorates the adverse effects of aneuploidy on HSP90-
dependent protein folding and proliferation in human cells.
Impaired HSP90 function in aneuploid cells affects the
abundance of HSP90 client proteins
HSP90 plays a critical role in the folding of a wide variety of client
proteins, in particular protein kinases as well as steroid hormone
receptors and subunits of macromolecular complexes (Rohl et al,
2013). Thus, we asked whether the defect in HSP90 activity in aneu-
ploid cells leads to a decreased abundance of client proteins that
rely on HSP90. To this end, we compared recently reported data that
elucidate the global HSP90 interactome and that classify interactors
based on the strength of their interaction with HSP90 (Taipale et al,
2012) to the transcriptome and proteome changes that we observed
in human aneuploid cell lines (Stingele et al, 2012). Our analysis
revealed that the abundance of proteins that strongly interact with
HSP90 was significantly lower in two out of the four aneuploid cell
lines tested (HCT116* 5/4 and HCT116 5/4). In contrast, the abun-
dance of non-interacting proteins was not affected in any of the
analyzed cell lines (Fig 5A, Supplementary Datasets S1 and S2).
Additionally, mRNA levels of strong interactors were unchanged,
indicating that only the protein levels are affected (Fig 5A). Because
this dataset of interactors may not represent a comprehensive list of
all HSP90 clients, we also compared protein expression data from
aneuploids with respect to another database of HSP90-interacting
proteins generated by the Picard laboratory (http://www.picard.ch/
Hsp90Int/index.php). Again, we observed a significant reduction in
the expression of HSP90 interactors in two out of four aneuploid
cells lines (HCT116 5/4 and RPE-1* 21/3; Fig 5B, Supplementary
Dataset S3). Taken together, the reduced abundance of HSP90-inter-
acting proteins in three out of four aneuploid cell lines supports the
hypothesis that the HSP90 machinery is impaired in aneuploid cells
and suggests that this impairment directly contributes to the altered
protein composition of aneuploid cells.
The global expression changes in aneuploids resemble the
cellular responses to HSP90 and HSF1 deficiency
HSP90 represents a critical hub in cell signaling through its chaper-
oning of a wide array of kinases and other proteins. Indeed, phar-
macological inhibition of HSP90 results in significant alterations in
the activity of multiple signaling pathways (Sharma et al, 2012).
Our previous analysis of the changes in pathway regulation in
human aneuploid cells identified a specific set of pathways that are
up- or downregulated in response to aneuploidy, and these path-
ways appear to be conserved (Sheltzer et al, 2012; Stingele et al,
2012; Durrbaum et al, 2014). However, it remains unclear which
molecular processes are responsible for these protein expression
changes observed in aneuploid cells. Thus, we first asked whether
the impairment in HSP90 function contributes to the changes of
protein abundance in aneuploids. We compared the quantitative
proteome changes in aneuploids cells with the proteome changes
occurring upon pharmacological inhibition of HSP90 for 24 h
(Sharma et al, 2012). The analysis of proteome changes upon
HSP90 inhibition was performed in HeLa cells that are extensively
aneuploid. Therefore, the proteome of treated cells was normalized
to the proteome of untreated HeLa cells. Using 2-dimensional anno-
tation enrichment analysis that enables direct comparison of relative
pathway enrichments (Cox & Mann, 2012), we found an overlap
between the proteome changes due to aneuploidy and proteome
changes due to HSP90 inhibition (Supplementary Dataset S4), in
particular among the downregulated pathways, which includes
pathways of DNA and RNA metabolism, such as DNA repair and
replication and RNA splicing, as well as cell cycle pathways (Fig 5C,
Supplementary Fig S5A and B).
HSF1 predominantly regulates the expression of genes involved
in proteostasis as part of the heat shock response, but has recently
been shown to control the transcription of multiple additional target
genes (Mendillo et al, 2012). We therefore compared the transcrip-
tional profile of aneuploid cells with the transcriptional profile of a
human hepatocellular carcinoma cell line (HCC) in which HSF1 was
depleted by RNAi (Chuma et al, 2014). Comparison of the pathway
enrichment in aneuploid cells and in cells depleted of HSF1 revealed
a striking similarity in both downregulated and upregulated path-
ways (Fig 5D, Supplementary Fig S5C, Supplementary Dataset S4).
Similar comparison with cells depleted of c-Myc showed no similari-
ties between the pathways changes. This analysis suggests that the
transcriptional activity of c-Myc does not affect the pathways that
are deregulated by aneuploidy and supports the notion that the
observed effect is specific for HSF1 (Supplementary Fig S5D). These
results suggest that functional deficiency in HSF1 is a major determi-
nant of the previously identified transcriptional aneuploidy response
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pattern (Stingele et al, 2012; Durrbaum et al, 2014). Taken together,
our analyses suggest that the functional HSF1 and HSP90 deficiency
caused by aneuploidy determines the global transcriptome and
proteome changes in these cells.
Discussion
Aneuploid cells often suffer from low proliferation rates and exhibit
hallmarks of cells undergoing proteotoxic stress as evidenced by
their sensitivity to conditions that compromise or overburden
protein folding (Torres et al, 2007; Tang et al, 2011; Oromendia
et al, 2012; Stingele et al, 2012). Here, we directly demonstrate for
the first time that human aneuploid cells suffer from a protein fold-
ing defect and show that in particular HSP90-dependent protein
folding is affected. Additionally, we identify a pronounced impair-
ment in the ability of aneuploids to trigger a full heat shock
response, suggesting that the functionality of heat shock-associated
factors, in particular, the responsible transcription factor HSF1, is
compromised. Importantly, we demonstrate that increasing the gene
copy number of HSF1 counters the effects of aneuploidy on HSP90
expression and protein folding. Finally, our analysis suggests that
the observed functional deficiency in HSP90 and HSF1 contributes
to the transcriptome and proteome changes observed in aneuploid
cells. Thus, we propose that the cellular defects associated with
aneuploidy may be direct consequences of impaired protein folding
capacity.
Aneuploidy impairs protein folding
Both disomic budding yeast and tri- and tetrasomic human cells
accumulate cytoplasmic protein deposits (Oromendia et al, 2012;
Stingele et al, 2012). Previously, it has been proposed that the
increased protein expression in aneuploid cells leads to a saturation
of protein folding capacity and to low-level but chronic protein
misfolding (Oromendia et al, 2012; Donnelly & Storchova, 2014).
The misfolding, in turn, leads either to the aggregation, or destabili-
zation and degradation of proteins with high or specific demands on
the chaperone machinery. Indeed, we show that the presence of
even one extra chromosome significantly impairs cellular protein
folding in human aneuploid cells (Fig 1). This is mainly due to a
defect in HSP90-dependent protein folding, whereas targeting the
early steps in protein folding immediately after release from the
ribosome, through AZC or HSP70 inhibition, does not preferentially
impair the viability of human aneuploid cells (Figs 1 and 2, and
Supplementary Fig S2). We hypothesize that the toxicity associated
with impairment of proper protein folding at an early stage is deter-
mined by how efficiently and quickly cells can dispose of terminally
misfolded proteins. Since both proteasome activity and autophagic
degradation are elevated in mammalian aneuploid cells (Supple-
mentary Fig S1B and C and Tang et al, 2011; Stingele et al, 2013),
this may explain why they are not more sensitive or even slightly
more resistant to such impairment. In contrast, we propose that the
sensitivity to HSP90 inhibition observed in all the aneuploids
analyzed in this study, regardless of the identity of the supernumer-
ary chromosome(s) or the cell line rather reflects the loss-
of-function of HSP90 clients and of HSP90-dependent processes.
Therefore, our data together with previous observations in trisomic
MEFs and disomic budding yeast (Tang et al, 2011; Oromendia
et al, 2012) make a compelling argument that aneuploidy leads to a
specific functional deficiency in HSP90-mediated protein folding.
In seeking to determine an explanation for why the HSP90 chap-
erone machinery is particularly affected by aneuploidy, we discov-
ered that HSP90 family proteins were downregulated at both the
mRNA and protein levels across a panel of six aneuploid cell lines.
Intriguingly, this downregulation correlated with a decrease in total
HSF1 levels in all four aneuploid cells lines tested and an impaired
ability to induce HSF1 activity in response to acute proteotoxic
stress (Fig 3). We emphasize, however, that the response to acute
proteotoxic stress was not completely abolished, but rather delayed
Figure 4. Endogenous or exogenous overexpression of HSF1 ameliorates the negative effects of aneuploidy on protein folding.
A, B Western blot analysis of HSF1 and HSP90 expression in HCT116 8/3* c1-c4 (A). Loading control: GAPDH. Shown are representative images of at least 3 independent
experiments. Quantification of the signal intensities from the Western blots (B), calculated relative to control cells (which were set to 1).
C FlucDM-mCherry was expressed in parental HCT116* and HCT116* 8/3 c1-c4 for 36 h. Cells were then incubated with either solvent control (DMSO) or 50 nM
17-AAG for 8 h followed by measurement of luminescent activity. The depicted values show the percentage of luminescence in cells treated with 17-AAG relative to
DMSO-treated cells (which were set to 100%).
D Parental HCT116* and HCT116* cells trisomic for chromosome 8 (HCT116 8/3* c1-c4) were treated with the indicated concentrations of 17-AAG, and cell number
was determined 72 h thereafter. Cell number is shown as the percentage of the DMSO-treated control (which was set to 100%).
E Western blot analysis of HSF1 expression and its downstream targets in the indicated aneuploid cells transfected with ca-HSF1. Loading control: GAPDH. Shown
are representative images of at least 3 independent experiments. Quantification of the signal intensities normalized to the loading control is shown above the
images.
F RPE-1* 21/3 cells were transiently transfected with either pCDNA or ca-HSF1 by electroporation. Forty-eight hours post-transfection cells were incubated with the
indicated concentrations of 17-AAG, and cell number was determined 72 h thereafter. Cell number is shown as the percentage of the DMSO-treated control.
G FlucDM-mCherry was co-expressed with either pCDNA or ca-HSF1 in the indicated cell lines for 36 h. Cells were then incubated with either solvent control (DMSO),
50 nM 17-AAG (HCT116), or 5 nM 17-AAG (RPE-1) for 8 h followed by measurement of luminescent activity. The depicted values show the percentage of
luminescence in cells treated with 17-AAG relative to DMSO-treated cells (which were set to 100%).
H Western blot analysis of HSF1 expression and its downstream targets in the indicated aneuploid cells transfected with ca-HSF1 using electroporation. Loading
control: GAPDH. Shown are representative images of at least 3 independent experiments. Quantification of the signal intensities normalized to the loading control
is shown above the images.
I Control HCT116* cells were transiently transfected with either pCDNA or ca-HSF1 by electroporation. Fourty-eight hours post-transfection cells were incubated
with the indicated concentrations of 17-AAG and cell number was determined 72 h thereafter. Cell number is shown as the percentage of the DMSO-treated
control.
J Control RPE-1* cells were transiently transfected with either pCDNA or ca-HSF1 by electroporation. Fourty-eight hours post-transfection cells were incubated with
the indicated concentrations of 17-AAG and cell number was determined 72 h thereafter. Cell number is shown as the percentage of the DMSO-treated control.
Data information: The data are the mean of at least three independent experiments ! SEM. *P < 0.05; **P < 0.01; ***P < 0.001; non-parametric t-test.
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and diminished. Notably, while a delay and decrease can be
detected in aneuploid budding yeast strains, this effect appears to be
more modest (Oromendia et al, 2012). Interestingly, elevated levels
of HSP72, but not HSP90 or other heat shock factors, were identified
in aneuploid murine fibroblasts compared to diploid controls (Tang
et al, 2011). The differential regulation of HSP72 and HSP90
suggests that the activation of HSP72 in murine aneuploids is not
due to elevated HSF1-dependent transcription, but rather modulated
by other means that are specific to HSP72. Despite this difference,
aneuploidy renders murine fibroblasts sensitive to the HSP90 inhibi-
tor 17-AAG similarly as human aneuploids, thus further strengthen-
ing the notion that HSP90-mediated protein folding is specifically
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limiting for aneuploid cells. In future, it will be important to address
by what mechanism aneuploidy impairs HSF1 function and why
HSP90-dependent protein folding is particularly affected. We
propose two hypothetical mechanisms for how HSF1 function might
be impaired by aneuploidy. First, the metastable protein HSF1 may
be incorporated into the ubiquitin-positive cytoplasmic deposits in
aneuploid cells, and thereby rendered inactive. Alternatively, the
HSF1 protein may be subject to post-translational inhibitory regula-
tion that is elevated in aneuploids. Interestingly, overexpression of
model b-sheet proteins in human cells also impairs the induction of
cellular stress responses (Olzscha et al, 2011). Uncovering the simi-
larities and differences in these two models of chronic proteotoxic
stress will improve our understanding of the mechanisms involved
in the maintenance of protein homeostasis.
We found that increased copy numbers of HSF1 can alleviate the
protein folding defect and the impaired response to proteotoxic
stress in aneuploid cells. This was confirmed in two different
scenarios, by transfer of chromosome 8 and by transient overexpres-
sion of transgenic HSF1 (Fig 4). We employed overexpression of the
upstream regulator of the heat shock response to ensure integrated
and balanced expression of HSP90 and its co-chaperones. This is
essential because the concentration of essential co-chaperones is
limiting for HSP90 activity (Li et al, 2012), and the chaperone-
dependent processes often require all components of a given chaperone
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Figure 5. The proteome and transcriptome changes in aneuploid cells resemble the cellular response to protein folding deficiency.
A Relative abundance (calculated aneuploid/diploid ratio) of proteins that were identified as non-interactors and strong interactors of HSP90 in human cells (left panel).
Relative abundance (calculated aneuploid/diploid ratio) of corresponding mRNAs (right panel). *P < 0.05; **P < 0.01; ***P < 0.001; Mann–Whitney U-test.
B Relative abundance (calculated aneuploid/diploid ratio) of factors that were identified to interact with HSP90. *P < 0.05; **P < 0.01; ***P < 0.001; Mann–Whitney U-
test.
C Changes in pathways identified in the proteome of cells upon inhibition of HSP90 compared to the proteome changes in trisomic cells using the 2D-annotation
enrichment analysis.
D Changes in pathway regulation identified in the transcriptome of HCC cells upon HSF1 knockdown compared to transcriptome changes in trisomic cells using the
2D-annotation enrichment analysis.
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system (Rampelt et al, 2012). It should be noted that the trans-
formed cell line HCT116 contains segmental aneuploidies, specifi-
cally copy gain on the long arms of chromosomes 8, 10, 16, and 17
and a loss of the Y-chromosome. These copy number changes are
preserved in all created trisomic and tetrasomic cell lines (Stingele
et al, 2012). However, our results suggest that an additional
increase in copy numbers of HSF1 is necessary to rescue the
defects arising in response to another whole chromosomal
aneuploidy in de novo created trisomic cells so that the activity of
HSF1 is sufficient to override the negative effects of aneuploidy on
the protein folding machinery. More generally, our results suggest
that in the context of the cellular response to severe proteotoxic
stress (e.g. HSP90 inhibition), augmentation of HSF1 levels and/or
activity fulfills a powerful cytoprotective function.
Previously, it was shown that a loss-of-function mutation in the
gene encoding the deubiquitinating enzyme Ubp6 also markedly
alleviated the negative effects of aneuploidy including impaired
proliferation and accumulation of cytoplasmic protein deposits in
budding yeast (Torres et al, 2010; Oromendia et al, 2012). Here,
we have identified the first aneuploidy-tolerating genetic modifica-
tion in human cells. These results support the interesting possibil-
ity that the adverse effects of aneuploidy can be suppressed either
by enhancing protein degradation or by increasing cellular protein
folding capacity. It is generally accepted that the sensitivity of
cancer cells to HSP90 inhibitors stems from their reliance on heat
shock proteins to chaperone the high number of overexpressed or
mutated oncoproteins, and from the role of chaperones in protect-
ing against general cellular stress associated with tumorigenesis
(Dai et al, 2007). Our findings together with previous work (Tang
et al, 2011) may provide an additional rationale for why inhibitors
of protein degradation and protein folding emerge as a potentially
effective cancer therapy and suggest that levels of HSF1 protein
and/or activity may be important determinants of sensitivity to
17-AAG.
Consequences of the protein folding defects for aneuploids
Chemical or genetic impairment of HSP90 leads to the destabiliza-
tion of multiple protein kinases and other proteins with critical
roles in diverse cellular processes (Taipale et al, 2012). We found
that the proteome of human aneuploid cells resembles the prote-
ome of HeLa cells treated with the HSP90 inhibitor, 17-DMAG. In
particular, pathways involved in DNA metabolic processes, chro-
matin modification, and transcription were downregulated in both
conditions, whereas the overlap among upregulated pathways
was rather modest. Even more similarities in both upregulated
and downregulated pathways were revealed by comparison
between transcriptional aneuploidy response patterns and the
transcriptome changes in response to HSF1 depletion in the
human HCC cell line (Chuma et al, 2014). Although HSF1,
the major heat shock transcription factor, is most known for its
role in regulating the expression of chaperones and proteins
involved in the maintenance of proteostasis, recent discoveries
have revealed its role in the regulation of a plethora of cellular
processes (Mendillo et al, 2012). Based on our observations, we
propose that the reduced HSP90 activity and the resulting
decrease in stability of HSP90 client proteins partially underlies
the pathway downregulation observed in aneuploid cells.
Simultaneously, the impaired HSF1 activity affects, both directly,
through the reduced expression of HSF1 target genes and indi-
rectly, through the reduced protein folding capacity of aneuploid
cells, the transcription of many targets. Taken together, we
propose that the proteotoxic stress imposed by the presence of
extra genetic material is a major determinant of the changes in
gene expression in aneuploid cells.
We hypothesize that the HSP90 defect may have additional
consequences for aneuploid cells. Two phenomena are worthy of
particular mention. First, there is now a large body of evidence to
suggest that HSP90 acts as a buffer against phenotypic variation by
masking the effects of genetic polymorphisms (Jarosz et al, 2010).
Second, HSP90 inhibition itself leads to chromosomal instability in
budding yeast (Chen et al, 2012). Taken together with our results,
we propose that aneuploidy is likely to further accelerate both the
rate and manifestation of genetic change and our data suggest a
general mechanism whereby changes in DNA copy number can lead
to further genetic alterations.
Relevance for cancer and other pathologies
Aneuploidy is a hallmark of cancer, where it correlates with malig-
nancy, drug resistance, and poor prognosis. However, trisomy and
tetrasomy markedly impair cellular functions including prolifera-
tion, suggesting that aneuploidy-tolerating changes might be neces-
sary to facilitate the growth of aneuploid cancer cells. Further,
whether a similar impairment of protein folding capacity also occurs
in cells of trisomy syndromes is currently not known and should be
addressed in future. Intriguingly, somatic trisomy of chromosome 8
is frequently found in myeloid lineage disorders, some lymphomas
and solid tumors such as breast and ovarian cancer. Interestingly,
8q24, where the HSF1 gene is located, is one of the most commonly
amplified regions in cancer cells (Beroukhim et al, 2010; Davoli
et al, 2013), and chromosome 8 is the largest somatic chromosome
whose trisomy is compatible, although extremely rarely, with post-
natal survival (Ganmore et al, 2009; Beroukhim et al, 2010).
Indeed, we show that the presence of HSF1 on chromosome 8
protects against some of the adverse effects of aneuploidy. HSF1 is a
critical facilitator of malignant proliferation, a role which it performs
by supporting many important cellular processes (Dai et al, 2007).
An additional role of HSF1 in promoting carcinogenesis may be to
protect cancer cells from the proteotoxic stress induced by aneu-
ploidy. Our results lend strong support to this notion and suggest
a causal link between two recurring features of cancer cells:
aneuploidy and altered HSF1 activity.
Materials and Methods
Cell lines and culturing conditions
The HCT116- and RPE-1-derived tri- and tetrasomic cell lines have
been constructed by micronuclei-mediated chromosome transfer as
described previously (Stingele et al, 2012). Parental cell line
HCT116 (human colon carcinoma cell line): HCT116 3/3 (trisomy 3),
HCT116 5/4 (tetrasomy 5) (Haugen et al, 2008); parental cell line
HCT116* stably expressing histone H2B-GFP: HCT116* 5/3 (trisomy
5), HCT116* 5/4 (tetrasomy 5), (Stingele et al, 2013), HCT116 8/3
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c1-c4; parental cell line RPE-1 (human retinal pigment epithelial cell
line, hTERT immortalized): RPE-1 5/3 12/3 (trisomy 5, 12); parental
cell line RPE-1* stably expressing histone H2B-GFP: RPE-1* 21/3
(trisomy 21). Cells were grown in DMEM GlutaMax (Gibco)
supplemented with 10% FBS and 5% Pen/Strep under standard
conditions.
Transfections and luciferase assays
Cells were transfected with a total of 1 or 1.5 lg of the indicated
plasmids in 12-well plates using X-tremeGENE HP DNA transfection
reagent (Roche) according to the manufacturer’s protocol. Cells
were trypsinized, counted, and seeded into 96-well plates 24 h after
transfection and then allowed to recover for 24 h. Then, cells were
treated with either solvent control (DMSO), 5 or 50 nM 17-AAG
(8 h), 2 lM 17-AAG (4 h), or 5 lM MG132 (8 or 20 h). 17-AAG and
MG132 were purchased from Enzo Life Sciences and Tocris Biosci-
ence, respectively. To measure luminescence, 30 ll of SteadyGlo
reagent (Promega) was added directly to the wells of the 96-well
plates and the plates were shaken for 10 s to ensure mixing and cell
lysis. Luminescence was measured on a Tecan plate reader after
15-min incubation in the dark.
Proteasome activity assay
Cells were seeded at 2 × 104 per well in triplicates in 96-well plates.
Forty minutes later, Proteasome-GloTM Chymotrypsin-Like Cell-
Based Assay (Promega) was added according to the manufacturer’s
protocol. Luminescence was detected using a Fluoroskan Ascent FL
plate reader operated by the Ascent software. For evaluation the
mean with SEM of biological triplicates was calculated.
Western blotting
Exponentially growing cells were harvested and lyzed in RIPA
buffer supplemented with protease inhibitors (Roche). 20 lg of
protein were then resolved on 10% polyacrylamide gels and trans-
ferred to nitrocellulose membranes using the semi-dry technique.
After blocking in low fat 5% milk in TBS-T, membranes were incu-
bated with the following primary antibodies: HSP90 (1:1,000; Cell
Signaling #4877), HSC70 (1:1,000; Enzo Life Sciences ADI-SPA-815),
HSP70 (1:1,000; Enzo Life Sciences ADI-SPA-810), HSP27 (1:1,000;
Enzo Life Sciences ADI-SPA-800), HSF1 (1:1,000; Enzo Life Sciences
ADI-SPA-901), cyclin E2 (1:1,000; Cell Signaling #4132), c-Myc
(1:200, Santa Cruz Biotechnology sc-40), GAPDH (1:2,000; Cell
Signaling #2,118). The antibodies against phospho-HSP70 and
phospho-HSP90 were a kind gift from Petr Müller, Masaryk Univer-
sity, Brno. After incubation with HRP-conjugated secondary anti-
bodies, HRP substrate was added and luminescent signals were
quantified using a LAS 3000 instrument (FujiFilm). Protein bands
were quantified using ImageJ software.
Colony formation assays
Cells were seeded at 1,000 per well in 6-well plates 24 h before
the treatment. Subsequently, cells were continuously treated with
17-AAG (5 or 25 nM) or DMSO for 10–12 days. Colonies were
fixed with methanol:glacial acetic acid (1:1) and stained with
0.02% crystal violet for 15 min before washing with tap water and
air-drying.
Cell viability assays
Cells were seeded at 2,000 per well in 96-well plates 24 h before the
treatment. Subsequently, cells were treated with the indicated drugs
at the indicated concentrations and cell viability was determined
after 72 h, unless otherwise stated. Viability was determined using
the CellTiterGlo luminescent cell viability assay (Promega) accord-
ing to the manufacturer’s instructions.
Chromosome transfer and preparation of chromosome spreads
and paints
Chromosome transfer and the preparation of spreads and paints
were performed as previously (Stingele et al, 2012).
RNA isolation and qPCR
Total RNA was isolated using the RNeasy kit (Qiagen) and reverse-
transcribed into cDNA using the First Strand cDNA synthesis kit
(Roche). qPCR was performed with a HSF1 assay from Qiagen (Cat.
No. 330001 PPH00164F) on a LightCycler 480 (Roche) instrument
using the KAPA SYBR FAST master mix. Absolute quantification
was performed with an external standard, and the specificity of the
amplicons was confirmed by melting curve analysis. HSF1 mRNA
expression was normalized to ribosomal protein L27 (RPL27) as a
housekeeping gene (de Jonge et al, 2007).
siRNA transfections
Cells were transfected at 50% confluency using 800 pmol siRNA
and Oligofectamine according to the manufacturer’s instructions.
Transfections were conducted in OptiMEM for 4 h. The siRNA
sequences used were acquired from Eurofins Genomics and are as
follows: HSF1 (50 CGGAUUCAGGGAAGCAGCUGGUGCA 30; (Jacobs
& Marnett, 2009); GL2 (50 CGUACGCGGAAUACUUCGATT 30).
Electroporation
Cells were electroporated using the Amaxa Nucleofector II apparatus
and following the manufacturer’s instructions and protocols for
HCT116 cells and RPE-1 cells, respectively. Briefly, 1 million cells
were resuspended in Cell Line Nucleofector Solution V containing
2 lg of either pCDNA or ca-HSF1 plasmid and transferred to
cuvettes. HCT116 cells were electroporated using the D-032 Program
and for RPE-1 cells the Program was U-017.
Transcriptome and proteome data analysis
The analyses of quantitative transcriptome and proteome data were
performed as previously described (Durrbaum et al, 2014). The data
were retrieved from the Gene Expression Omnibus database with
the following accession numbers: knockdown of HSF1 in HCC:
GSE47639; knockdown of c-myc in HeLa, BT-474, MCF-7, MDA-MB-
231: GSE5823; HCT116- and RPE-1-derived trisomies and tetraso-
mies: GSE47830 and GSE39768.
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Statistical analyses
All data related to viability, Fluc folding and protein expression
were analyzed using Student’s t-test; *P < 0.05; **P < 0.01;
***P < 0.001. All statistically analyzed experiments were performed
at least three times.
Supplementary information for this article is available online:
http://emboj.embopress.org
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6.3 microRNA deregulation contributes to the cellular response to aneuploidy 
In this study we investigated the contribution of miRNA deregulation to the 
consequences of aneuploidy in human cell lines. Aneuploidy results in profound changes 
of the cellular physiology as well as of the transcriptome and proteome (Donnelly and 
Storchova, 2015; Dürrbaum et al., 2014; Oromendia et al., 2012; Passerini et al., 2016; 
Stingele et al., 2012; 2013; Torres et al., 2007). Given that miRNAs post-transcriptionally 
regulate up to 60% of the transcriptome (Friedman et al., 2009) and their deregulation 
affects diverse cellular processes (Hwang and Mendell, 2006; Landgraf et al., 2007), we 
asked whether miRNAs play a role in the response to aneuploidy. 
To investigate the miRNAome in aneuploid cells we sequenced small RNA of seven 
different aneuploid model cell lines and their corresponding parental cell lines. We found 
that the miRNAome in cells with extra chromosomes is genome-wide altered. Moreover, 
the deregulated miRNAome is rather a response to aneuploidy per se than caused by the 
specific extra chromosomes. Strikingly, the deregulated miRNAome affects common 
cellular functions such as cellular development, growth and proliferation. Integrated 
analysis of RNA sequencing data and previous acquired proteome data revealed that the 
majority of miRNA targets are negatively affected by the deregulated miRNAs. We found 
hsa-miR-10a-5p upregulated in 5 out of 7 sequenced cell lines and validated its 
overexpression in 15 different aneuploid cell lines. We show that this upregulation of 
hsa-miR-10a-5p governs resistance to shut down of ribosomal protein translation upon 
starvation.  
Our analysis reveals for the first time, that the addition of extra chromosomes 
affects genome-wide miRNA expression. The downregulation of miRNA targets associated 
with cellular growth and proliferation indicates a direct contribution of miRNAs to the 
adverse effects of aneuploidy on cell physiology. Moreover, the commonly upregulated 
hsa-miR-10a-5p presents an adaptation mechanism of aneuploid cells that enhances 
translation under stress conditions such as starvation. Future studies will reveal the 
broader relevance of this adaptation to aneuploidy. 
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The deregulated microRNAome contributes to the cellular response to 
aneuploidy 
 
Dürrbaum M, Kruse C, Nieken KJ, Habermann B, Storchová Z 
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Aneuploidy, or abnormal chromosome numbers, severely alters cell physiology and is 
widespread in cancers and other pathologies. In model cell lines, aneuploidy impairs 
proliferation, leads to proteotoxic as well as replication stress and triggers conserved 
transcriptome and proteome changes. The underlying regulatory mechanisms of the 
response to aneuploidy remain elusive. In this study we show that the expression of 
microRNAs is greatly altered in cells with additional chromosomes. We demonstrate that 
the alterations occur in response to aneuploidy per se and independently of the identity of 
the extra chromosome. Further, we found that the deregulated microRNAome contributes 
to the cellular response to aneuploidy by negatively affecting cell development, growth 
and proliferation. Strikingly, we discovered hsa-miR-10a-5p upregulated in the majority of 
analyzed cell lines. We show that hsa-miR-10a-5p overexpression provides resistance to 
starvation- induced shut down of ribosomal protein translation. Thus, the changes of the 
microRNAome contribute on one hand to the adverse effects of aneuploidy on the cell 
physiology, but on the other hand also to the adaptation to aneuploidy by supporting the 
survival under adverse conditions such as starvation. 
 
 
Introduction 
 
A balanced karyotype is essential for cell viability and therefore aneuploidy, characterized 
by unbalanced changes in chromosome numbers and sub-chromosomal structural 
variations, has often profound detrimental consequences for cell physiology. In humans, 
aneuploidy is the major cause of spontaneous abortions and the few trisomies compatible 
with life result in severe developmental defects (Colnaghi et al., 2011). Aneuploidy in 
somatic cells is frequently associated with cancer, as 70% of haematopoietic and 90% of 
solid cancers show an abnormal karyotype (Mitelman et al., 2016; Weaver and Cleveland, 
2006). Recently developed aneuploid model systems that allow studying the consequences 
of aneuploidy have accelerated our understanding of the effects of aneuploidy per se. The 
physiological changes in response to an unbalanced karyotype are multifold, including 
impaired proliferation, replication stress and proteotoxic stress that is characterized by 
changes in protein stoichiometry, reduced protein folding capacity and chaperon levels as 
well as by activation of autophagy (Ariyoshi et al., 2016; Donnelly et al., 2014; Nawata et 
al., 2011; Niwa et al., 2006; Ohashi et al., 2015; Oromendia et al., 2012; Passerini et al., 
2016; Pavelka et al., 2010; Stingele et al., 2013; Torres et al., 2007). The physiological 
response to aneuploidy goes hand in hand with a conserved transcriptional response that 
is manifested in a conserved pathway deregulation (Dürrbaum et al., 2014; Sheltzer et al., 
2012). What triggers these changes in gene transcription and how exactly this specific 
response is modulated has not been clarified so far. 
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Given that the triggers of the transcriptional deregulations remain unclear, we asked 
whether microRNA (miRNA) regulation is involved in the response to aneuploidy. miRNAs 
are small non-coding RNA molecules that posttranscriptionally regulate gene expression of 
over 60% of protein coding genes (Friedman et al., 2009). The regulatory function of 
miRNAs is mediated by their binding to the target 3’untranslated region (UTR) via 
partially complementary sequences, thereby inducing translational repression and/or 
mRNA decay. Alternatively, some miRNAs bind to sites within the coding region or the 
5’UTR (Liu et al., 2013; Schnall-Levin et al., 2011). One mRNA can be affected by multiple 
miRNAs that cooperatively translationally repress or degrade the target mRNA or compete 
for target regulation (Selbach et al., 2008). In turn, one single miRNA can repress 
hundreds of mRNAs and lead to large-scale transcriptome changes that for example play a 
key role in stem cell differentiation (Shenoy and Blelloch, 2014). Moreover, the complex 
miRNA-target network allows to fine-tune diverse cellular processes by modulating the 
amount of transcripts translated particularly upon stress conditions or changes in the 
environment (Hwang and Mendell, 2006; Leung and Sharp, 2010). 
In the disease context such as in cancer, alterations of miRNA expression are common and 
specific miRNA deregulation profiles are sufficient to distinguish cancerous from non-
cancerous tissues and to predict invasiveness and aggressiveness of various cancers 
(Kurozumi et al., 2016; Thomas et al., 2015; Yeh et al., 2016). The wide miRNA 
deregulation in cancers has been attributed to genomic copy number changes. For 
instance, the gain of arm of chromosome 1 relates to miRNA expression changes in 
cervical cancer (Wilting et al., 2012) and downregulation of let-7 family was associated 
with copy number changes in medulloblastoma, breast and ovarian cancer (Wang et al., 
2012). In some cancers, deregulated miRNAs promote genomic and chromosomal 
instability by targeting the mitotic checkpoint or DNA damage repair components (Choi et 
al., 2014; Hell et al., 2014). Yet, beyond these few examples, we lack a deeper 
understanding of how aneuploidy in cancer and miRNAs are associated. Moreover, the 
relation of miRNA and aneuploidy per se has not been studied so far.  
We have asked whether aneuploidy per se results in miRNA deregulation and whether this 
deregulation is specific to the numerical chromosome changes or general to aneuploidy. 
To this end, we have used a series of human trisomic and tetrasomic cell lines and their 
isogenic counterparts that were established previously in our laboratory (Stingele et al., 
2012). Indeed, we found that chromosome copy number changes strongly deregulate the 
expression of more than 25% of miRNAs with only a few individual miRNAs commonly 
altered among different aneuploidies. Most of the identified miRNA deregulations 
negatively affect cell growth and proliferation, thus suggesting that miRNAs suppress 
proliferation of aneuploid cells. Most aneuploids strongly overexpress the miRNA hsa-miR-
10a-5p that acts also via the 5’UTR of target mRNAs. We show that this provides the 
aneuploid cells with resistance to starvation by insuring sustained translation of ribosomal 
mRNAs. Our analysis of the global miRNAome changes in response to chromosome gain 
reveals a complex interplay of the gene expression regulatory mechanisms that shape the 
global transcriptome and proteome dynamics.  
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Results 
Deregulation of miRNAome in human aneuploid model cell lines 
In order to determine the effects of a chromosome gain on miRNA expression in human 
cells, we used a series of cells derived from HCT116 and RPE1 cell lines that contain one 
or more extra copies of chromosomes ((Donnelly et al., 2014; Passerini et al., 2016; 
Stingele et al., 2012), see Material and Methods for more details). We subjected four 
HCT116- derived cell lines trisomic for chromosome 3, 8 or 18 and tetrasomic for 
chromosome 5 as well as the parental HCT116 cell line to small RNA sequencing. In 
addition, we sequenced three RPE1- derived cell lines trisomic for chromosome 7, 21 and 
a cell line trisomic for both chromosome 5 and 12 as well as the parental RPE1 cell line. 
We have used the miRBase repository (http://www.mirbase.org, (Kozomara and Griffiths-
Jones, 2013)), where 1881 mature human miRNAs are listed to date, as the miRNA data 
source for mapping. Mapping of the raw sequences to the human genome and subsequent 
identification of miRNAs with mirdeep2 (Friedländer et al., 2011) resulted in at least 554 
and up to 719 identified mature miRNAs in the sequenced cell lines (Table 1).  
Table 1. Detected mature miRNAs 
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mature miRNAs in 
miRBase 
1881 
mature miRNAs 
detected by mirdeep2 
719 554 592 747 572 562 650 628 647 663 646
miRNAs with detected 
read count in every 
biological replicate 
626 486 510 647 485 490 566 564 562 575 564 
While the numbers of identified miRNAs were similar for all sequenced aneuploid cell 
lines, the extent of miRNA deregulation differed. We analyzed the differential miRNA 
expression in aneuploid cell lines in comparison to their diploid counterparts by applying 
DESeq2 for normalization and statistical testing (Love et al., 2014). Under the assumption 
of a negative binominal distribution, DESeq2 applies generalized linear models to test for 
differential expression. To estimate the variability, the assumption that genes with similar 
abundance show similar variance is made. Since miRNAs with very low expression levels 
are characterized by low read counts and an inherent large variability on the logarithmic 
scale, these miRNAs are pre-filtered (Love et al., 2014). This filtering reduced the number 
of miRNAs in the aneuploid cell lines with a read count greater than 10 to a range from 
231 to 293 (Table 2). The RPE1- derived aneuploid cell line with three copies of 
chromosome 21 and carrying H2B-GFP (RPE1* 21/3) showed the lowest number of 
significantly deregulated miRNAs (log2 fold change +/-0.6, adjusted p-value <0.05) with 
23 significantly deregulated miRNAs. The highest number of 74 deregulated miRNAs was 
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found in RPE1 5/3 12/3 and HCT116 5/4 (Table 2). The percentage of deregulated 
miRNAs ranged from 9.6% (in RPE1* 21/3) up to 31.2% (in RPE1 5/3 12/3).  
Table 2. Deregulated miRNAs and mRNAs in aneuploid cell lines 
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miRNAs with a mean count >=10 249 280 279 293 237 247 231 
miRNAs significantly deregulated 
log2 fold change >0.6 or <-0.6 
(padj. <0.05) 
74 57 27 44 74 33 23 
percentage of significantly 
deregulated miRNAs  
29.7 20.4 9.7 15.0 31.2 13.4 10.0 
mRNAs with a mean count >=10 13887 - - 13873 13278 - 13101 
mRNAs significantly deregulated 
log2 fold change >0.6 or <-0.6 
(padj. <0.05) 
2885 - - 410 2210 - 434 
percentage of significantly 
deregulated mRNAs 
20.8 - - 3.0 16.6 - 3.3 
There was only a weak correlation between the percentages of deregulated miRNAs with 
the amount of extra DNA (Suppl. Fig 1B). Thus, the altered miRNA expression in response 
to aneuploidy is largely independent of the amount of added extra DNA suggesting that 
the alteration in the miRNAome is a general response to aneuploidy. 
Effects of the deregulated miRNAome on the aneuploid transcriptome 
To directly compare the changes in miRNA expression with the mRNA expression, we 
analyzed the transcriptome of HCT116 5/4, HCT116* 8/3 c7, RPE1 5/3 12/3 and RPE1* 
21/3 by RNA sequencing. The percentage of deregulated mRNAs (log2 fold change +/-
0.6, adjusted p-value <0.05) highly differed among the cell lines, with 3.3% in RPE1* 
21/3, 16.6% in RPE1 5/3 12/3, 3.0% in HCT116* 8/3 c7 and 20.8% in HCT116 5/4 
(Table 2). Thus, the percentage of deregulated mRNAs in specific cell lines shows a similar 
trend as the percentage of deregulated miRNAs. However, when comparing these 
percentages with the above-described percentages of deregulated miRNAs, we found that 
a larger fraction of miRNAs (ranging from 9.6 to 35%) than mRNAs (ranging from 3.0 to 
20.8%) was altered in all cell lines. Thus, addition of extra chromosomes affects miRNA 
expression to a larger extent than it affects the mRNA expression. 
We asked to what extend the transcriptional response to aneuploidy can be explained by 
miRNA regulation. To model the miRNA-target network, we retrieved reported miRNA 
targets from miRTarBase (v6.1) for all deregulated miRNAs of each cell line (Vergoulis et 
al., 2012). We then filtered these miRNA targets for those that were altered in response to 
aneuploidy. To simplify the complex multiple miRNAs to one target relation, we analyzed 
whether these deregulated mRNA targets were inversely expressed to their related 
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miRNAs. Compared to the total number of deregulated mRNAs, 22% of mRNAs are 
potentially targeted by deregulated miRNAs, judged by their inverse expression in HCT116 
5/4 (Table 3). The percentage is lower in RPE1* 21/3, RPE1 5/3 12/3 and HCT116* 8/3 
c7, were 18%, 16% and 3% of deregulated mRNAs are potentially targeted by the 
deregulated miRNAs, respectively. Thus under these approximations, only a minor fraction 
of the mRNA changes in response to aneuploidy might be directly influenced by miRNA 
regulation.  
Table 3. Percentage of mRNA targets that are inversely expressed to the deregulated miRNAs 
Cell line Deregulated mRNAs 
Deregulated 
miRNAs 
Number of 
targets of 
deregulated 
miRNAs 
Number of 
DE miRNA 
targets that 
are 
deregulated 
on mRNA 
level 
Number of DE miRNA 
targets that are 
deregulated on mRNA 
level and show inverse 
expression 
HCT116 
5/4 3342 74 
9111 miRNA-
target 
interactions 
1280 904 miRNA-target interactions 
6644 unique 
targets 38.30% 
729 unique targets 
21.81% 
RPE1 
5/3 
12/3 
2484 74 
6487 miRNA-
target 
interactions 
604 406 miRNA-target interactions 
4605 unique 
targets 24.30% 
345 unique targets 
16.34% 
RPE1* 
21/3 788 23 
6036 miRNA-
target 
interactions 
214 142 miRNA-target interactions 
5078 unique 
targets 27.20% 
127 unique targets 
18.02% 
HCT116 
8/3 c7 250 44 
965 miRNA-
target 
interactions 
12 7 miRNA-target interactions 
877 unique 
targets 4.80% 7 unique targets 2.8% 
Finally, we asked whether the deregulated miRNAs would specifically target and regulate 
the expression of genes encoded on the aneuploid chromosomes to a near diploid 
expression (so called dosage compensation), which occurs for a small subset of genes 
(Stingele et al., 2012). However, our analysis of the target genes encoded on the 
aneuploid chromosomes did not indicate any role of miRNAs in dosage compensation 
(data not shown). 
Cell line specific and general miRNA deregulation in response to aneuploidy 
Comparison of the significantly altered miRNAs in aneuploid cell lines revealed a pattern 
of miRNA expression changes that is largely distinct for each specific cell line (Fig. 1A). 
Interestingly, the Euclidean distance clustering was not defined by the parental cell type, 
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but rather by distinct and cell line specific miRNA expression clusters of each aneuploid 
cell line. HCT116 5/4 showed the most prominent clusters of down- and upregulated 
miRNAs and appeared as an outlier in the Euclidean distance cluster. The upregulated 
miRNA cluster in HCT116 5/4 partially overlapped with the upregulated miRNAs in RPE1 
5/3 12/3; among them most prominently the miRNA family miR-192/215 and the nearby 
located miR-194 and miRNAs hsa-miR-29b and hsa-miR-29c, which are encoded in a 
cluster on chromosome 1. Majority of the deregulated miRNA clusters overlapped only 
poorly with the other aneuploid cell lines. However, some similarities in the deregulated 
miRNAs were found. For instance, hsa-miR-21-5p and hsa-miR-24-2-5p showed similar 
upregulation in all HCT116-derived cell lines (Fig. 1B). Moreover, five out of seven 
sequenced aneuploid cell lines shared the upregulation of hsa-miR-10a-5p and hsa-miR-
139-5p (Fig. 1C). Intriguingly, this upregulation did not affect the entire miRNA family 
and seems to be specific for the individual miRNA: while hsa-miR-10a-5p was upregulated 
in five out of seven of the analyzed cell lines, the family member hsa-miR-10b-5p was 
upregulated only in RPE1 5/3 12/3. Similarly, hsa-miR-22-5p was upregulated in five out 
of seven aneuploid cell lines. Moreover, hsa-miR-374b-5p was downregulated in all cell 
lines except RPE1 5/3 12/3 (Fig. 1D). In summary, there are vast dissimilarities in the 
deregulation patterns between the aneuploid cell lines and only a few miRNAs show 
common differential expression changes. 
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Figure 1. miRNAome in aneuploid model cell lines. A Heatmap of significantly altered miRNAs 
in aneuploid cell lines (adjusted p-value <=0.05). Blue indicates downregulation, red 
upregulation. Row and column dendrograms show Euclidean distance between miRNA expression 
profiles and cell lines, respectively. Commonly deregulated miRNA clusters are highlighted by black 
lines. B miRNA expression profile of miRNA cluster upregulated in all HCT116-derived aneuploid 
cell lines. C miRNA expression profile of miRNA cluster containing hsa-miR-10a-5p and hsa-miR-
139-5p that are upregulated in 5 out of 7 sequenced aneuploid cell lines (red line). Grey lines 
indicate miRNAs in the same cluster that are not commonly deregulated. D miRNA expression 
profile of miRNA cluster containing hsa-miR-374b-5p that is down regulated in 6 out of 7 
sequenced aneuploid cell lines (red line). Grey lines indicate miRNAs in the same cluster that are 
not commonly deregulated. Cell lines ordered according to Euclidean distance. Asterisks indicate 
cell lines with H2B-GFP. 
The presence of extra chromosomes in cells generally leads to an elevated expression of 
the genes that are located on the supernumerary chromosomes; thus the abundance of 
transcripts largely scales with the gene copy numbers (Dürrbaum and Storchova, 2015; 
Nawata et al., 2011; Sheltzer et al., 2012; Stingele et al., 2012; Torres et al., 2007; 
Upender et al., 2004; Williams et al., 2008). To determine whether this holds also true for 
miRNA expression, we ordered the miRNAs according to their chromosome location. We 
then compared the distribution of the miRNA expression from the aneuploid chromosomes 
to miRNA expression from the diploid chromosomes and tested whether higher expression 
of the aneuploid distribution occurs just by chance. The aneuploid chromosome-specific 
miRNA expression was significantly higher than the diploid miRNA expression only for 
RPE1* 7/3, RPE1* 21/3 and for the miRNAs encoded on chromosome 12 in RPE1 5/3 
12/3 (Fig. 2A–C). In all other aneuploid cell lines, the miRNA expression distribution did 
not scale with the number of chromosome copies, although the miRNAs encoded on 
chromosome 5 in HCT116 5/4 and RPE1 5/3 12/3 showed an elevated median expression 
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in comparison to the disomic chromosomes (Fig 2C–G). Due to the relatively small number 
of deregulated miRNAs that were encoded on the aneuploid chromosomes, we cannot rule 
out that the shift of the expression towards higher levels occurs just by chance (Suppl. 
Table 1). In addition, the median miRNA expression is often higher than expected also for 
some disomic chromosomes (Suppl. Fig 2A). For instance, the median expression of 
miRNAs encoded on chromosome 11 and 17 are significantly increased in HCT116 5/4. 
Similar effect was observed in other analyzed aneuploid cells lines, where the median 
expression of miRNAs encoded on one or more disomic chromosomes is significantly 
higher or lower than expected. In summary, although 10-31% of miRNAs were strongly 
deregulated in response to aneuploidy in each individual cell line, only a few miRNAs 
showed a common deregulation pattern. These miRNAs were mostly upregulated, but 
their upregulation could not be explained by gene copy number changes, as they were 
largely not encoded on any of the aneuploid chromosomes. This suggests that not the gene 
copy number changes are responsible for the deregulation of these specific miRNAs, but 
rather that the increased expression reflects the cellular response to abnormal 
chromosome numbers.  
Figure 2. Expression of miRNAs encoded on the aneuploid chromosomes versus miRNAs 
encoded on disomic chromosomes. Each blue dot represent one miRNA with its log2 fold change 
expression normalized to the corresponding parental cell line. Boxplots present 75%, 50% and 25% 
quantile, with median value shown. A RPE1* 7/3 that has additional copy number changes of 
chromosome 9 and 12 B RPE1* 21/3 C RPE1 5/3 12/3 D HCT116 5/4 E HCT116 18/3 c2 F 
HCT116* 3/3 c11 G HCT116* 8/3 c7 and H miRNAs of all aneuploid chromosomes compared to all 
disomic miRNAs. Note that the number of miRNAs does not correlate with the median expression 
fold change of the aneuploid chromosomes. Significance tested with Mann-Whitney-Wilcoxon test. 
Asterisks indicate cell lines with H2B-GFP. 
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Deregulated miRNAs affect similar molecular functions 
To determine which cellular functions are affected by the changes in the miRNAome in 
aneuploid cells, we performed functional analysis based on the manually curated 
knowledge base of Ingenuity Pathway Analysis (IPA http://www.ingenuity.com). This 
analysis revealed that the top five molecular and cellular functions affected by the 
deregulated miRNAs in response to aneuploidy were largely shared among the seven 
aneuploid cell lines. In particular, “Cell Cycle” was affected in all sequenced aneuploid cell 
lines (Fig. 3A). It should be noted, however, that only a few miRNAs (from two in 
HCT116* 3/3 to seven in HCT116 5/4) were implicated in this biological function. Most 
miRNAs were involved in “Cellular Movement”, “Cellular Growth and Proliferation” and 
“Cellular Development”. The miRNAome of HCT116* 3/3 showed different functional 
associations than all other cell lines and the number of miRNAs involved was less than 
seven. HCT116* 3/3 is also the only cell line were the pathway “Cellular Function and 
Maintenance” was identified as affected. The only pathways in HCT116* 3/3 that were 
shared with the majority of the other aneuploid cell lines were “Cellular Development” 
and “Cell Cycle”.  
The cellular and molecular function categories of IPA are divided into sub-functional 
annotation terms. We employed IPA to infer an activation state of the biological functions 
as an activation z-score. The IPA activation z-score is a quantitative measure of the 
predicted effect of the deregulated miRNAome on a biological function (Kraemer et al., 
2014). It is calculated based on the direction of miRNA deregulation and the literature-
derived positive or negative effects of these miRNAs on a biological function. Our miRNA 
dataset was sufficient to retrieve the z-score for the sub-functional annotation terms within 
the categories “Cell Death and Survival”, “Cellular Development, Cellular Growth and 
Proliferation”, “Cellular Growth and Proliferation” and “Cellular Movement” (Fig. 3B). 
Strikingly, the effect of the deregulated miRNAome on these functions is mostly negative. 
Almost all sub-functional annotation terms within the four parent categories were 
predicted to be inhibited or deactivated in HCT116 18/3, HCT116 5/4 and RPE1* 7/3. 
HCT116 5/4 shows the strongest effect with stringent z-scores below -2. No conclusive z-
score could be retrieved for HCT116* 8/3 c7, RPE1 5/3 12/3 and RPE1* 21/3, with the 
exception of the pathway “Invasion of Tumor Cell Lines” with a z-score of 1.6 in RPE1* 
21/3. In concordance with the identity of the five top molecular and cellular functions, 
HCT116* 3/3 miRNA deregulation does not predict an activation z-score for proliferation 
or growth associated functions, but only for the category “Cell Death and Survival”. 
Therein, “apoptosis” is predicted to be activated with a z-score of 1.8 and 2 and “cell 
death” as well as “necrosis” with a z-score of 1.5 and 1.4, respectively. In summary, 
although only small numbers of commonly deregulated miRNAs were identified in cells 
with extra chromosomes, the miRNAome affects largely overlapping molecular and 
cellular functions, which were associated with cellular growth and proliferation. The 
negative effect on cell proliferation and growth executed either directly by impairing the 
proliferation pathway or indirectly by activation of cell death and apoptosis was 
conclusively predicted based on the miRNA changes in four out of seven aneuploid cell 
lines. We conclude that the miRNA expression changes in response to aneuploidy result in 
a largely negative effect on cellular proliferation. 
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Figure 3. miRNAome of aneuploid cells affects cellular development, growth and proliferation 
A Top five cellular and molecular functions affected by the deregulated miRNAs in individual 
aneuploid cell lines. Dot size and colour indicates the number of miRNAs that are associated with a 
specific cellular function. B Subfunctional annotation terms for the four cellular and molecular 
functions with the most miRNAs involved (columns). Each row contains subfunctional annotations 
for one aneuploid cell line. The size of the boxes indicates the numbers of miRNAs associated (y-
axis); the colour indicates the predicted activation z-score. Asterisks indicate cell lines with H2B-
GFP. Hep. cells abbreviates hepatoma cell lines. 
 
 
Integration of miRNA, RNA and protein expression data infers an effect on cellular 
development, cellular growth and proliferation  
 
To further investigate how the miRNAs execute their negative impact on cellular 
development, growth and proliferation in aneuploids, we analyzed their targets. This 
analysis was performed for HCT116 5/4, RPE1 5/3 12/3 and RPE1* 21/3, for which 
miRNAome, transcriptome and proteome data were available (this work and (Stingele et 
al., 2012)). In total, 40 miRNAs were found to be associated with the cellular 
development, growth and proliferation category (Suppl. Fig 3A). The set of miRNAs 
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affecting cellular development, growth and proliferation was diverse and only partially 
overlapped within a subset of the analyzed cell lines. For the 20 miRNAs associated with 
the development, growth and proliferation category in HCT116 5/4, 604 experimentally 
validated miRNA-target interactions were found, with 325 unique targets (Fig. 4A). In 
RPE1 5/3 12/3 and RPE1* 21/3, 19 and 13 miRNAs interact with 238 and 208 unique 
targets, respectively (Suppl. Fig 3B,C). Importantly, chromosome alignment of the miRNAs 
reveals no bias for the aneuploid chromosome in either of the cell lines.  
miRNAs may affect target protein levels only, or mRNA and protein levels simultaneously. 
To infer the effect of miRNA regulation on previously experimentally validated targets, we 
matched the transcriptome and proteome data to the targets of miRNAs within the cellular 
development, growth and proliferation category. Targets were filtered for their expression 
changes above/below a threshold ratio of +/-0.6 (log2 fold change) and only targets with 
a potential miRNA relation, that is, targets with inverse expression to the interacting 
miRNA, were considered for the annotation enrichment analysis. Strikingly, 72% of the 
filtered targets were downregulated at least on protein level in HCT116 5/4 (Fig. 4B). This 
is in line with the predicted downregulation of the molecular function term by the 
activation z-score. Importantly, this holds also true for RPE1 5/3 12/3 and RPE1* 21/3, 
for which the predicted activation z-scores were below the threshold (Suppl. Fig 3D,E). 
Thus, the target gene expression substantiates the predicted activation state of the 
molecular function, which was based solely on the miRNA expression values. This 
confirms the largely negative effect of the deregulated miRNAs on cell cycle and 
proliferation in response to aneuploidy. 
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Figure 4. miRNA target expression analysis infers functional role of miRNAs A Number of 
targets with strong evidence for each deregulated miRNA annotated in the “Cellular Development, 
Cellular Growth and Proliferation” category in HCT116 5/4. The size indicates the number of 
targets; the colour shows the significance of miRNA deregulation. The miRNAs are presented 
according to their chromosome location. B Target genes within the “Cellular Development, Cellular 
Growth and Proliferation” category and their mRNA and protein expression. Selected gene labels 
indicate targets with inverse miRNA-target expression, which are associated with cell cycle 
processes. Shape indicates the type of experimental evidence for a miRNA-target interaction. The 
colour indicates log2 fold change miRNA expression. 
To analyse whether the filtered miRNA targets were indeed involved in the analyzed 
molecular functions, we performed functional annotation clustering with the DAVID 
functional annotation tool. As expected, the top annotation cluster was associated with 
cell cycle functions in HCT116 5/4 and RPE1 5/3 12/3, respectively (Suppl. Table 2). In 
RPE1* 21/3, cell cycle associated annotations were enriched in the second top cluster. 
Among the deregulated targets associated with the cell cycle function in HCT116 5/4 we 
found key players of proliferation, such as the mitotic checkpoint serine/threonine kinases 
(BUB1), cell division cycling 20 (CDC20), cyclin-dependent kinase 4 (CDK4) and 
checkpoint kinase 1 (CHEK1) (Fig. 4B). Two targets, namely the high motility group A2 
(HMGA2) and regulator of chromosome condensation (RCC2), show a strong 
downregulation of both mRNA and protein levels in HCT116 5/4. RCC2 is also 
downregulated and targeted in RPE1 5/3 12/3. Also in RPE1- derived aneuploid cell lines, 
RPE1 5/3 12/3 and RPE1* 21/3, cell cycle associated factors were targeted (Suppl. Fig 
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3D,E). For example, the minichromosome maintenance protein complex members (MCM2, 
3 and 6) and Cyclin E1 were found downregulated in RPE1 5/3 12/3. Hence, the 
deregulated targets of the identified deregulated miRNAs in response to aneuploidy 
implicated in cellular development, growth and proliferation were indeed involved in 
these molecular functions and showed a strong association with cell cycle progression. The 
fact that majority of these targets were found downregulated and the interacting miRNAs 
upregulated suggests that the miRNAome in aneuploid cells negatively affects cellular 
proliferation and might contribute to the proliferation defect observed in aneuploid model 
cell lines.  
hsa-miR-10a-5p activity is increased in human aneuploid model cell lines 
Remarkably, we found miRNA hsa-miR-10a-5p upregulated in five out of seven aneuploid 
cell lines. Quantitative real-time PCR of 18 different aneuploid model cell lines, among 
them different clones with the same chromosome (for details see Material and Methods), 
revealed that the mean expression of hsa-miR-10a-5p was significantly increased above 
the levels of the parental cell line in 7 out of 18 cell lines and elevated in additional 8 cell 
lines (Fig. 5A). The trend towards upregulation were in line with the sequencing data, 
where a strong upregulation in HCT116 5/4, RPE1 5/3 12/3 and RPE1* 21/3 was 
observed, whereas HCT116* 8/3 c7 and HCT116 18/3 c2 showed a minor increase (Fig. 
1D). The increased expression of hsa-miR-10a-5p might be a secondary effect of the 
expression of HOXB3 in which the miRNA sequence is located. Comparison of the hsa-
miR-10a-5p and HOXB3 expression levels in four cell lines revealed that only in two cell 
lines, HCT116 5/4 and RPE1* 21/3, both miR-10a-5p and HOXB3 are significantly 
upregulated (Suppl. Fig 4). The expression levels are remarkably similar in RPE1* 21/3, 
suggesting that the increased hsa-miR-10a-5p might indeed be a result of elevated HOXB3 
expression in this cell line. In HCT116 5/4, however, the levels of hsa-miR-10a-5p are 
much higher than HOXB3 levels. In the additional two cell lines, the upregulation of hsa-
miR-10a-5p does not coincide with HOXB3 overexpression. Thus we conclude that the 
increased hsa-miR-10a-5p cannot be generally explained by increased expression of the 
host gene HOXB3. 
To determine whether hsa-miR-10a-5p overexpression indeed affects gene expression in 
aneuploid cells, we used a luciferase reporter assay to determine its translational 
repression efficiency. The luciferase reporter consists of a miR-10a binding site in a 
synthetic 3’untranslated region (UTR) of the Renilla luciferase gene (Fig. 5B). The 
reporter contains a second unmodified Firefly luciferase gene to normalize for the 
transfection efficiency. Binding of hsa-miR-10a-5p to the luciferase 3’UTR shall result in 
translational repression of the luciferase mRNA and subsequent decrease in the luciferase 
signal. Indeed, the luciferase signal was significantly lower in four out of five tested 
HCT116- derived and RPE1- derived aneuploid cell lines (Fig. 5C). No changes in 
luciferase signal were detected in the HCT116* 8/3 c7 cell line; this is likely due to a 
relatively minor increase in hsa-miR-10a-5p expression in this cell lines (see Fig. 5A). 
Taken together, hsa-miR-10a-5p is overexpressed in aneuploid cell lines and shows higher 
endogenous translational repression activity of the luciferase reporter gene.  
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Figure 5. hsa-miR-10a-5p levels and activity are increased in aneuploid cell lines. A hsa-miR-
10a-5p expression analyzed by quantitative real-time PCR in 18 different aneuploid model cell 
lines. Boxplots present minimal, maximal and the mean value.  Relative expression levels 
normalized to corresponding parental cell line is shown. B Luciferase reporter construct to 
determine hsa-miR-10a-5p endogenous gene repression activity. hsa-miR-10a-5p targets its binding 
site in a synthetic 3’UTR of the Renilla luciferase mRNA resulting in translational repression and/or 
degradation of Renilla luciferase mRNA. Renilla luciferase signal is normalized to internal Firefly 
luciferase control (not shown). C Endogenous hsa-miR-10a-5p activity determined by psiCheck2-
10a luciferase reporter assay with hsa-miR-10a-5p binding site in the synthetic 3’UTR. HCT116-
derived and RPE1-derived cell lines were transfected with psiCheck2-10a luciferase reporter 
construct. Luciferase reporter assay was conducted 48hrs post transfection. Data represent the 
normalized mean values +/- SEM from at least three independent experiments each performed in 
triplicates. One-way ANOVA,  multiple comparison correction with Dunnett test. ns= not 
significant, *P<0.0332, **P<0.0021, ***P<0.0002, ****P<0.0001. Asterisks indicate cell lines 
with H2B-GFP. 
The target database lists 298 unique target genes for hsa-miR-10a-5p. Majority of the 
targets have only weak experimental evidence and only nine targets were previously 
verified by luciferase reporter assays. Functional annotation enrichment of all on 
transcriptome level deregulated targets in HCT116 5/4 revealed that these were mostly 
phosphoproteins associated with the membrane and/ or the nucleus (Suppl. Table 3). 
Only six of the targets were downregulated on both transcriptome and proteome in 
HCT116 5/4. For example LIM domain and actin-binding protein 1 (LIMA1) that plays a 
role in cytoskeleton stabilization or metabolic enzymes such as fatty acid synthetase (FAS) 
and sorbitol dehydrogenase (SORD) (Suppl. Fig 5A). Of the 270 hsa-miR-10a targets with 
available expression data in RPE1- derived aneuploid cell lines, only two were 
downregulated on transcriptome and proteome in both RPE1 5/3 12/3 and RPE1* 21/3 
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(Suppl. Fig 5B,C). Thus, although hsa-miR-10a-5p expression and translational repression 
activity is increased in majority of the aneuploid model cell lines, only a very few targets 
of this miRNA show downregulation on mRNA and protein levels. This suggests that the 
hsa-miR-10a-5p function in regulating gene expression via binding to the 3’UTR of target 
mRNAs does not strongly contribute to the changes in response to aneuploidy. 
hsa-miR-10a-5p overexpression governs resistance to starvation stress 
To understand the role of hsa-miR-10a-5p in aneuploid cells, we considered the fact that 
hsa-miR-10a-5p binds also to the 5’UTR downstream of the 5’TOP motif that is found in 
mRNAs of ribosomal proteins (RP) and other translation associated protein mRNAs (Ørom 
et al., 2008). This binding results in enhanced translation of RP mRNAs and alleviates 
redistribution of RP mRNAs from active polysomes to inactive RNP complexes upon amino 
acid starvation. We asked whether the observed upregulation of hsa-miR-10a-5p 
influences the translation of 5’TOP motif mRNAs in aneuploid cells. To analyse the 
translation efficiency of mRNAs with the 5’TOP motif in aneuploid cells, we employed a 
luciferase reporter construct containing the transcriptional start site of the ribosomal 
protein S16 (Rps16) and 29nt of the exon 1 including the 5’TOP motif in the 5’UTR of a 
luciferase gene (pS16-wt-luc) (Fig. 6A, (Ørom et al., 2008)). We first determined the 
steady state levels of 5’TOP motif mRNA translation with the pS16-wt-luc luciferase 
reporter. Interestingly, despite the increased levels of endogenous hsa-miR-10-5p in all 
analyzed aneuploid cell lines, we have not observed any significant increase in the 
normalized Firefly luciferase signal compared to the wild type (Fig. 6B). In fact, HCT116 
5/4 with high endogenous levels showed even significantly decreased luciferase activity. 
Next, we asked whether modulating the levels of hsa-miR-10a-5p affects the translation of 
5’TOP mRNA in aneuploid cell lines, as it was previously described for Mouse E14 ES cells 
(Ørom et al., 2008). To this end, we measured the luciferase activity after overexpression 
of hsa-miR-10a-5p mimic (Suppl. Fig 6A). The functionality of hsa-miR-10a-5p mimic 
overexpression was validated via its 3’UTR-mediated repression activity (Suppl. Fig 6B). 
Using the pS16-wt-luc luciferase reporter, we observed that hsa-miR-10a-5p 
overexpression enhances the 5’UTR-mediated effect on the translation of 5’TOP motif 
mRNAs in the parental HCT116 cell line as well as in three out of four tested aneuploids 
(Fig. 6B). A significant induction of luciferase activity was not observed only for HCT116 
5/4. Thus, the expression of mRNAs with the 5’TOP motifs is sensitive to hsa-miR-10a-5p 
levels also in aneuploid cells and the degree of the responsiveness does not correlate with 
the endogenous amount of hsa-miR-10a-5p. 
The translation of 5’TOP motif mRNAs such as RP mRNAs is tightly regulated and cellular 
stresses such as starvation result in their translational repression and redistribution into 
inactive ribonucleoprotein complexes (Meyuhas and Kahan, 2015). We hypothesized that 
upregulation of hsa-miR-10a-5p in aneuploid cell lines might provide resistance to cellular 
stresses such as starvation. To test this hypothesis, we deprived serum for 3 hours and 
measured the 5’TOP motif mRNA translation via the luciferase reporter assay (Fig. 6C). 
Serum starvation led to significant decrease of the luciferase activity in the parental 
HCT116 cell line. Intriguingly, all aneuploid cell lines were resistant to the reduction of 
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the 5’TOP motif mRNA translation that is induced by serum starvation in the parental cell 
line. This suggests that an increase in hsa-miR-10a-5p levels protects aneuploid cell lines 
from reduction of 5’TOP motif mRNA translation in response to cellular stress. 
Figure 6. 5’TOP motif luciferase activity is less sensitive to starvation in aneuploid cells. A 
Schematic illustration of the pS-16-wt-luc luciferase reporter construct. RPS16 transcriptional start 
side and 29nt of Exon 1 including the 5’TOP motif is incorporated into the 5’UTR of luciferase gene. 
B pS16-wt-luc activity after overexpression of hsa-miR-10a-5p. Cells were reverse transfected with 
hsa-miR-10a-5p mimic or control molecule and forward transfected with pS16-wt-luc and pRL-TK 
24hrs post mimic transfection. 72hrs later a luciferase assay was conducted. C pS-16-wt-luc activity 
after starvation. Cells were transfected as in B and 3hrs FCS starved before the luciferase reporter 
assay was conducted. Data presents Renilla normalized mean +/- SD values. Two-way ANOVA, 
multiple comparison correction with Sidak test. ns= not significant, *P<0.0332, **P<0.0021, 
***P<0.0002, ****P<0.0001. 
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Discussion 
Using an integrated approach of large-scale miRNA, RNA and protein expression data 
analysis and cell biology, we document here the deregulation of the miRNAome and its 
consequences in human aneuploid model cell lines. For the first time, we show that the 
addition of one or two chromosomes results in extensive genome-wide miRNA expression 
changes in human cells. We demonstrate that the deregulated miRNAome negatively 
affects development, growth and proliferation, thereby contributing to the cellular 
response to aneuploidy. Moreover, our evidence suggests that upregulation of hsa-miR-
10a-5p in aneuploid cell lines might present an adaptation to aneuploidy by providing 
resistance to adverse growth conditions. 
Karyotype alterations were previously associated with deregulated miRNA expression in 
some cancers. In general, miRNA coding regions show high frequency of copy number 
variations in ovarian, breast, melanoma and lung cancer (Czubak et al., 2015; Zhang et 
al., 2006). Thus, aneuploidy or genomic instability can be a direct cause for miRNA 
deregulation. Yet, only in three out of seven analyzed aneuploid cell lines we observed a 
significant upregulation of the median miRNA expression from the extra chromosomes 
(Fig. 2, Suppl. Fig. 2). Therefore, the genome-wide deregulation of miRNAs observed in 
model aneuploid cells rather suggests a response to aneuploidy per se. 
Aneuploidy results in impaired growth in mammalian and yeast model systems (Stingele 
et al., 2013; Torres et al., 2007; Williams et al., 2008). This is at least partially reflected in 
the conserved transcriptional changes in response to aneuploidy that includes the 
downregulation of DNA and RNA associated pathways (Dürrbaum et al., 2014; Sheltzer et 
al., 2012). Analysis of the cellular functions affected by the deregulated miRNAs revealed 
that cellular development, growth and proliferation are commonly targeted. Intriguingly, 
our integrated data analysis showed that the majority of targets that show an inverse 
expression to the deregulated miRNAs are indeed downregulated (Fig. 4, Suppl. Fig. 3). 
Among the downregulated targets are proteins that are crucial for the cell cycle 
progression such as BUB1, CDC20, CDK4 and CHEK1 in HCT116 5/4 or CyclinE1 and RB1 
in RPE1-derived aneuploid cell lines. One of the targets, HMGA2 is strongly 
downregulated on both mRNA and protein level in HCT116 5/4. HMGA2 is a target of 
hsa-miR-26a-5p, let-7a-5p and hsa-miR-125b-5p that were found to affect cellular growth 
and proliferation. Downregulation of HMGA2 by hsa-miR-26a negatively affects cell 
proliferation and has tumour suppressive effects in gallbladder cancer (Zhou et al., 2014). 
Another strongly downregulated target is RCC2, which is targeted by hsa-miR-192-5p and 
hsa-miR-7-5p in HCT1165/4 and RPE1 5/3 12/3. RCC2 is essential for mitotic spindle 
assembly and recently an important, although poorly characterized function of RCC2 for 
G1-S transition has been recognized (Mollinari et al., 2003; Rosasco-Nitcher et al., 2008; 
Yenjerla et al., 2013). Together, these results suggest that the identified deregulation of 
miRNAs might contribute to the growth defects in aneuploid cells.  
Remarkably, the deregulated miRNAome is largely unique for each of the analyzed 
aneuploid cell lines. Only a few deregulated miRNAs are shared in the majority of the 
analyzed cell lines. This is similar to the conserved transcriptional response to aneuploidy, 
where the individual deregulated genes are largely dissimilar, yet the affected pathways 
are common (Dürrbaum et al., 2014). Among the few commonly upregulated miRNAs is 
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hsa-miR-139-5p. This is in contrast to cancer where hsa-miR-139-5p is frequently 
downregulated and associated with poor prognosis (Watanabe et al., 2015; Wong et al., 
2011). This opposite expression pattern is similar to the changes of mRNA levels, where 
the transcriptional response to model aneuploidy is inverse to the cancer transcriptome 
(Sheltzer, 2013, our unpublished data).  
Among the few commonly upregulated miRNAs we found hsa-miR-10a-5p and confirmed 
its increased endogenous activity using a specific luciferase-based reporter system. The 
function and expression of this miRNA are largely ambivalent in cancer and up- and 
downregulation as well as growth inhibiting and promoting functions have been reported 
(Jia et al., 2014; Ohuchida:2012ju; Long et al., 2012). Only a few hsa-miR-10a-5p targets 
showed a concordant downregulation on protein or mRNA level in human aneuploid 
model cell lines. These few affected targets were involved in diverse cellular functions 
such as cytoskeleton stabilization, transcriptional regulation and metabolic processes 
(Suppl. Fig 5, Suppl. Table 3). 
The observation of only a few inversely expressed hsa-miR-10a-5p targets prompted us to 
investigate another possible function of hsa-miR-10a-5p. Hsa-miR-10a-5p binds upstream 
of the mRNA 5’TOP motif, thereby influencing the translation of mRNAs with this motif. 
The 5’TOP motif is a cis-regulatory motif present in transcripts encoding for the 
translational machinery, mostly ribosomal proteins ((Levy et al., 1991), reviewed in 
(Meyuhas and Kahan, 2015)). Assessment of the 5’TOP motif translation with the RPS16 
luciferase reporter construct revealed that the higher levels of hsa-miR-10a-5p in 
aneuploid cells did not coincide with increased steady state 5’TOP motif mRNA translation 
(Fig. 6). However, overexpression of hsa-miR-10a-5p induced 5`TOP motif luciferase 
activity in diploid and analyzed aneuploid cell lines, just as previously described (Ørom et 
al., 2008).  
What is the function of the upregulated hsa-miR-10a-5p in aneuploid cells? Upon nutrition 
deprivation or cell cycle arrest the translation of 5’ TOP mRNAs is repressed, which is 
indicated by their shift to inactive ribonucleoprotein complexes (Ørom et al., 2008). We 
observed that the 5`TOP motif luciferase activity is not repressed upon starvation in 
aneuploid cells, whereas in the diploid parental cell line the 5`TOP motif luciferase 
activity is sensitive to starvation. Thus, we hypothesize that the upregulation of hsa-miR-
10a-5p in aneuploid cell lines might be a protective adaption of aneuploid cells to adverse 
conditions such as starvation.  
In conclusion, our systems biology approach demonstrates how the addition of extra 
chromosomes alters the miRNAome and consequently explains some of the transcriptome 
and proteome changes that occur in response to aneuploidy. We found that the 
deregulated miRNAome in response to aneuploidy contributes to the detrimental effects of 
aneuploidy on cell physiology. Moreover, we show that the miRNA deregulation might 
also provide an advantage for the cells by granting resistance to stress conditions. Our 
unique data set describes the aneuploid cells from an “omics” perspective and allows a 
global, quantitative analysis of the consequences of aneuploidy as well as the comparison 
of different aneuploid systems. With our analyses we uncovered the complex and multi-
layered pathway deregulations in aneuploid cells and described the regulatory 
relationships that shape the gene expression in response to chromosome copy number 
changes.  
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Materials and Methods 
Cell lines 
The retinal pigment epithelial cell line RPE1 hTERT and RPE1 hTERT H2B-GFP were a 
kind gift from Stefan Taylor (University of Manchester, UK). The human colorectal cell 
line HCT116 was obtained from American Type Culture Collection (no. CCL-247). 
HCT116 H2B-GFP was generated previously by lipofection (FugeneHD, Roche) 
transfection of pBOS-H2B-GFP (BD Pharmingen) according to manufacturer’s protocols 
(Kuffer et al., 2013)The tetrasomic cell line HCT116 5/4 were a kind gift of Minoru Koi 
(Baylor University Medical Centre, Dallas, Texas, USA). All other trisomic and tetrasomic 
cell lines were generated by microcell-mediated chromosome transfer as described 
previously (Donnelly et al., 2014; Passerini et al., 2016; Stingele et al., 2012). Cell lines 
originating from individual clonal populations arising from a single cell after by microcell-
mediated chromosome transfer are indicated with their clone number (c#). The genome 
sequencing data of all cell lines are available upon request.  
Table 4. List of all cell lines used in the analysis.  
Cell line name Origin Full cell line name Analysis in this 
manuscript 
Remarks 
HCT116 Koi laboratory RNA and sRNA 
sequencing; qPCR 
Kindly provided by 
Minoru Koi  
HCT116 5/4 Koi laboratory RNA and sRNA 
sequencing; qPCR 
Kindly provided by 
Minoru Koi  
HCT116 13/3 
c2 
MMTC into 
HCT116 
HCT116 13/3 clone 2 qPCR this work 
HCT116 13/3 
c3 
MMTC into 
HCT116 
HCT116 13/3 clone 3 qPCR This work 
HCT116 18/3 
c1 
MMTC into 
HCT116 
HCT116 18/3 clone 1 qPCR This work 
HCT116 18/3 
c2 
MMTC into 
HCT116 
HCT116 18/3 clone 2 sRNA sequencing; 
qPCR 
This work 
HCT116 21/3 
c1 
MMTC into 
HCT116 
HCT116 21/3 clone 1 qPCR This work 
HCT116 21/3 
c3 
MMTC into 
HCT116 
HCT116 21/3 clone 3 qPCR This work 
HCT116* HCT116 from 
AATC 
introduction of 
H2B-GFP 
HCT116 H2B-GFP qPCR (Kuffer et al., 
2013) 
HCT116* 5/3  MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 5/3 qPCR (Stingele et al., 
2012) 
HCT116* 3/3 
c11 
MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 3/3 
clone 11 
sRNA sequencing; 
qPCR 
(Passerini et al., 
2016) 
HCT116* 3/3 
c13 
MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 3/3 
clone 13 
qPCR (Passerini et al., 
2016) 
HCT116* 8/3 
c5 
MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 8/3 
clone 5 
qPCR (Donnelly et al., 
2014) 
HCT116* 8/3 
c6 
MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 8/3 
clone 6 
qPCR (Donnelly et al., 
2014) 
HCT116* 8/3 
c7 
MMTC into 
HCT116 H2B-GFP 
HCT116 H2B-GFP 8/3 
clone 7 
RNA and sRNA 
sequencing; qPCR 
(Donnelly et al., 
2014) 
HCT116* 8/3 MMTC into HCT116 H2B-GFP 8/3 qPCR (Donnelly et al., 
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c8 HCT116 H2B-GFP clone 8 2014) 
RPE1 Taylor laboratory  RPE1 hTERT RNA and sRNA 
sequencing; qPCR 
Kindly provided by 
Steven Taylor 
RPE1 5/3 
12/3 
MMTC into RPE1 RPE1 hTERT 5/3 12/3 RNA and sRNA 
sequencing; qPCR 
(Stingele et al., 
2012) 
Spontaneous gain 
of chromosome 12 
RPE1* Taylor laboratory RPE1 H2B-GFP hTERT  RNA and sRNA 
sequencing; qPCR 
Kindly provided by 
Steven Taylor 
RPE1* 21/3 MMTC into RPE1 
H2B-GFP 
RPE1 H2B-GFP hTERT 
21/3 
RNA and sRNA 
sequencing; qPCR 
(Stingele et al., 
2012) 
RPE1* 7/3 MMTC into RPE1 
H2B-GFP 
RPE1 H2B-GFP hTERT 
7/3 
sRNA sequencing; 
qPCR 
This work 
Spontaneous gain 
of chromosome 
9,12 
RPE1* 3/3 MMTC into RPE1 
H2B-GFP 
RPE1 H2B-GFP hTERT 
3/3 
sRNA sequencing; 
qPCR 
This work 
 
RNA sequencing and data processing 
Following aneuploid cell lines and parental diploid cell lines were subjected to RNA 
sequencing: HCT116, HCT116 H2B-GFP (in the following indicated by *), HCT116 5/4, 
HCT116* 8/3 clone7, RPE1, RPE*, RPE1 5/3 12/3, RPE1* 21/3. 
Total RNA was extracted using RNeasy Mini Kit (QIAGEN). TruSeq RNA library 
preparation and Illumina HiSeq2500 sequencing with 25 million 100bp single reads per 
library were performed by the Max Planck-Genome-Center Cologne, Germany 
(http://mpgc. mpipz.mpg.de/home/). Subsequently, sequencing adapters were removed 
from the raw sequences with cutadapt and sequencing reads were mapped to the human 
genome (hg19) using TopHat (v2.0.10) with the following parameters: “tophat2 -g1 -G”. 
RefSeq information in the GTF file was downloaded from the UCSC genome browser. 
featureCounts (v1.4.3) was used to generate the count matrix with the same GTF file as 
for the alignment with the following parameters: “-t exon -g gene_id”. Normalization and 
differential expression analysis was performed using the R/Bioconductor package DESeq2 
(Love et al., 2014). For differential expression analysis, trisomic and tetrasomic cell lines 
were compared to the parental diploid cell line. The RNA sequencing data of all cell lines 
are available upon request.  
 
small RNA sequencing and data processing 
Following aneuploid cell lines and parental diploid cell lines were subjected to small RNA 
sequencing: HCT116, HCT116*, HCT116 5/4, HCT116 18/3 clone2, HCT116* 8/3 clone7, 
HCT116* 3/3, RPE1, RPE*, RPE1 5/3 12/3, RPE1* 21/3 and RPE1* 7/3.  
Total RNA, including small RNAs from 18 nucleotides upwards, was extracted using 
miRNeasy Mini Kit (QIAGEN). TruSeq small RNA library preparation and Illumina 
HiSeq2500 sequencing with 25 million 100bp or 75bp single reads per library were 
performed by the Max Planck-Genome-Center Cologne, Germany (http://mpgc. 
mpipz.mpg.de/home/). If necessary, raw sequencing read ends were trimmed for low 
quality base calls using the FASTQ quality trimmer with the following parameters: “-Q33 -t 
20 -l 17“ (Hannon Lab, Cold Spring Harbor Laboratory). Sequencing adapters were 
removed with cutadapt. Mapping to the human genome hg19 and miRNA identification 
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was performed using mirdeep2 (v2.0.0.8) (Friedländer et al., 2011) with the following 
commands: “mapper.pl -e -h -i -j  -l 18 -m -p hg19 -q” and “miRDeep2.pl reads.fa hg19.fa 
genome.arf human_mature_rmspace.fa others_mature_rmspace.fa 
human_hairpin_rmspace.fa -d -t Human”. The three biological replicates of aneuploid and 
the corresponding parental cell line were analyzed within the same analysis run. For 
subsequent normalization and differential expression analysis 
miRNA_expressed_all_samples.csv was used as an input for DESeq2. Differential 
expression analysis was performed between aneuploid cell lines and corresponding 
parental diploid cell line. To account for sequencing batch effects, paired replicate 
information in addition to condition information was input to the DESeq2 analysis for 
HCT116 5/4, RPE1 5/3 12/3 and RPE1* 21/3 and corresponding parental cell lines. The 
sRNA sequencing data of all cell lines are available upon request.  
Integrative mRNA, miRNA and target analysis 
Data analysis, such as integration and data visualization was performed using the 
computing environment R. Mapping of identifiers as well as genome locations was 
performed with BioMart using biomaRt package in R (Durinck et al., 2009; Smedley et al., 
2015). miRNA (miRNA) identifiers were retrieved from miRBase (v21). miRNA target 
information was retrieved from miRTarBase (v6.1) (Chou et al., 2016; Vergoulis et al., 
2012). 
Functional annotation analysis 
miRNA differential expression datasets were analyzed using the Ingenuity Pathway 
Analysis Software (IPA http://www.ingenuity.com, QIAGEN). Core analysis was 
performed with the differential expressed miRNAs (log2 fold change +/-0.6, adjusted p-
value <0.05) against the Ingenuity knowledge base considering direct experimentally 
observed relationships in human species. Functional annotation analysis results were 
exported and visualized in R.  
Functional annotation analysis of target genes was conducted using the Database for 
Annotation, Visualization and Integrated Discovery (DAVID v6.8) by applying functional 
annotation clustering.  
Quantitative real-time PCR of miRNAs 
Total RNA, including small RNAs from 18 nucleotides upwards, was extracted using 
miRNeasy Mini Kit (QIAGEN). Reverse transcription was performed using the universal 
cDNA synthesis kit miRCURY LNA™ (Exiqon) according to manufacturers protocol. 
UniSp6 RNA spike-in control was added to each sample in equal amounts. Quantitative 
PCR was conducted using the Light Cycler 480 System (Roche Diagnostics) using the 
ExiLENT SYBR® Green master mix miRCURY LNA™ (Exiqon) and miRNA specific LNA™ 
PCR primer sets (Exiqon) as well as the UniSp6 RNA spike control primer set (Exiqon). 
Absolute quantification with an external standard was performed and negative non-
template controls were included in all experiments. The specificity of the primer product 
amplification was confirmed in each run by melting curve analysis. miRNA expression was 
normalized to the control spike RNA and corresponding diploid miRNA expression. 
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Luciferase reporter constructs 
hsa-miR-10a-5p 3’UTR luciferase reporter (psiCheck2-10a) was constructed by cloning the 
complementary miRNA target sequence in the synthetic 3’UTR of psiCHECK™-2 Vector 
(Promega). PCR cloning was performed with the following primers:  
top 5’-CACAAATTCGGATCTACAGGGTAGTTTAAACCTAGAGCGGCCGCT-‘3 and  
bottom 5’-CTGACCTATGAATTGACAGCCGCGATCGCCTAGAATTACTGC-‘3.  
pS16-WT luciferase vector containing the transcriptional start site of the ribosomal protein 
S16 (Rps16) and 29nt of the exon 1 including the 5’TOP motif was a kind gift of Anders H. 
Lund (University of Copenhagen, Denmark). pRL-TK Renilla vector was a kind gift of 
Reinhard Fässler (Max Planck Institute of Biochemistry, Martinsried).  
Endogenous hsa-miR-10a-5p mediated 3’UTR repression assay 
Cell lines were forward transfected with psiCheck2-10a using Lipofectamine 200 (Thermo 
Fisher Scientific) according to manufacturer’s protocol. Cells were reseeded into 96 well 
plates 24 hours (hrs) post transfection at 20.000/ well HCT116- derived cell lines and 
10.000/ well RPE1 derived cell lines. Luciferase activity was monitored 48hrs post 
transfection using the Dual-Glo® Luciferase Assay System (Promega). Renilla luciferase 
activity values were normalized to the Firefly luciferase activity and subsequently to the 
parental cell line. Statistical testing and data plotting was performed in GraphPad Prism 6. 
hsa-miR-10a-5p mediated 5`TOP motif mRNA translation assay 
Cell lines were reverse transfected with miRCURY LNA™ miRNA Mimic or miRCURY 
LNA™ miRNA Mimic Negative Control (Exiqon) at 50nM using Lipofectamine 200 
(Thermo Fisher Scientific) according to manufacturers protocol. Cells were forward 
transfected with the pS16-wt-luc Firefly luciferase reporter construct and pRL-TK Renilla 
luciferase control vector 24hrs post mimic transfection. 48hrs post mimic transfection, 
cells were reseeded into 96 well plates at 20.000/ well HCT116- derived cell lines and 
10.000/ well RPE1- derived cell lines. Luciferase activity was monitored 72hrs post 
transfection using Dual-Glo® Luciferase Assay System (Promega). Starvation was 
performed by replacing the Dulbecco's Modified Eagle Medium (DMEM) supplemented 
with 10% fetal bovine serum and 1% penicillin/ streptomycin with DMEM without 
supplements for 3hrs prior measurement of luciferase activity. Firefly luciferase activity 
values were normalized to Renilla luciferase activity and subsequently to the parental cell 
line. Statistical testing and data plotting was performed in GraphPad Prism 6. 
Supplementary Information (upon request) 
Supplementary Table 1 
Total number and number of deregulated miRNAs per chromosome (log2 fold change 
>0.6 or <(-0.6). 
Supplementary Table 2 
DAVID functional annotation clustering of "Cellular Development, Cellular Growth and 
Proliferation" miRNA target genes that are significantly deregulated (log2 fold change 
>0.6 or <-0.6) and have an inverse expression to the miRNA expression of HCT116 5/4, 
RPE1 5/3 12/3, RPE1* 21/3. 
Supplementary Table 3 
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DAVID functional annotation clustering and functional annotation chart of hsa-miR-10a-5p 
targets, which are downregulated in HCT116 5/4. 
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Supplementary Figures 
Supplementary Figure 1. Correlation of extra DNA and the percentage of deregulated microRNAs 
in aneuploid cell lines. Extra DNA was estimated as the bp length of the aneuploid chromosome. 
Blue line presents fitted linear regression with R squared=0.35. 
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Supplementary Figure 2. microRNA expression aligned according to their chromosome position A 
HCT116 5/4, HCT116* 8/3 c7, HCT116* 3/3 c11, RPE1 5/3 12/3, RPE1* 7/3 and RPE1* 21/3 
with significantly increased or decreased median expression of chromosomes labelled with a red 
asterisks (Mann-Whitney-Wilcoxon test, p-value <0.05). B HCT116 18/3 c2 does not show altered 
median miRNA expression of any disomic chromosomes. Each blue dot represents a microRNA with 
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its chromosome location (x-axis) and log2 fold change normalized to corresponding parental cell 
line (y-axis). Red lines indicate log2 fold change >0.6/ <-0.6. Boxplots present 75%, 50% and 25% 
quantile of the microRNA expression per chromosome. Asterisks indicate cell lines with H2B-GFP. 
 
 
 
Supplementary Figure 3. A Heatmap of microRNAs associated with molecular function term 
“Cellular Development, Cellular Growth and Proliferation”.  Blue indicates downregulation, red 
upregulation. B Number of targets with strong evidence for each deregulated microRNA annotated 
in the “Cellular Development, Cellular Growth and Proliferation” category in RPE1 5/3 12/3. The 
size indicates the number of targets; the colour shows the significance of microRNA deregulation. 
The microRNAs are presented according to their chromosome location. C same as B in RPE1* 21/3. 
D Target genes within the “Cellular Development, Cellular Growth and Proliferation” category and 
their mRNA and protein expression. Selected gene labels indicate targets with inverse miRNA-target 
expression, which are associated with cell cycle processes. Shape indicates the type of experimental 
evidence for a microRNA-target interaction. The colour indicates log2 fold change microRNA 
expression in RPE1 5/3 12/3 and E in RPE1 H2B-GFP 21/3. 
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Supplementary Figure 4. Comparison of hsa-miR-10a-5p expression and HOXB3 mRNA 
expression. Bars represent log2 fold change expression ratio (aneuploid/ parental cell line) derived 
from RNA and sRNA sequencing. 
Supplementary Figure 5. hsa-miR-10a targets mRNA and protein expression levels. A hsa-miR-
10a-5p target expression in HCT116 5/4 on protein level (x-axis) and mRNA level (y-axis). B hsa-
miR-10a-5p target expression in RPE1 5/3 12/3. C hsa-miR-10a-5p target expression in RPE1* 
21/3. Each dot represents one target, colour indicates the adjusted p-value for the mRNA levels. 
Dotted lines indicate log2 fold change of 0.6 and -0.6. Asterisks indicate H2B-GFP. 
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Supplementary Figure 6. Overexpression of hsa-miR-10a-5p leads to repression of luciferase 
activity. A Schematic illustration of the mechanism of overexpression via miRNA mimic molecule 
transfection. Mimic transfection leads to enhanced translational repression of target molecules by 
incorporation of the guide strand into the miRISC. B hsa-miR-10a-5p mimic transfection results in 
repression of Renilla luciferase activity in HCT116 and RPE1 cell lines. Cell lines were transfected 
with hsa-miR-10a-5p and control mimic molecules. 24hrs post transfection, cell lines were forward 
transfected with psiCheck2 luciferase reporter construct. Luciferase reporter assay was conducted 
72hrs post mimic transfection. Data present Firefly normalized mean values +/- SD. 
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6.4 Chromosomal instability, tolerance of mitotic errors and multidrug resistance are 
promoted by tetraploidization in human cells 
Kuznetsova AY, Seget K, Moeller GK, de Pagter MS, de Roos JA, Dürrbaum M, Kuffer C, 
Müller S, Zaman GJ, Kloosterman WP, Storchová Z. Chromosomal instability, tolerance of 
mitotic errors and multidrug resistance are promoted by tetraploidization in human cells. 
Cell Cycle 2015 Jul 07;14(17):2810–2820.  
In this study we investigated the consequences of whole-genome doubling in 
transformed and non-transformed cell lines. Whole-genome doubling events that occur 
frequently in cancer are associated with numerical and structural chromosome 
aberrations. This suggests a link between tetraploidy, GIN and aneuploidy. However, the 
long-term effects of tetraploidy and the underlying molecular mechanisms of how 
tetraploid cells survive are not well understood.  
To evaluate the long-term effect of tetraploidy, whole-genome doubling was 
induced and rare surviving cell populations were isolated and analyzed. These 
post-tetraploid cell lines show mostly a near-tetraploid karyotype with complex numerical 
and structural chromosomal aberrations. We showed that this is the result of a CIN 
phenotype with an increased frequency of pre-mitotic and mitotic errors such as anaphase 
bridges, unattached and lagging chromosomes. The frequency of cell cycle arrest following 
chromosome missegregation is reduced in post-tetraploid cells, thereby indicating elevated 
tolerance to mitotic errors. Reduced nuclear p53 activation and expression abnormalities 
of p53 pathway components suggest an impaired activation of the p53 pathway as the 
underlying molecular cause of this tolerance. Finally, we demonstrate that post-tetraploid 
cells confer multi-drug resistance and increased capacity of in vivo transformation of some 
cell lines. 
The fate of tetraploid cells is governed by higher tolerance of GIN that results in 
highly complex aneuploid progenitor cells. The mechanistic cue most likely lies in the 
perturbed p53 pathway, which might serve as a novel target in preventing GIN and 
multi-drug resistance in tetraploid-derived tumors. 
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Chromosomal instability, tolerance of mitotic
errors and multidrug resistance are promoted
by tetraploidization in human cells
Anastasia Y Kuznetsova1, Katarzyna Seget1, Giuliana K Moeller1, Mirjam S. de Pagter2, Jeroen A D M de Roos3,
Milena D€urrbaum1, Christian Kuffer1, Stefan M€uller4, Guido J R Zaman3, Wigard P Kloosterman2, and Zuzana Storchov"a1,*
1Group Maintenance of Genome Stability; Max Planck Institute of Biochemistry; Martinsried, Germany; 2Department of Medical Genetics; Center for Molecular Medicine;
University Medical Center Utrecht; Utrecht, The Netherlands; 3Netherlands Translational Research Center B.V.; Oss, The Netherlands; 4Institute for Human Genetics;
Ludwig Maximilian University; Munich, Germany
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Up to 80% of human cancers, in particular solid tumors, contain cells with abnormal chromosomal numbers, or
aneuploidy, which is often linked with marked chromosomal instability. Whereas in some tumors the aneuploidy occurs
by missegregation of one or a few chromosomes, aneuploidy can also arise during proliferation of inherently unstable
tetraploid cells generated by whole genome doubling from diploid cells. Recent findings from cancer genome
sequencing projects suggest that nearly 40% of tumors underwent whole genome doubling at some point of
tumorigenesis, yet its contribution to cancer phenotypes and benefits for malignant growth remain unclear. Here, we
investigated the consequences of a whole genome doubling in both cancerous and non-transformed p53 positive
human cells. SNP array analysis and multicolor karyotyping revealed that induced whole-genome doubling led to
variable aneuploidy. We found that chromosomal instability (CIN) is a frequent, but not a default outcome of whole
genome doubling. The CIN phenotypes were accompanied by increased tolerance to mitotic errors that was mediated
by suppression of the p53 signaling. Additionally, the expression of pro-apoptotic factors, such as iASPP and cIAP2, was
downregulated. Furthermore, we found that whole genome doubling promotes resistance to a broad spectrum of
chemotherapeutic drugs and stimulates anchorage-independent growth even in non-transformed p53-positive human
cells. Taken together, whole genome doubling provides multifaceted benefits for malignant growth. Our findings
provide new insight why genome-doubling promotes tumorigenesis and correlates with poor survival in cancer.
Introduction
Many malignant tumors contain cells with aberrant chromo-
some numbers. These changes vary from aneuploidy (imbalanced
chromosome numbers) of one or multiple chromosomes, to
numbers approaching triploidy or tetraploidy.1 Aneuploidy is
often accompanied by chromosomal instability (CIN), which
manifests as ongoing gains and losses of chromosomes during
mitosis2 CIN contributes to tumor heterogeneity and is associ-
ated with increased resistance to drug treatment and poor patient
prognosis.3 Studies revealed that CIN might be triggered by
mutations in genes that control chromosome segregation.4-6
Whole-genome doubling that leads to tetraploidy provides
another route by which aneuploidy can arise in tumors indepen-
dently of mutations in mitotic genes.7,8 In this model, tetraploid
cells formed by cytokinesis failure, endoreduplication or cell-cell
fusion divide in a highly unstable manner due to supernumerary
centrosomes and increased chromosome numbers. The compro-
mised maintenance of genomic stability of tetraploids facilitates
CIN and tumorigenesis. Indeed, injection of p53-deficient
tetraploid cells into nude mice triggers tumor formation, whereas
isogenic diploid cells show no effect.9 Similarly, tetraploids aris-
ing from mouse ovarian surface embryonic cells develop aneu-
ploidy, CIN and promote tumorigenesis when injected into
mice.10
Remarkably, tetraploid cells were found in early stages of sev-
eral tumors and in total tetraploidy was documented in 37% of
cancers.11 This frequent occurrence suggests that passage through
tetraploidy provides advantages that facilitate tumor growth.
However, experimentally generated tetraploid cells often fail to
propagate, as these cells arrest in a p53-dependent manner imme-
diately after whole genome doubling or after the first tetraploid
mitosis, which is often severely erroneous.9,12-15 This further
impairs the proliferation after tetraploidization, as chromosome
missegregation of even a single chromosome triggers a p53-
dependent arrest.14,16,17 Also, aneuploid cells arising due to chro-
mosome missegregation suffer from proliferation delays and
other physiological defects.18,19 So far, only little is known how
human cells survive tetraploidy and what the long-term effects of
whole genome doubling are. Previous data suggest that
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tetraploidy increases CIN to generate karyotypic heterogeneity,
while also providing tolerance to potentially deleterious genetic
changes.20,21 However, little experimental data is available to
document the long-term effects of whole genome doubling in
human cells.
Results
Whole genome doubling triggers aneuploidy and
chromosome instability
To determine the long-term consequences of tetraploidiza-
tion in human cells, we analyzed the fate of tetraploids gener-
ated from 2 p53-positive cell lines, HCT116 and hTERT-
RPE1. HCT116 is a near-diploid cell line derived from
human hereditary non-polyposis colon cancer and is chro-
mosomally stable with characteristic microsatellite instabil-
ity.2,22 hTERT-RPE1 (hereafter RPE1) is a chromosomally
stable diploid retinal pigment epithelium cell line immortal-
ized by constitutive expression of human telomerase. Both cell
lines stably express H2B-GFP for visualization of chromatin
by fluorescence microscopy. Tetraploid cells were generated by
inhibition of the actomyosin ring with the actin depolymeriz-
ing drug cytochalasin D (DCD), which lead to cytokinesis
failure in approximately 60% of cells.9,14 600 DCD-treated
cells were plated by limiting dilution into 96-well plates and
allowed to expand for 6 weeks (Fig. 1A). All surviving cell
populations were analyzed by flow cytometry. This analysis
revealed near-tetraploid DNA content in 8 out of the 64 sur-
viving HCT116-derived cell lines and in 7 out of 58 RPE1-
derived cell lines (Fig. S1A), hereafter referred to as PostTetra-
ploid (PT) cell lines (HPT – derived from HCT116, RPT –
derived from RPE1). To minimize the effect of further evolu-
tion, all PTs underwent minimal passages before the analysis
and were compared at the same “early” passage, unless other-
wise stated. The posttetraploid cell lines showed only a mild
proliferation delay and the duration of mitosis as well as the
robustness of mitotic checkpoint activation were comparable
to that of controls (Fig. S1B-G).
To determine the copy number changes after tetraploidiza-
tion, we performed SNP array analysis in 6 HPTs, 3 RPTs cell
lines and the respective parental cells. Recurrent chromosome
copy number changes were observed in 3 out of 9 analyzed PTs
(HPT1, HPT6 and RPT3; Fig. 1B, C, and Fig. S2A, B). SNP
arrays analyze a pool of cells, which only allows detection of com-
mon changes that are shared by a majority of cells. To detect
chromosomal changes in individual cells, we used multicolor
fluorescence in situ hybridization (mFISH) karyotyping of
HCT116, HPT1 and HPT2 cell lines. This analysis revealed het-
erogeneity within the PT populations, but not in parental
HCT116: all 12 clonal cell lines originating from individual
HCT116 cells remained chromosomally stable even after 80 gen-
erations, thus excluding that the emergence of karyotypic diver-
sity is a consequence of clonal outgrowth of cells with preexisting
karyotypic heterogeneity or an intrinsic characteristic of the
parental line (Fig. 1D, and Fig. S2C, S3A-E). Moreover, the PTs
also contained more chromosomal rearrangements than the dip-
loids, although the difference was not statistically significant
(Fig. S3A-E).
Since all PTs arose from a single cell, we hypothesized that the
karyotypic heterogeneity indicates chromosomal instability aris-
ing after tetraploidization. We used fluorescence in situ hybrid-
ization (FISH) utilizing the chromosome enumeration probes to
compare “early” karyotypes with karyotypes after additional 36
passages. The distribution of the chromosome copy numbers
remained nearly identical in early and late HCT116 cells,
whereas in HPT1 and HPT2 the numbers of chromosomes dif-
fered markedly (Fig. 2A and Fig. S4A). Chromosomal instability
was also identified in RPT3 after 12 passages; in contrast, RPT1
cell line did not show significant changes in the FISH signal
(Fig. S4B). Additionally, FISH analysis revealed a loss of the sig-
nal of chromosome 7 in 2 out of 4 analyzed posttetraploid cell
lines (HPT1 and RPT3) that was present in both early and late
passages. Changes in the number or structure of chromosome 7
are common in human cancers: trisomy of chromosome 7 is
among the most frequently observed aberrations in cancers of the
large intestine, while a loss of part or all of one copy of chromo-
some 7 is common in leukemia and lymphoma.23 Taken
together, transient tetraploidization can generate aneuploid and
chromosomally unstable progeny even in non-transformed p53-
proficient parental cell lines.
Mitotic errors frequently occur in posttetraploid cell lines
To further characterize the chromosomal instability in the
posttetraploid progeny, we imaged fixed cells and found that
15.8%, 15.0% and 13.8% of anaphases displayed segregation
aberrancies in HPT1, HPT2 and HPT4, respectively, whereas
only 3.7% of HCT116 underwent erroneous anaphase (Fig. 2B).
The frequency of both anaphase bridges as well as the presence of
lagging or unattached chromosomes was increased, suggesting
that the frequency of both pre-mitotic and mitotic errors was ele-
vated. Among the 3 RPT cell lines, only one displayed increased
frequency of abnormal mitoses: 11.6% in RPT3 in comparison
to 3.0% in RPE1, 3.1% in RPT1 and 1.4% in RPT4 (Fig. 2C).
The multipolar mitoses were rare in PTs; the vast majority of
cells segregated their chromosomes in a bipolar manner
(Fig. S5A, B). In addition, a detailed analysis by imaging fixed
cells stained with centrosome- and centriole-recognizing antibod-
ies revealed no significant increase in the numbers of centrosomes
and centrioles in PTs compared to the respective parental cell
lines (Fig. S5C-G). This indicates that multipolarity alone can-
not explain the high frequency of chromosome segregation errors
in PTs.
The frequency of chromosome segregation errors could be ele-
vated simply as a consequence of the increased chromosome
numbers under the assumption that the error frequency correlates
to chromosome number. However, normalization of the fre-
quency of mitotic errors to the median chromosome number of
each cell line revealed that the frequency of abnormal mitoses
increases more than expected according to chromosome number
in CINC PTs (Fig. S4C). Specifically, the mitotic error frequency
increased 3.7–4.3 fold (from 3.7% to 13.8–15.8%), whereas
www.tandfonline.com 2811Cell Cycle
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modal chromosome numbers increased 1.7–1.8 fold (from 44 to
75–78) in HPTs. Similarly, the increase in chromosome numbers
was 1.7 fold in RPT3, whereas the increase in mitotic errors
reached 3.9 fold. Thus, the high frequency of mitotic errors in
CINC PTs does not result from a simple linear increase of
mitotic errors due to the higher numbers of chromosomes. Taken
together, whole genome doubling supports the emergence of a
CINC phenotype even in p53-positive non-cancerous cells, but it
is not a default consequence.
Posttetraploid cells show increased tolerance to mitotic
errors
The efficient proliferation of PT cell lines despite their aneu-
ploidy and CIN suggests that the cells became more tolerant to
mitotic errors. We analyzed the fate of parental diploid and tetra-
ploid cells, as well as PTs after abnormal mitosis by long-term
live cell imaging. The analysis revealed that 34.2% of diploid and
54.1% of newly formed tetraploid HCT116 cells that missegre-
gated chromosomes arrested for at least 48 h or died in the
Figure 1. Posttetraploid progenies (PTs) are chromosomally unstable. (A) Schematic depiction of the experimental strategy. (B, C) SNP array profiles of
HCT116, RPE1 and their posttetraploid derivatives. Copy numbers are indicated by colors. The log R represents the copy number; B-allele frequency
(BAF) indicates the allele composition: BAF of 0 or 1 represents genotype of AA / A- / BB / B-, respectively; BAF of 0.5 represents AB. (D) Multicolor FISH
karyotyping of 2 cells from the HPT2 cell line (number of chromosomes was 72 and 79, respectively). Note the difference in copy number of chromo-
somes 1, 3, 4, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17, 18 and 20.
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subsequent interphase (Fig. 3A). In contrast, only 11.0% of
HPT1 and 9.8% of HPT2 cells arrested after chromosome misse-
gregation (Fig. 3A, for fate analysis of individual cells see
Fig. S6). Thus, whole genome doubling increases cell tolerance
to errors in chromosome segregation.
The p53 pathway is deregulated in posttetraploid cells
We hypothesized that the tolerance to abnormal mitosis in
PTs is due to changes in activation of the p53 pathway. To test
this, we performed a micronucleation assay which allows
visualization of missegregated lagging chromosome as a micronu-
cleus in the daughter cells, combined with immunostaining with
an antibody against p53. Whereas nearly 42.0% of HCT116 cells
with micronuclei accumulated nuclear p53, only 25.0% of
HPT1 and 26.9% of HPT2 cells showed nuclear p53 accumula-
tion when a micronucleus was present in the cell (Fig. 3B, C). A
similar experiment in RPE1 and its posttetraploid derivatives
revealed that 66.4% and 50.7% of RPT1 and RPT4 cells that
underwent missegregation accumulated nuclear p53, which is
similar to parental RPE1 (66.8%). In contrast, we observed that
Figure 2. Posttetraploid cells display chromosomal instability and an increased frequency of abnormal mitosis. (A) Fluorescence in situ hybridization
(FISH) against centromeric regions of HCT116 and HCT116-derived PTs. Comparison of chromosome number distribution for chromosome 7 in early pas-
sages and 36 passages later; mean and SEM of 2 independent FISH experiments. Chromosome 7 – red, chromosome 1- green, DNA was counterstained
with DAPI (objective 63x, bar: 10 mm). Percentage of abnormal mitoses evaluated in fixed images of HCT116 (B) and RPE1 (C) and their respective postte-
traploid derivatives; mean and SD of 3 independent experiments. AnaphBridge – cells that contain an anaphase bridge; LaggingChr – cells containing a
lagging chromosome; AnaphBridge-LaggingChr – cells containing both an anaphase bridge and a lagging chromosome; Multipolar – cells that under-
went multipolar anaphase.
Figure 3. Posttetraploid cells are tolerant to mitotic errors. (A) Frequency of cell cycle arrest/cell death after bipolar mitosis with no apparent defects
(normal mitosis) and with visible chromosome segregation defects (abnormal mitosis). Mean of 4 independent experiments and SD is plotted. Unpaired
Student t-test was used to test for statistical significance. (B) Examples of p53 accumulation in the nuclei and micronuclei of the micronucleated cells. Yel-
low and white arrowheads indicate the micronuclei with and without p53 enrichment, respectively. p53-red, DNA was counterstained with DAPI, bar:
10 mm. (C and D) Accumulation of p53 in the nuclei of cells forming micronuclei (MNC) in HCT116, RPE1 and their respective posttetraploid derivatives
(panels C, D, respectively). Mean of 4 independent experiments and SEM are plotted.
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only 25.9% of RPT3 cells with a micronucleus accumulated p53
in the nucleus (Fig. 3C, D). Thus, whereas chromosomally stable
PTs accumulated nuclear p53 as the parental cell line, the p53
signaling upon chromosome missegregation is attenuated in the
CINC posttetraploids (compare Figs. 2C and 3B-D).
The activation of the p53 pathway upon chromosome misse-
gregation occurs possibly via phosphorylation of p53 on serine
15 or by activation of the p38/MAPK pathway.14,16,17 Analysis
of the p53 and p38 protein levels revealed no significant changes
in parental and PT cell lines during unperturbed growth
(Fig. S7A, B). Next, we induced chromosome missegregation by
treatment with 20 mM VS83, an inhibitor of the kinesin Eg5
that results in the formation of mitotic cells with monopolar
spindles. Subsequent wash out of VS83 ensures bipolar spindle
formation and progress through mitosis; however, the mitosis is
highly erroneous.16 The frequency and type of errors upon treat-
ment with VS83 was similar in both posttetraploid and parental
cell lines (Fig. S7C, D). Markedly, we observed that p53 was not
stabilized in HPTs and in RPT3 upon VS83 treatment, whereas
the levels of p53 increased in HCT116 and RPE1, RPT1 and
RPT4 (Fig. 4A, C). This finding is in agreement with the dimin-
ished nuclear accumulation of p53 that we identified in the
CINC clones (Fig. 3C, D).
Next, we analyzed transcriptome changes in 2 HPTs (HPT1
and HPT2) and 3 RPTs (RPT1, 3 and 4). We focused on 388
previously identified upstream and downstream interactors of
p53 (see Material and Methods). Markedly, 23% of the analyzed
genes were significantly deregulated with respect to the parental
lines with a fold change of 1.5 in at least one of the HPTs or
RPTs, but only 6 factors were upregulated in all PTs: LDHA
(lactate dehydrogenese A), DGKA (diacylglycerol kinase),
HIF1A (hypoxia induced factor 1), 2 inhibitors of apoptosis
iASPP (inhibitory member of the ASPP family, encoded by
PPP1R13L) and BIRC3 (Baculoviral IAP Repeat Containing 3),
transcriptional factor ETS1 and transforming growth factor
TGFA (Fig. 4E, and Table S1). Two genes were downregulated
in all PTs: DUSP5, an inhibitor that negatively regulates mem-
bers of the mitogen-activated protein (MAP) kinase superfamily
(MAPK/ERK, SAPK/JNK, p38) and MST1 (macrophage signal-
ing growth factor), a member of the MSP-RON signaling that
plays a role in malignant invasive growth. We found 2 genes that
were upregulated specifically in CINC cells: FOXO1 and
NDRG1 that are both involved in response to oxidative and met-
abolic stress. Taken together, whole genome doubling promotes
upregulation of factors promoting cell survival upon stress
(HIF1, FOXO1) and alters expression of factors that inhibit apo-
ptosis and MAP kinases (iASPP, BIRC3, DUSP5).
Posttetraploid cell lines acquire multidrug resistance and
transform in vitro
To test whether whole genome doubling promotes increased
resistance to cancer treatments, we compared the sensitivity of
PTs with their respective parental cell lines to a broad range of
anti-cancer agents. Effects of compounds on cell proliferation
were determined using measurement of intracellular ATP con-
tent as an indirect readout of cell number.24 We profiled 17
different anti-cancer agents at a wide concentration range over 9
points from 32 mM to 0.32 nm on the 2 parental cell lines and
in HPT1 and 2, RPT1, 3 and 4 in 3 independent experiments.
The inhibitory potency of the compounds was expressed as
pIC50 (-
10logIC50) values. Comparison of the relative drug sen-
sitivity of the parental cells with that of the PTs revealed a gen-
eral multidrug resistant phenotype in all analyzed posttetraploid
lines derived from the non-transformed hTERT-RPE1 cell line
(Table S2, Fig. 5A) as well as in the 3 posttetraploid lines
derived from the colon cancer line HCT116 (Table S2,
Fig. 5B). All PTs showed significant resistance to the topoisom-
erase II inhibitors daunorubicin, doxorubicin and etoposide
(Tables S2 and S3; Fig. 5A, B). In addition, RPTs were signifi-
cantly resistant to the pyrimidine antagonist 5-fluoracil, the
inhibitor of the p53-MDM2 interaction nutlin3a and the growth
factor receptor kinase inhibitor pelitinib. HPT cell lines showed
significant resistance to the DNA crosslinker cisplatin, the micro-
tubule-targeting agents docetaxel and paclitaxel, and the inhibitor
of histone deacytelases vorinostat (Tables S2 and S3). Interest-
ingly, HPTs showed increased sensitivity to the purine antagonist
6-mercaptopurine (Fig. 5A). Thus, whole genome doubling pro-
vides a general protection against drug treatment in both non-
transformed and cancer cells. This marked feature might explain
why whole genome doubling correlates with a poor prognosis
and resistance to therapy in some cancer types.21
Finally, we determined the impact of tetraploidization on
transformation capacity by assaying the anchorage independent
growth of the posttetraploid progeny in soft agar (Fig. 5C). Since
HCT116 is a cell line derived from colorectal cancer and there-
fore proficient in anchorage independent growth, we tested
RPE1, a primary p53–positive immortalized cell line and its
derivatives. The diploid RPE1 showed no anchorage-indepen-
dent growth even after initiation/promotion treatment, where
cells were exposed to the mutagen 7,12-dimethylbenz[a]anthra-
cene (DMBA) alone or followed by exposure to the tumor pro-
moter 12-O-tetradecanoylphorbol-13-acetate (TPA). In contrast,
RPT cell lines efficiently formed colonies in soft agar even in
absence of any treatment, indicating that the selected surviving
populations became transformed in vitro (Fig. 5C). This result
was observed in 2 independent experiments in all 3 posttetraploid
cells lines derived from RPE1. Thus, whole genome doubling
promotes in vitro transformation even in p53-positive non-
cancerous cell lines.
Discussion
Whole genome doubling (WGD) is considered to contribute
to eukaryotic evolution by facilitating adaptation while simulta-
neously buffering the possible effects of deleterious mutations.25
Recent findings support a similar role for WGD in fostering
tumor genome evolution in mammalian cells, however, it
remains unclear how exactly tetraploidy benefits malignant
growth. The cellular fates of tetraploids were previously analyzed
in populations isolated by serial FACS sorting.20,26 These cells
were found to be chromosomally stable likely because the serial
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sorting to cellular DNA content eliminated aneuploid cells that
arise from tetraploids.26 In another study, spontaneously arising
tetraploid cells were isolated from the cancer cell line
HCT116.21 This approach can only be used in cancer cell lines
as spontaneous tetraploidization is rare in non-transformed
human cells; an additional drawback is that the mechanism of
spontaneous tetraploidization and possible underlying mutations
remain enigmatic. Here, we isolated clonal cell lines from both
cancerous and non-transformed cells that arose from survivors of
induced cytokinesis failure. We found that all PTs harbored
aneuploid karyotypes, but showed marked differences in the
degree of CIN (Figs. 1, 2). Our findings demonstrate that tetra-
ploidy leads to aneuploidy and chromosomal instability even in
p53-positive non-cancerous cell lines, but also establish that a
bona fide CINC phenotype is not a default outcome of whole
genome doubling.
Figure 4. The p53 pathway is deregulated in posttetraploids. (A, B) Changes in abundance in p53, p38 and p21 and phosphorylation of p53 on Ser15
(p53-p) and phosphorylation of p38-p on Threonine180 and Tyrosine 182 (p38-p) in HCT116, RPE1 and respective posttetraploid cell lines with and with-
out VS83 treatment. Four independent experiments were performed, an example of immunoblotting is shown; a Ponceau S stain was used as a loading
control. (C, D) Quantification of the response to the missegregation triggered by release from VS83 treatment. The relative signal levels are presented as
fold change of treated-to-untreated cells. Mean of at least 3 independent experiments with SD is shown, * marks statistically significant difference (P <
0.05). (E) Heat map of transcriptional fold changes of 91 significantly altered p53 interactors in posttetraploid cell lines (normalized to the respective
parental cell lines).
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What causes the chromosomal instability in posttetraploid cell
lines? CIN after whole genome doubling is often explained by a
doubling of the centrosome number, however, the centrosome
numbers in HPT and RPT cell lines were nearly normal
(Fig. S5), in line with recent finding that multipolar mitoses are
highly detrimental in human cells and thus an early loss of extra
Figure 5. Posttetraploid cell lines are resistant to a broad spectrum of chemotherapeutic drugs and transform in vitro. (A) Dose-response curves of
compounds showing different sensitivities in proliferation assays with the hTERT-RPE1 cell line and the posttetraploid cell lines RPT1, RPT3 and RPT4.
(B) Dose-response curves of compounds showing different sensitivities in proliferation assays with the HCT116 cell line and the posttetraploid cell lines
HPT1, HPT2 and HPT4. The posttetraploids lines are resistant to a broad spectrum of anti-cancerous drugs; except HPT1, 2 and 4 that are relatively more
sensitive to 6-mercaptopurine. Fitted curve for 2 replicates from one or 2 independent experiments is plotted. Note that no fitted curve was determined
for HPT1 upon etoposide treatment. See Material and Methods for details. (C) Phase contrast images of anchorage-independent colony growth in soft
agar.
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centrosomes is necessary to ensure survival.26,27 The fact the cen-
trosome numbers and multipolarity are not responsible for the
CIN phenotype in PTs is best illustrated by the comparison of
the RPT cell lines. Although both RPT1 and RPT3 show similar
distribution of centrosome numbers, RPT1 is chromosomally
stable, while RPT3 is chromosomally unstable and highly aneu-
ploid (Fig. S5E and Fig. 2C). This implies that the chromosome
composition of the cells may determine whether they are CINC
or not. For example, imbalanced gene copy numbers due to
aneuploidy might affect the functionality of protein complexes
required for spindle functions or for the spindle assembly check-
point.28 Alternatively, microtubule dynamics might be altered
due to changes in expression of microtubule associate proteins
and motors, thus interfering with the stability of microtubule-
kinetochore attachments. This hypothesis is in line with the pre-
vious findings that microtubule dynamics are often altered in
CINC cancer cell lines and affect the frequency of errors during
mitosis.29,30
Tetraploidy as well as chromosome segregation errors activate
p53 pathway, thereby driving cells into irreversible arrest.14,16,17
Accordingly, TP53 mutations and p53 pathway alterations are
frequently found in CIN tumors.31 Importantly, we found that
the CINC posttetraploids were able to overcome the p53 activa-
tion as the levels of p53 and its nuclear accumulation were dimin-
ished upon chromosome missegregation (Figs. 3 and 4A).
Additionally, analysis of transcriptome changes of the p53 inter-
actors found 11 factors to be similarly deregulated in all PTs
(Fig. 4D); all of the identified factors positively affect cell sur-
vival. Two genes were downregulated in all PTs: DUSP5, a direct
target of p53 and an inhibitor of the mitogen-activated protein
(MAP) kinases32 and MST1 (macrophage signaling growth fac-
tor), a member of the MSP-RON signaling; expression of MST1
is repressed in many types of human cancer.33 Notably, expres-
sion of apoptotic inhibitors iASPP and BIRC3 (cIAP2) was upre-
gulated in all PTs. Both iASPP and cIAP2 are upregulated in
many cancers and facilitates their survival.34-36 TGFa, a growth
factor, which activates signaling pathways for proliferation, dif-
ferentiation and development and has been associated with many
types of cancers,37 is upregulated in all posttetraploids, similar to
another pro-proliferative factor Ets1 that controls the expression
of cytokines and chemokines.38 Another upregulated transcrip-
tion factor, Hif-1a, is required for the response to hypoxia as
well as for regulation of apoptosis.39 PTs also upregulate expres-
sion of a downstream target of Hif-1a, the lactate dehydrogenase
A (LDHA) that catalyzes the conversion of pyruvate to lactate.
LDHA is a key factor of anaerobic glycolysis and instrumental
for the switch from oxidative phosphorylation to increased gly-
colysis, so called Warburg effect that is typical for malignant
cells.40
Two p53 interactors were overexpressed only in CINC
cells: FOXO1, the main target of insulin signaling and a
transcription factor that regulates metabolic homeostasis in
response to oxidative stress,41 and NDRG1 that has a poorly
characterized function in stress response.42 The upregulation
of stress-response factors in CINC PTs suggests that chromo-
somal instability imposes an ongoing metabolic and oxidative
stress on human cells that might arise in response to the dis-
ruption of the protein homeostasis due to ongoing changes
in chromosome content.43
Aneuploidy and CIN in tumors are often associated with
increased resistance to drug treatment and therefore poor prog-
nosis for cancer patients.44,45 We found that the posttetraploid
cell lines gained resistance to a broad spectrum of small inhibitors
that are used in chemotherapy. This multidrug resistance profile
was found in both cells derived from a cancer cell line HCT116
as well as in posttetraploids originating from RPE1, a non-trans-
formed and p53-positive cell line (Fig. 5). Several lines of evi-
dence have been advanced recently demonstrating that aneuploid
and tetraploid cancer cells confer resistance to some drugs.20,46,47
Why whole genome doubling provides increased multidrug resis-
tance remains enigmatic and should be analyzed in future.
Finally, we found that whole genome doubling promotes anchor-
age-independent growth, and hence in vitro transformation even
in p53-positive cells. This ability was independent of the CINC
phenotype. We propose that the expression changes that allow
efficient proliferation despite abnormal karyotype by inhibiting
apoptosis and stimulating pro-proliferative pathways contribute
to the multidrug resistance and to in vitro transformation of
human cells.
Taken together, tetraploidization benefits uncontrolled
growth in both cancerous and non-cancerous cells. The molecu-
lar mechanisms underlying these effects remain to be addressed
in the future. Identification of pathways that promote tetraploidy
and its survival will be essential not only to understand the mech-
anisms leading to tumor formation but also for the development
of novel strategies to prevent acquired multidrug resistance dur-
ing cancer treatment.
Materials and Methods
Generation and culturing of posttetraploid cell lines
HCT116 H2B-GFP and RPE1 H2B-GFP (a gift from Dr.
Steven Taylor, The University of Manchester, UK) were treated
with 0.75 mM of the actomyosin inhibitor dihydrocytochalasin
D (DCD, Sigma) for 18 h. The cells were then washed, placed
into a drug-free medium and subcloned by limiting dilution in
96-well plates (0.5 cell per well). Tetraploid RPE1 H2B-GFP
cells were grown on plates coated with gelatin (Merck). After
clone expansion, cells were harvested for flow cytometry to mea-
sure the DNA content. All cell lines were cultured in Dulbecco’s
modified medium (Gibco), supplemented with 10% fetal calf
serum (Gibco), 50 IU/ml penicillin, and 50 mg/ml streptomycin
(Gibco) at 37!C with 5% CO2.
Immunoblotting
Total cell lysate was separated by SDS-PAGE and transferred
to a polyvinylidene fluoride membrane (Roche) or nitrocellulose
membrane (Whatman) as previously described. Following
antibodies were used: anti-p53 antibody (1:100,Santa Cruz Bio-
technology, Inc.), anti-pSer15-p53 antibody (1:500, Santa Cruz
Biotechnology, Inc.), anti- p21 antibody (1:1000, Cell
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Signaling), anti-p38 antibody (1:1000, Cell signaling), anti-
pThr180/Tyr182-p38 antibody (1:200, Cell signaling). Immu-
noblot quantification was performed using Image J software.
Live cell microscopy
Long term live cell data were recorded on an inverted Zeiss
Observer.Z1 microscope (Visitron Systems) equipped with a
humidified chamber (EMBLEM) at 37!C, 40% humidity and in
the atmosphere of 5% CO2 using CoolSNAP HQ2 camera (Pho-
tometrics), Plan Neofluar 20x or 10x air objective NA 1.0, epi-
fluorescent X-Cite 120 Series lamp (EXFO), using GFP filter
and differential interference contrast (DIC) in DMEM. Imaging
of fixed cells was carried out on Marianas SDCTM system
(inverted Zeiss Observer.Z1 microscope, Plan Apochromat 63x
magnification oil objective or 20x magnification air objective,
equipped with spinning disc head (Yokogawa) and a CoolSNAP-
HQ2 and CoolSNAP-EZ CCD Photometrics cameras (Intelli-
gent Imaging Innovations, Inc.).
Chromosome spreads
The cells were treated with 50 ng/ml microtubule-depolyme-
rizing drug colchicine (Serva) for 4.5 h, collected and pelleted
using table-top centrifuge, swollen in 75 mM KCl in a 37!C
water bath for 15 minutes, fixed with Carnoy solution (75%
methanol and 25% acetic acid) and spread on a wet glass slide
with a glass Pasteur pipette. The slides were dried at 42!C and
stained with Giemsa dye (Fluka).
Fluorescence in situ hybridization (FISH)
FISH was carried out using satellite enumeration probes
against centromeric regions of specific chromosomes (1, 3, 7, and
12) conjugated either to a red or a green fluorophore according
to manufacturer’s protocol (Cytocell, UK). DNA was counter-
stained with DAPI, and the cover slips were mounted on slides
using antifade solution (Cytocell, UK).
Whole chromosome multicolor FISH (mFISH karyotyping)
Multicolor FISH was performed as previously described with
a DNA probe mixture (24XCyte Human Multicolor FISH Probe
Kit, MetaSystems, Altlussheim, Germany). The analysis was car-
ried out using Adobe Photoshop (Adobe Systems, San Jose,
USA) for visual inspection of the images; statistical analysis was
performed using MS Excel (Microsoft) and Prism. Aberration
ratio was calculated as number of derivative chromosomes nor-
malized to a total number of chromosomes identified in analyzed
cell spread.
SNP array profiling
Human CytoSNP-12 bead chip arrays (Illumina) were used
for detection of copy number aberrations (CNAs) in clonal aneu-
ploid and diploid cell lines. Array hybridization was performed
according to the manufacturer’s recommendations. CNAs were
identified using Nexus software (version 7.5.1) with standard set-
tings. To identify unique CNAs in clonal cell lines, we used the
Nexus call coordinates and removed all calls of the same type
with a reciprocal overlap of at least 60%. All profiles were manu-
ally checked.
Analysis of mitotic abnormalities
The cells were grown in the glass-bottom 96-black well plates
and fixed with 100% methanol for 10 min at -20!C. DNA was
stained with SYTOX Green Nucleic Acid dye (Molecular Probes,
Invitrogen) with added RNAse. The imaging was carried out on
Visitron Systems microscope.
Micronucleation test followed by anti-p53 immunostaining
The cells were seeded in the glass-bottomed 96-black well
plates 48 h prior the experiment and then treated with DCD for
18 h. Only cells that became binucleated were scored. Cells were
fixed with 100% MeOH and stained with DAPI (Carl Roth).
Anti-p53 antibody (1:500, Cell Signaling) was used. The acquisi-
tion and analysis were performed using Slidebook 5 software
with 3I microscope, 20x magnification objective. p53 status in
the nuclei was determined by automated measurement of median
intensities of p53 in the nucleus normalized by median intensity
of p53 in cytoplasm.
Transcriptome data processing and analysis
Total RNA was extracted using RNeasy Mini Kit (QIAGEN).
For the HPT cell lines microarray data preprocessing, normaliza-
tion and analysis was conducted as described previously.48 For
next generation RNA sequencing of the RPTs, TruSeq RNA
library preparation and Illumina HiSeq2500 sequencing with
25 million 100bp single reads per library were performed by the
Max Planck-Genome-Center Cologne, Germany (http://mpgc.
mpipz.mpg.de/home/). Subsequently to adapter removal with
cutadapt, reads were mapped to the human genome (hg19) using
TopHat (v2.0.10) with the following parameters: “tophat2 -g1
-G”. RefSeq information in the GTF file was downloaded from
the UCSC genome browser. featureCounts (v1.4.3) was used to
generate the count matrix with the same GTF file as for the align-
ment and the following parameters: “-t exon -g gene_id”. Nor-
malization and differential expression analysis of the count
matrix data was performed using the R/Bioconductor package
DESeq2. For differential expression analysis, PTs were compared
to the parental diploid cell line. Processed and normalized RNA
sequencing data (RPE1 derived cell lines) or microarray data
(HCT116 derived cell lines) were analyzed by QIAGEN’s Ingen-
uity! Pathway Analysis and visualized with R. p53 physical and
genetic interactors were identified in the IPA knowledge base.
Cell proliferation assay
The compounds were obtained from commercial suppliers and
dissolved in 100% DMSO. Cells were dispensed in a 384-well
plate at 400 cells per well. After 24 h, 5 ml of compound dilution
was added and plates were further incubated for another 72 h,
after which 25 ml of ATPlite 1StepTM (PerkinElmer, Groningen,
The Netherlands) solution was added to each well. Luminescence
was recorded on an EnvisionTM multimode reader (PerkinElmer,
Waltham, MA, USA). IC50s were fitted by non-linear regression
using XLfitTM5. A two-tailed Student’s t-test was performed
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to determine whether differences in sensitivity (DpIC50) were
statistically significant (i.e., P < 0.05).
Anchorage independent growth assay
Cells were treated with ethanol as a vehicle or DMBA (2mM
or 4 mM) for 3 days. Subsequently cells were either seeded on
soft agar or treated with 100 ng/ml TPA or with DMSO as a
vehicle control for next 10 days before seeding on soft agar.
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7 Discussion 
Aneuploidy has profound effects on cellular physiology. Although there are many 
variations of the aneuploid karyotype, the phenotypic consequences such as impaired 
proliferation and sensitivity to certain cellular stresses are similar. During my thesis, I set 
out to determine the common molecular cues of the response to aneuploidy. I applied 
large-scale analysis of miRNAome, transcriptome and proteome data and their integration 
to reveal the common determinants of the effects of aneuploidy.  
7.1 Proteotoxic stress underlies the response to aneuploidy 
The addition of extra chromosomes results in unbalanced and elevated gene 
expression that bear two major challenges for the cell: first, a higher demand for the 
protein synthesis as well as protein folding machinery; second, an imbalance of the protein 
stoichiometry, particularly affecting protein complex members. Cumulative evidence 
points to a defect in maintenance of proteostasis in aneuploid model systems (Donnelly et 
al., 2014; Oromendia and Amon, 2014; Pavelka et al., 2010; Tang et al., 2011; Torres et 
al., 2007), but the underlying molecular mechanisms have not been fully characterized. 
We show that the proteotoxic stress in aneuploid cells is characterized by impaired HSP90 
dependent protein folding. Further, my global analysis of the transcriptome and proteome 
of aneuploid cells revealed that the HSP90 family is significantly downregulated. To find 
the underlying causes for impaired protein folding and downregulation of the HSP90 
family, we investigated the levels and activity of HSF1. Although steady state levels of 
HSF1 were not significantly altered, we found an impaired induction of HSF1 activity 
upon heat stress. Endogenous overexpression of HSF1 protects aneuploid cells from 
sensitivity to protein folding stress. Why HSF1 function is impaired and fails to 
transcriptionally activate the heat shock response in aneuploid cells remains an open 
question. Certain is that the proteotoxic stress and especially compromised HSP90 
function inflicts severe consequences on the cells. Our new finding that proteotoxic stress 
is a hallmark of aneuploid human cells suggests that proteotoxic stress is the underlying 
cause for the other well-documented phenotypes of aneuploid human cells such as the 
growth defect, accumulation of protein deposits and activation of autophagy, maintenance 
of genome stability and the global transcriptional response 
7.1.1 Protein deposits and elevated autophagy as a consequence of proteotoxic stress in 
aneuploid cells 
Most likely a direct consequence of unbalanced proteostasis in aneuploid cells is 
the accumulation of protein deposits that show features of protein aggregates observed in 
aneuploid yeast and human cells (Oromendia et al., 2012; Stingele et al., 2013). Defective 
HSP90-dependent protein folding might result in accumulation of unfolded or misfolded 
proteins. In addition, the altered gene expression results in unbalanced levels of subunits 
of protein complexes. Subunits of protein complexes are particularly aggregation-prone 
because of their exposed hydrophobic amino acids and are kept soluble by their binding to 
cellular chaperons (Balchin et al., 2016). Thus, an excess of macromolecular complex 
subunits results in protein aggregates, a process that might be further enhanced by 
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reduced chaperone levels that fail to keep unbound protein complex subunits in solution. 
In both cases, these aggregates might not only be the result of HSP90 disturbances, but 
may also contribute to it by overburdening the proteostasis network and titrating away 
chaperons, similar as demonstrated in yeast and C. elegans (Geiler-Samerotte et al., 2011; 
Gidalevitz et al., 2009). To date, it is not known whether the observed deposits are mainly 
due to unbalanced protein complex subunits or due to defective protein folding in general. 
Recent advances in quantitative proteomics allow studying the composition of protein 
aggregates (May et al., 2014). Such an approach could be applied to determine the exact 
protein aggregate composition, which would give further insights into the main 
mechanism leading to aggregate formation in aneuploid cells.  
The requirement for clearance of these aggregates might connect defects in the 
maintenance of proteostasis with another feature of aneuploid cells, which is the activated 
autophagy (Ariyoshi et al., 2016; Ohashi et al., 2015; Stingele et al., 2013). The 
autophagy-lysosome system is, among other functions, involved in targeted clearance of 
aggregates that are resistant to degradation by the ubiquitin-proteasome system (Kubota, 
2009). Although proteasomal degradation is one way to compensate excess complex 
subunits (Dephoure et al., 2014), increased autophagic activity has also been detected in 
yeast and human aneuploid cell lines. Upon acute chromosome missegregation, 
autophagosomes in lysosomes accumulate and are not efficiently degraded (Santaguida et 
al., 2015). This leads to translocation of the transcription factor TFEB into the nucleus and 
subsequent activation of transcription of autophagic and lysosomal genes. Whether similar 
mechanisms lead to the upregulation of autophagic and lysosomal genes in human model 
cell lines with chronic autophagy remains to be investigated.  
7.1.2 Proteotoxic stress might contribute to the proliferation defect of aneuploid cells 
The proteostasis network and the central hub protein HSP90 are crucial for 
functional cellular processes (da Silva and Ramos, 2012). We found that endogenous 
overexpression of HSF1 mitigates the proliferation defect compared to aneuploid cells 
without additional copy of HSF1 (Donnelly et al., 2014). This in turn suggests that 
compromised HSF1 transcriptional activity contributes to the growth defect of aneuploid 
cells. Reduced HSF1 transcriptional activity might result in slow cell cycle progression 
since HSF1 target genes include proliferation and mitogenic signaling genes (Santagata et 
al., 2013). Moreover, reduced HSF1 transcriptional activity and resulting low HSP90 levels 
might contribute to the impaired growth of aneuploid cells, since several cell cycle 
regulators are among the HSP90 clients including regulators of the G1/ S phase transition 
such as CDK 4, 6 and 2 and Cyclin D as well as Cyclin E (Burrows et al., 2004). In 
addition, the unbalanced proteostasis network and accumulation of aggregates might 
present a cellular stressor leading to reduced growth. In support, depletion of the 
deubiquitinating enzyme Ubp6, which results in acceleration of proteosomal substrate 
processing, increases the fitness of aneuploid yeast cells (Torres et al., 2010). Thus, I 
hypothesize that the cumulative effects of disturbed proteostasis and the consequential 
effects on cell physiology lead to growth defects in aneuploid cells (Figure 6).  
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7.1.3 Proteotoxic stress might affect genomic maintentance of aneuploid cells 
 Proteotoxic stress might also affect genome maintenance in aneuploid cell lines. 
Recent results demonstrate that human cells with additional chromosomes are sensitive to 
replication stress and exhibit increased GIN (Passerini et al., 2016). I demonstrated by 
proteome analysis that the aneuploid proteome landscape overlaps with the proteome of 
HeLa cells, in which HSP90 was inhibited (Donnelly et al., 2014). In particularly, DNA 
replication and other DNA-associated pathways were downregulated in both cases. This 
suggests, that impaired HSP90 function affects clients associated with genome 
maintenance. Indeed, impaired HSP90 function promotes GIN by various mechanisms 
(reviewed in (Kaplan and Li, 2012). For instance, HSP90 is important for several DNA 
repair pathways; for example by stabilization of the Fanconi anemia complex members 
HSP90 facilitates repair of DNA crosslinks (Oda et al., 2007). Moreover, inhibition of 
HSP90 impairs DNA double strand repair via its clients and has secondary effects on the 
RAD51 mediated homologous recombination (Noguchi et al., 2006). In addition, HSP90 
inhibition destabilizes CHK1 kinase and sensitizes cells to replication stress (Arlander et 
al., 2003). Since CHK1 is a key regulator of the cell cycle, DNA replication and origin 
firing upon DNA damage, depletion of CHK1 is detrimental for genomic stability. Based on 
these reports disturbed HSP90 function in aneuploid cells might play a role in aneuploidy 
driven genome instability. Moreover, affected CHK1 kinase might explain the sensitivity to 
replication stress. An intriguing possibility is that limited HSP90 function not only 
contributes to GIN in aneuploid cells but also mediates the adaptive potential of the cells. 
In wild type haploid yeast strains, a growth under HSP90 inhibiting conditions induced 
aneuploidy at high rates and conferred adaptations to various stress conditions (Chen et 
al., 2012a). Thus, GIN promoted by hampered HSP90 function may convey adaptation 
potential to adverse conditions. Future studies will shed light on the relation of impaired 
HSP90 function and GIN as well as the adaptability of aneuploid cells to stress conditions. 
 
7.1.4 Proteotoxic stress shapes the conserved transcriptional response to aneuploidy 
 It has become clear from various aneuploid model systems that the genome-wide 
expression is affected by aneuploidy (Upender et al., 2004; Torres et al., 2007; Nawata et 
al., 2011; Stingele et al., 2012; Hervé et al., 2016). Yet, whether these transcriptional 
changes are common to different aneuploid cell lines has not been systematically 
analyzed. My in-depth comparison of multiple different human aneuploid cell lines created 
in different laboratories and of different cell line origin or type of aneuploidy revealed that 
the transcriptional response is largely conserved (Dürrbaum et al., 2014). The 
conservation was found within the identity of deregulated pathway annotations; 
downregulation of DNA and RNA metabolic pathways and upregulation of endoplasmic 
reticulum, Golgi apparatus, lysosome and vacuoles as well as membrane metabolism 
associated pathways. The deregulated pathways overlap with the pathways that were 
found to be affected by aneuploidy in mammalian cell lines (Sheltzer et al., 2012). In 
yeast, the transcriptional response to aneuploidy closely resembles an environmental stress 
response (ESR) that characterizes a gene expression signature commonly observed upon 
various environmental stresses (Gasch et al., 2000; O'Duibhir et al., 2014). The pathways 
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affected in the ESR are partially overlapping with the pathways altered in the response to 
aneuploidy in mammalian cells. Particularly, RNA and ribosomal associated pathways are 
downregulated in response to aneuploidy in both yeast and mammalian cells (Sheltzer et 
al., 2012). In contrast, the upregulated pathways differ; for example genes associated with 
oxidative stress response and protein folding are upregulated in aneuploid yeast strain but 
not in mammalian aneuploids. Although the upregulated pathways in yeast and 
mammalian aneuploid cells differ in both cases, the altered pathways in mammalian cells 
might also reflect a stress response, such as the ESR in yeast.  
What are the factors shaping the conserved transcriptional response to aneuploidy? 
One limitation of the global transcriptional analysis of an adapted aneuploid cell 
population is that the conserved aneuploid pathway response pattern probably reflects 
both the primary and secondary effects of aneuploidy. The transcriptome might be directly 
influenced by the expression of genes encoded in the aneuploid regions. Some deregulated 
genes of the aneuploid regions, such as transcription factors, may further affect the 
genome-wide transcription including the expression of genes in disomic regions. As a 
secondary effect, the altered genome content per se affects the cellular physiology, which 
initiates a feedback to gene expression. We compared the transcriptional response to 
aneuploidy with the response to various stresses. Only the inhibition of autophagy results 
in similar pathway deregulations as aneuploidy (Dürrbaum et al., 2014). Given that in 
aneuploid cells autophagy is activated, these similarities might be rather counterintuitive. 
Since inhibition of autophagy causes proteotoxic stress (Doerr et al., 2013), one possible 
explanation is that the common transcriptome changes reflect the proteotoxic stress in 
both conditions. Further evidence for this comes from my comparative analysis with the 
transcriptome of human hepatocellular carcinoma cell line depleted for HSF1, that also 
shows large similarities to the transcriptional response to aneuploidy (Donnelly et al., 
2014). Thus, these results suggest that one factor shaping the conserved transcriptional 
response in aneuploid cell is proteotoxic stress.  
One of the complications in finding the determinants of the conserved 
transcriptional response is that the aneuploid phenotypes are interlinked: for instance 
proteotoxic stress is probably connected to the growth defect and GIN. This makes it 
difficult to clearly differentiate between primary and secondary responses. For example, 
the transcriptome of aneuploid yeast strains correlates with the transcriptome of yeast 
strains with delayed cell cycle progression due to mutations in regulatory cell cycle factors 
Cdc28 and Cdc23 (Torres et al., 2007). Moreover, the transcriptome of mammalian 
aneuploid cells also correlates with the transcriptome of these growth-delayed yeast 
strains (Sheltzer et al., 2012). Yet, in our analysis of aneuploid cells derived from a 
tetraploid intermediate that proliferate without any significant growth defect revealed 
similar pathway deregulations (Dürrbaum et al., 2014). In addition, aneuploid yeasts 
grown with the same proliferation rate as the diploid yeast strain still show transcriptional 
changes that are shared by most aneuploid yeast strains, but are not present in growth 
impaired mutant control strains, such as ribosomal biogenesis and nucleic acid metabolism 
associated genes (Torres et al., 2007). Thus, impaired proliferation might contribute to the 
transcriptional profile changes that arise in response to aneuploidy, but does not seem to 
be the major factor determining the aneuploidy response pattern.  
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Taken together, I hypothesize that the transcriptional response to aneuploidy is 
determined by the cumulative physiological consequences of aneuploidy (Figure 6). Most 
of the physiological consequences can be explained by the impact of proteotoxic stress, in 
particular compromised HSF1 and HSP90 function, on cellular processes. This shapes 
directly, via HSF1 transcriptional activity, or indirectly, via transcriptional feedback of the 
affected pathways, the conserved transcriptional response to aneuploidy.  
Figure 6. The physiological and conserved transcriptional response to aneuploidy is shaped by 
proteotoxic stress. Addition of chromosomes results in increased mRNA expression and protein 
levels. This additional unbalanced expression presents a burden for proteostasis that might be 
the cause of the observed protein deposits and increased autophagy. The activity of the 
transcription factor HSF1 is reduced by as yet unknown mechanisms. In turn, both protein 
aggregates and reduced HSF1 activity may lead to compromised HSP90 function. Diminished 
HSP90 function may impair growth of aneuploid cells and facilitate genomic instability. These 
altered cellular functions and the reduced activity of HSF1 transcription factor may feed back 
to transcription, resulting in conserved transcriptional changes. 
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7.2 Implications of the transcriptional response to aneuploidy in cancer 
Since many cancer cells are aneuploid, the question arises whether a similar 
transcriptional profile as detected in model aneuploid cell lines can be identified in 
aneuploid cancer. In the transcriptional analysis of cancers, so called “gene signatures” are 
often employed that describe a group of genes for which the expression correlates with 
certain cancer characteristics (Chibon, 2013). To assess the implication of the 
transcriptional response to aneuploidy in cancer, we can evaluate the correlation of these 
signatures with aneuploidy and then compare the pathways for which the gene signatures 
are enriched with the deregulated pathways in aneuploid cells. Several transcriptional 
analyses of aneuploid cancers revealed gene expression signatures that correlate with 
aneuploidy and/or chromosomal instability (reviewed in (Dürrbaum and Storchova, 
2015a)). For instance, the previously identified CIN70 signature contains 70 genes, for 
which high expression correlates with the overall ploidy across diverse tumor types (Carter 
et al., 2006). Moreover, a signature correlating with karyotype heterogeneity in the 
NCI-60 cancer cell line panel and high expression of the involved genes was predictive of 
poor prognosis (Sheltzer, 2013). These signatures are enriched for genes with a function 
in proliferation and cell cycle regulation, mitosis, replication and DNA damage repair and 
high expression of these genes predicts poor prognosis. However, genes involved in these 
processes are largely downregulated in the conserved transcriptional pathway response in 
aneuploid model systems (Dürrbaum and Storchova, 2015b; Dürrbaum et al., 2014; 
Sheltzer et al., 2012; Torres et al., 2007). Similarly, the mean expression levels of nine 
cancer subtypes anticorrelate with gene expression levels from trisomic mouse embryonic 
fibroblasts (Sheltzer, 2013). As a result, the pathways that are enriched among the 
upregulated genes in cancer are among the downregulated pathways in aneuploid cells. 
This includes the cell cycle, DNA repair, transcriptional and chromosome associated 
pathways, which were found in the conserved transcriptional response in aneuploid model 
cell lines. Among the pathways that are upregulated in aneuploid cells and downregulated 
in cancer are mainly membrane-associated pathways. Few pathways are still commonly 
upregulated, such as ER to Golgi transport vesicle, extracellular matrix binding and 
protease binding associated pathways (Sheltzer, 2013). Thus, the global gene expression 
deregulation in aneuploid model cell lines and cancer does not correlate. This is reflected 
in the inverse deregulation of pathways that were found in the conserved transcriptional 
response to aneuploidy. 
How can we explain this anticorrelation of the transcriptional response? First of all, 
it reflects the generally opposite phenotypes of aneuploid model cell lines and aneuploid 
cancers, most prominently the proliferation defect observed in aneuploid model cell lines 
versus the unlimited proliferation of cancer cells. As discussed above, an imbalanced 
proteostasis network most likely causes the phenotypes of aneuploid cells. The question 
arises, whether this is different in aneuploid cancers. Tumorigenesis is associated with 
multiple stress phenotypes such as DNA damage stress, mitotic stress, metabolic stress, 
oxidative stress and also proteotoxic stress (Wondrak, 2014). A variety of exogenous and 
endogenous stimuli such as hypoxia, nutrient deprivation and mutation-driven misfolding 
of proteins but also aneuploidy result in accumulation of unfolded and misfolded proteins, 
which in turn challenges proteostasis (Clarke et al., 2012; Dai et al., 2012; Feldman, 
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2005). Yet, evidence described below suggests that in the course of tumorigenesis, the 
cancer cells evolve various mechanisms to counteract the stresses and to promote cell 
survival. The adaptation mechanisms to the various stresses experienced by cancer cells 
are multifold including mutations and copy number variations. Large-scale analysis of over 
8,200 tumors demonstrated that somatic copy number alteration are non-random, but 
specifically selected for regions with known tumor suppressors or oncogenes (Davoli et al., 
2013). Interestingly, the fourth most frequent amplification is the 8q chromosome arm on 
which HSF1 is encoded. Indeed, HSF1 is frequently upregulated in different human 
cancers such as in human colorectal cancer, breast cancer and endometrial carcinoma 
(Jiang et al., 2015; Mendillo et al., 2012). We show that additional copies of HSF1 
mitigate the effects of proteotoxic stress in our aneuploid model cell lines (Donnelly and 
Storchova, 2015). Therefore, one possibility would be that copy number gain of HSF1 in 
cancer presents a way to counteract proteotoxic stress. Overcoming the proteotoxic stress 
and the secondary adaptive changes through higher levels of chaperons and their 
interactors would ultimately lead to a different transcriptional response than in aneuploid 
cells.  
Another possibility how the adaptation to cellular stresses such as proteotoxic 
stress results in a different transcriptional program in cancer cell lines compared to 
aneuploidy model cell lines comes from genome-wide analysis. Analysis of the HSF1 
occupancy and transcription activity revealed that the HSF1 transcriptional program in 
malignant cells differs from the heat shock program (Mendillo et al., 2012). Although it 
includes some heat shock proteins such as HSP90, multiple cellular processes are activated 
in addition such as translation, cell cycle, DNA repair and chromatin remodeling. 
Moreover, this HSF1 transcriptional response was conserved across a panel of cancer cell 
lines. These transcriptionally activated pathways were downregulated in response to 
aneuploidy. In the context of the cellular stresses cancer cells experience, gain of 
additional copies of HSF1 may result in a malignancy specific transcriptional response that 
fundamentally differs from the conserved response to aneuploidy. 
In summary, the effects of aneuploidy per se in model cell lines result in an 
anticorrelated transcriptional response compared to aneuploid cancer cell lines. I 
hypothesize that this is the result of adaptive mechanisms in cancer cells that counteract 
the proteotoxic stress response. The resulting transcriptome changes differ from the 
transcriptional response in aneuploid model cell lines that suffer from proteotoxic stress. 
7.3 microRNA regulation of the response to aneuploidy in human cells 
Given the conserved transcriptional changes in response to aneuploidy and 
diversity of the affected pathways, we hypothesized that multiple different factors may 
affect the transcriptional consequences of aneuploidy. One recently discovered route of 
gene expression regulation is via miRNA post-transcriptional regulation of mRNA levels 
and translation. The deregulation of miRNAs is associated with cancer and altered cancer 
cell physiology (for example reviewed in (Chen et al., 2012b; Peng and Croce, 2016; 
Svoronos et al., 2016)). However, the relation between miRNA regulation and the 
response to aneuploidy per se has not been studied so far. In some cancers, the copy 
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number changes are a direct source of the miRNA deregulation (Calin et al., 2004; 
Ramsingh et al., 2013; Veigaard and Kjeldsen, 2014). We found that indeed an addition of 
one or more chromosomes alters the miRNA expression in human cell lines. Interestingly, 
only in a minority of aneuploid cell lines the extra chromosome directly affects the 
expression of miRNAs encoded on that chromosome. Thus, our results suggest that miRNA 
deregulation in aneuploid cells is a general response to the extra chromosomes.  
 How do the deregulated miRNA contribute or regulate the response to aneuploidy? 
Based on our analysis, the deregulated miRNAs particularly affect cellular development, 
growth and proliferation. We show that it is not a single miRNA, but the cumulative effect 
of the deregulated miRNAome that targets cellular proliferation. Similar synergistic effect 
of the miRNAome on target repression was demonstrated for example in gastric 
(Hashimoto et al., 2013) and lung cancer (Kumar et al., 2013). This may be explained by 
the fact that one miRNA targets multiple transcripts and one transcript is targeted by 
multiple miRNAs (Zhou et al., 2013). As discussed above, impaired proliferation is one of 
the cardinal features of the response to aneuploidy. Our target expression analysis of the 
deregulated miRNAs revealed, that majority of the targets with inverse expression to the 
corresponding miRNAs are downregulated. Many of these targets are involved in cell cycle 
regulation such as BUB1, CDC20, CDK4 and Cyclin E1. Our analysis provides the first 
indications that the deregulated miRNAome might contribute to the reduced proliferation 
of aneuploid cells. Importantly, the individual deregulated miRNAs and the individual 
affected targets are different between the aneuploid cell lines. Hence, although similar 
functions are affected by the deregulated miRNAs, different aneuploid cell lines achieve 
this by different means. This is remarkably similar to the findings in the global 
transcriptome analysis where the affected pathways are conserved but the individual genes 
causing or contributing to the pathway deregulation are different.  
 We found that the identity of the deregulated miRNAs in the aneuploid cell lines 
largely differs. One of the commonly deregulated miRNAs is hsa-miR-10a-5p that is 
upregulated in 5 out of 7 sequenced cell lines. Our data suggests, that the reason for 
hsa-miR-10a-5p overexpression in response to aneuploidy is due to a 3’UTR independent 
function of hsa-miR-10a-5p. hsa-miR-10a-5p binds downstream of the 5’TOP motif of 
ribosomal protein mRNAs (Ørom et al., 2008). The 5’TOP motif is characteristic for 
mRNAs of proteins involved in translation, mainly ribosomal proteins (Hamilton et al., 
2006). Binding of hsa-miR-10a-5p enhances 5’TOP motif mRNA translation and alleviates 
starvation-induced relocation from active polysomes to inactive sub-polysomal fractions 
(Ørom et al., 2008). We found that overexpression of hsa-miR-10a-5p enhances 5’TOP 
motif mRNA translation in the analyzed aneuploid cell lines. Further, we demonstrated 
that the elevated expression of hsa-miR-10a-5p in aneuploid cells renders them less 
sensitive to translational downregulation of mRNAs with the 5’TOP motif. Currently, we 
do not understand the exact reason for the protection against starvation stress by hsa-miR-
10a-5p overexpression. One hypothesis is that the extra chromosomes in aneuploid cell 
lines infer a higher requirement for the translation machinery, in particularly under stress 
conditions. Common upregulation of hsa-miR-10a-5p expression might be an adaptation 
mechanism of aneuploid cells. Further studies are required to test whether the 
overexpression of hsa-miR-10a-5p in cells with extra chromosomes indeed protects them 
from adverse growth conditions such as starvation or amino acid deprivation. 
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In summary, we show for the first time that the miRNAome is altered as a response 
to aneuploidy per se. The deregulated miRNAs may affect the response to aneuploidy in 
two different ways. First, the deregulated miRNAome seems to negatively affect 
proliferation, thus suggesting a contribution to the growth impairment of aneuploid cells. 
Second, the conserved upregulation of hsa-miR-10a-5p in aneuploid cell lines may present 
an adaptation to the aneuploid stress conditions and grants a robust translation under 
adverse conditions such as starvation. This would suggest upregulation of hsa-miR-10a-5p 
as a crucial mediator of survival of aneuploid cells. Future studies will reveal its potential 
in aneuploid cancer research. 
7.4 Tolerance to genomic instability in post-tetraploid cells and its implications in cancer 
Large-scale analysis of 4934 cancers revealed that approximately 37% of cancers 
underwent tetraploidization during tumorigenesis (Zack et al., 2013). This suggests that 
tetraploidization might be beneficial for tumorigenesis. Yet, induction of tetraploidy often 
results in cycle arrest, in majority of the cases by p53 activation (Andreassen et al., 2001; 
Castedo et al., 2006; Ganem et al., 2009; Kuffer et al., 2013; Lanni and Jacks, 1998). How 
cancer cells survive genome-doubling and how the survived cells contribute to the tumor 
development has not been fully understood. To elucidate the consequences of whole-
genome doubling, we induced tetraploidization and followed the fate of surviving 
post-tetraploid cells (Kuznetsova et al., 2015). We found that tetraploid progenies are 
highly aneuploid and often show elevated rates of chromosome missegregations and 
abnormal mitosis. Moreover, these post-tetraploid cells are more tolerant to these errors, 
as they arrest less frequent than diploids or tetraploid cells immediately after 
whole-genome doubling. Also evolved naturally occurring tetraploids show high CIN 
(Dewhurst et al., 2014), suggesting that karyotype instability is a characteristic outcome of 
whole-genome doubling survival. My in-depth transcriptome analysis of the post-tetraploid 
cells revealed possible molecular mechanisms for the tolerance to mitotic errors. The 
expression of one fourth of p53 interactors is changed in chromosomally unstable 
post-tetraploid cell lines (Kuznetsova et al., 2015), among them commonly upregulated 
expression of the inhibitor of apoptosis-stimulating protein of p53 (iASPP), which is a 
negative regulator of p53. Moreover, nuclear accumulation of p53 is diminished in these 
cells. These results suggest that overriding the p53 response is the underlying mechanism 
of the tolerance to mitotic errors. This is supported by transcriptome analysis after acute 
tetraploidization by cytokinesis inhibition that revealed activation of the p53 pathway in 
retinal epithelial cell lines (Potapova et al., 2016). In addition, knock down of p53 or p21 
resulted in increased proliferation. Taken together, cells that survived tetraploidization are 
unstable, probably due to a diminished p53 response. Tumors that have undergone a 
whole-genome doubling event exhibit a high genome instability score (Dewhurst et al., 
2014). Since TP53 mutations and alterations of the p53 pathway are common in cancer, 
abrogation of the p53 response might present one way to allow karyotype instability also 
in tetraploid cancers.  
Tetraploidy is associated with poor prognosis based on survival analysis of 
colorectal cancer patients (Dewhurst et al., 2014). Given that genome instability in cancer 
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correlates with tumor aggressiveness as well (Carter et al., 2006; reviewed in McGranahan 
et al., 2012), this suggests that the tolerance to genome instability in tetraploid cells 
confers an advantage for tumorigenesis. We found that chromosomal instable 
post-tetraploid cells show increased tolerance to a broad spectrum of chemotherapeutic 
drugs (Kuznetsova et al., 2015). Moreover, the transcriptome analysis revealed 
upregulation of pro-proliferative genes and downregulation of proapoptotic genes. These 
results suggest that post-tetraploid cells have a general tolerance to adverse stress 
conditions. One possibility is that higher rates and tolerance to karyotype instability 
endows higher adaptive potential to cellular stress as experienced by cancer cells. In the 
cancer context, surviving post-tetraploid cells might therefore benefit the adaptability of 
tumors. Thus, the elevated genome instability and the increased tolerance to stresses 
might bring major advantages to the cells in the changing environment during tumor 
development. Therefore, tetraploidization observed early in tumor development probably 
benefits tumor evolution and aggressiveness. 
 
7.5 Big data in aneuploidy research – conclusions and perspective 
 The work presented in this thesis aimed to elucidate the effects of aneuploidy per 
se on the cell physiology in human aneuploid model cell lines with defined 
whole-chromosome aneuploidy or post-tetraploid cells with complex aneuploidy by 
applying transcriptome, miRNAome and proteome data analysis. This approach is unique 
as it allows global quantitative analysis of the response to aneuploidy within a cell line and 
large-scale comparison between different model systems.  
 What becomes evident from the transcriptome analysis of aneuploid cells is that 
the differential expression of individual genes is largely unique for different 
whole-chromosome and also complex aneuploid cells, but the affected pathways are 
similar (Dürrbaum et al., 2014; Kuznetsova et al., 2015; Potapova et al., 2016; Sheltzer et 
al., 2012). This suggests that while the ultimately affected pathways are the same and 
reflect common adaptation mechanisms, aneuploid cells undertake different evolutionary 
routes to adapt to the abnormal karyotype. In cancer, the adaptation to aneuploidy results 
in an inverse transcriptional response compared to aneuploid model systems (Sheltzer, 
2013). The landscape of mutations and genomic aberrations is highly diverse between 
cancers and different combinations of tumor suppressor inactivations or oncogene 
activations may promote tumor development (Vogelstein et al., 2013). Yet, the ultimate 
resulting hallmarks of cancer such as unlimited proliferation, resistance to cell death, 
increased invasion ability and metastasis are common to all cancers. Thus, similar as in the 
response to aneuploidy, the adaptation routes of cancer cells are diverse, but the resulting 
affected pathways are the same. This suggests that in both cases, the conserved altered 
cellular functions are evolutionary favored and selected for. 
 The aneuploidy research has greatly benefited from the cancer sequencing projects. 
With the access to public databases of high-throughput genome, transcriptome and 
proteome data, it is nowadays possible to translate hypotheses drawn from studies in 
model cell lines to cancer by meta-analysis of cancer genome and transcriptome data. For 
instance, published transcriptome and corresponding patient outcome data allowed to test 
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whether significant alterations in chromosomal instability associated genes is of clinical 
relevance (Sheltzer, 2013). The net expression levels of these genes are predictive for 
cancer progression and patient outcome. In another study, published survival and 
SNP-array data from 539 patients was used to verify the association of whole-genome 
doubling events with poor prognosis (Dewhurst et al., 2014). Thus, whereas the “omics” 
perspective on aneuploid model cell lines helps us to understand the effects of aneuploidy 
per se, the rapidly growing amount of data in cancer research allows to test the relevance 
of the observed effects in model cell lines in tumorigenesis. 
 Besides the new possibilities through the technical advances of big data science, 
there are two major obstacles in big data driven aneuploidy research as presented in this 
thesis. First, the cellular heterogeneity within an aneuploid tumor population and also 
within aneuploid cell lines masks the differences in the aneuploidy response that may 
occur only in a subset of the cell population. Although single cell sequencing has advanced 
our understanding of the occurrence of aneuploidy during tumor evolution (Navin et al., 
2011), most major cancer genome studies are based on high-throughput analysis of a 
whole tumor cell population. Moreover, the current state-of-the-art sequencing parameters 
do not allow to characterize an aneuploid or clonal heterogeneous tumor sample in-depth 
(Griffith et al., 2015). Single-cell analyses have given insights into the heterogeneity and 
stochasticity of gene expression in healthy tissue (reviewed in (Yu and Lin, 2016)). Given 
the additional genome changes and evolutionary adaptation in tumor cells, this complexity 
probably scales by orders of magnitude. Single cell sequencing of a wide range of tumors, 
but also of aneuploid model cell line systems, might reveal new aspects of the 
consequences of aneuploidy in terms of hidden population patterns in aneuploid 
subpopulations and the connectivity and interactions between the subpopulations. Yet, 
besides providing researchers new opportunities to understand aneuploidy, single cell 
sequencing poses additional challenges in respect to data complexity and variety to 
computational biologists. For example, the analysis of single cells is much more prone to 
technical artifacts and noise as the analysis of a whole population. In addition, having the 
information of multiple single cells of multiple tumors multiplies this problem. To account 
for this, new computational tools and approaches are being developed. Continued 
improvement of single cell analysis opens up new avenues for capturing the variation 
within a tumor and based on that a personalized cancer therapy. 
 A second limitation of the current large-scale aneuploid “omics” paradigms is that 
these reflect mostly a steady state picture of the aneuploid cell. This is exemplified by the 
conserved transcriptional response to aneuploidy in diverse model systems, which poses a 
challenge to dissect primary gene expression changes from secondary transcriptional 
feedback. Time-resolved “omics” analysis would therefore accelerate the comprehensive 
understanding of the evolutionary adaptation mechanisms. Since the evolutionary routes 
might be multifold, only a large-scale study would allow drawing conclusion on the 
favorable evolutionary paths of the adaptation to aneuploidy. Insights into the key 
processes important for the adaptation to an abnormal karyotype might provide novel 
therapeutic strategies to target aneuploidy in cancer. 
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